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Abstract 
The molybdo-enzyme xanthine oxidase (XO) accelerates hydroxylation of a range of planar 
aromatic substrates such as purines. The enzyme has been associated with a number of 
medical conditions including hyperuricemia (gout), therefore screening for possible clinical 
inhibitors is being actively pursued. This thesis is concerned with the design and preparation 
of luminescent probes to investigate metallo-enzymes. 
Luminescent probes have been prepared, based on a water-soluble zinc porphyrin derivative, 
an aromatic linker and a simplified substrate. The synthesis was performed initially with 
tetraphenyl porphyrin (TPP) rather than the water-soluble derivatives. TPP was 
monofunctionalised by nitration followed by reduction to give the corresponding amine. 
DCC mediated amide coupling was used to link the porphyrin to 2-methoxy-4-nitrobenzoic 
acid, the linker. The nitro substituent was reduced selectively using indium and ammonium 
chloride to give the corresponding amine. A second 2-methoxy-4-nitrobenzoic acid unit 
was coupled and reduced in the same way to give probes of different lengths. The 
spectroscopic properties of the TPP compounds were dependent on solvent and the nature of 
the terminal substituents (nitro vs. amine). 
The trismethyl pyridinium (TMPyP) analogues were synthesised by coupling the linker 
followed by the substrate, isonicotinic acid anhydride. The compounds were characterised 
by 1H, 13C NMR (COSY, HMQC, HMBC), FTIR, UV-Vis spectroscopy, ESI-MS and 
fluorimetry. A [Ru(bpy)2(phen)]2+ analogue was crystallographically characterised in order 
to demonstrate the presence of an intramolecular hydrogen bond between the amide proton 
and the methoxy oxygen on the neighbouring ring. 
Enzyme affinity bioassays were carried out and IC50 values were calculated for potential 
substrates, substrate-linker compounds and probes and were converted to K, values. In order 
for the probe to be displaced by a potential inhibitor, a moderate affinity is required. This 
was achieved for the isonicotinic acid derivative Kf =31.9 ± 0.3 µmol (allopurinol Ki = 1.37 
± 0.36 pmol), appropriate for this application. Binding of the probes to the enzyme caused a 
red shift in the porphyrin absorption and quenching of the luminescence. 
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CHAPTER 1 
INTRODUCTION 
Chapter 1 Introduction 
1. Introduction 
1.1. Xanthine Oxidase 
1.1.1. Structure and Reactivity 
Xanthine oxidasel is a multifunctional enzyme occurring across a diverse range of species, 
from bacteria to humans, and tissues, ranging from the liver to the brain. It belongs to a 
family of hydroxylase enzymes which catalyse hydroxylation of otherwise stable carbon 
centres using oxygen derived from water. Within this class are the xanthine oxidoreductases 
(XORs), xanthine dehydrogenase (XDH) and xanthine oxidase (XO). XDH uses NAD+ as 
the terminal electron acceptor, XO uses molecular oxygen. The human form of XO is 
converted from the native form, XDH, by proteolysis of the enzyme polypeptide chain or 
oxidation of sulfhydryl residues. This results in a conformational change at the electron 
acceptor binding site so that NAD+ can no longer fit2'3. 
The crystal structure of XDH (Figure 1.1) reveals a 300 kDa homodimer4. Each monomer 
functions as an independent catalytic unit containing one flavin adenine dinucleotide (FAD), 
one molybdenum-pterin centre and two iron-sulfur clusters. Modification of the cysteine 
residues causes a structural rearrangement around the FAD site which alters the reactivity 
towards the substrate at that active site2. However, the substrate specificity at the 
molybdenum centre is unaffected. Since this is the active site of interest for the purpose of 
this work, it will be XO activity which will be further discussed. However, the principles 
outlined will apply equally to the oxidoreductases in general. 
1 
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Figure 1.1: Crystal structure of the xanthine dehydrogenase homodimer5; colours 
correspond to structure types: protein scaffold (green, pink), FAD (blue), molybdenum- 
pterin centre (red) and salicylate (orange). Original in colour. 
The enzyme catalyses the hydroxylation of aromatic heterocycles, such as purines, 
pteridines and aromatic aldehydes': 
RH + H2O ROH + 2H+ + 2[e-] 
This reaction occurs at a molybdopterin active site, which contains oxygen and sulfur 
ligands coordinated to the Mo centre as shown in Figure 1.26. A recent report by Doonan 
el al. 7 confirms that the Mo=O is apical and the Mo=S is in the equatorial position (A) and 
that the remaining ligand is OH rather than OH-). It is thought that the Mo=S group 
participates in catalysis as a proton or a hydride acceptor. 
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A 
Glu 802 
Phe 914 
Phe 1009 
Glu 1261 )'Arg 
880 
0 
B0H SH 
HEN N SH 
C 
S-Mo-OH 
NH2 NN0 CH2OPO3 
H 
Figure 1.2 (A) The active site of XOR8, colours correspond to atoms: carbon: mauve; 
nitrogen: blue; oxygen: red; sulfur: yellow; molybdenum: green; phosphorus: orange; bound 
salicylate: orange; (B) structure of the pterin cofactor, (C) structure of the Mo centre: 
approximately square planar coordination geometry, with M=O at the apical position, the 
bidentate enedithiolate ligand form Mo=S and Mo-OH groups in the equatorial plane. 
Original in colour. 
The oxidation of xanthine to uric acid is particularly important in the catabolism (energy- 
releasing breakdown) of ATP as shown in Figure 1.3. 
3 
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HP042- 
H+ 
ADP 
HPO42- 
H+ 
AMP 
5' nucleotidase 
0 
<Dl 
NH XO 
HN 
Hypoxanthine 
Adenosine 
deaminase 
e 
0 
N 
NH 
XO (/\N 
NO HH 
Xanthine 
Inosine 
phosphorylase 
Hypoxanthine 
0 
H 
N 
NH I 
,ý NNO HH 
Uric Acid 
Figure 1.3 Catabolism of ATP to uric acid. 
The reaction is likely to proceed via discrete two electron steps, as illustrated in Figure 1.4. 
The Mo active site is reduced from Mo(VI) to Mo(IV), coupled with hydride transfer. The 
oxidised Mo(VI) site is regenerated by two sequential one electron transfers to a second 
4 
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active site, an FAD, via 2 Fe2S2 clusters, where a second substrate, NAD+ in XDH but 
molecular oxygen in XO, is reduced9. The initial step is base catalysed by G1u1261, 
generating Mo-O- which attacks the C-8 position of xanthine, which is intercalated between 
the phenylalanine residues. This is followed by hydride transfer to yield LMo(IV)O(SH)-P 
(L = pyranopterin cofactor). Isotope-labelling studies have shown that a catalytically labile 
site (Mo-OH) donates the oxygen atom which is incorporated into the product. This site is 
regenerated with oxygen from neighbouring water when the product is displaced1°. 
O 
S-Mllyý S 
6ký 
1 O 
GIu1261---LO 
O 
ý S-Ml 
ivl_S 
S/ 
\OH 
=---O 
P, e HO-, 
Figure 1.4 Postulated catalytic mechanism for XO10, P= uric acid. 
co 
5 
H+, e 
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1.1.2. Associated Medical Conditions and XOR Inhibitors 
A number of medical conditions are associated with XO. It is released into the circulation 
from XO rich organs (such as the liver or intestine) at times of metabolic stress and during a 
number of pathological states. A build up of uric acid as a result can cause conditions such 
as hyperuricemia or gout. The release of oxygen-derived free radicals leads to tissue 
damage. This has also been linked to NO activity resulting in vascular constriction or 
combination of the superoxide radical with NO directly to form the even more reactive 
species ONOO`. Increased concentrations of XO have been found in tumours and it is 
believed that XO is associated with heart failure, cancers, and vascular problems. A build 
up of uric acid as a result can cause conditions such as hyperuricemia or gout. Therefore, 
there are a host of potential medical applications for XOR inhibitors to block the activity of 
the enzyme, the most commonly used being allopurinol. 
Allopurinol is a suicide inhibitor of XOR. It is likely that the conformation of the nitrogen 
atoms in xanthine is crucial to the hydride transfer mechanism. In the case of allopurinol, 
the substrate is oxidised to alloxanthine, which binds tightly to the molybdenum as 
illustrated in Figure 1.5. Despite being successfully used for several decades as a clinical 
inhibitor of XOR for the prevention of gout, regular, high doses are required, and unpleasant 
side affects are known. For this reason there is a prevailing push to discover new, effective 
clinical inhibitors of XOR. 
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Glu 232 
Introduction 
Arg 310 
Glu 730 
0 
H \N HBO 
N 2e, -2H N 
H 
Allopurinol 
O 
ONN 
HH 
Alloxanthine 
Figure 1.5 The active site of XO bound by allopurinol, colours correspond to atom 
types: carbon: mauve; nitrogen: blue; oxygen: red; sulfur: yellow; molybdenum: 
green; phosphorus: orange. Original in colour. 
A thorough review of XOR inhibitors by Borges, Fernandes and Roliera' 1 lists a range of 
compounds which bind near the molybdenum cofactor (MoCo) active site. The scope of the 
review highlights the low specificity of the enzyme, binding a range of heterocyclic systems 
containing one to three rings. The most potent inhibitors are planar aromatic systems with 
hydrogen bonding substituents, which are stabilised in the active site by corresponding 
hydrogen bonding residues and it-stacking. 
7 
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Okamoto et a1.12 have investigated a number of non-purine inhibitors. Each has similar 
binding characteristics, exhibiting mixed-type inhibition. The crystal structures show that 
the inhibitors bind in the long, narrow channel leading to the Mo active site. Inhibition is 
achieved by filling the immediate environment of the cofactor, preventing substrate binding. 
The inhibitors are held in place by hydrogen bonds and hydrophobic interactions, without 
directly binding to the molybdenum. 
TEI-6720 (2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid) is an 
extremely potent inhibitor of XO. Unlike allopurinol, it remains unchanged when recovered 
from XO (i. e. no hydroxylation) since it is not coordinated to the molybdenum cofactor. 
The inhibitor is bound by six hydrogen bonds and one charge-charge interaction, Figure 
1.6. The carboxylate group is the most tightly bound, located in the same position as that of 
salicylate in Figure 1.14. The thiazole ring is sandwiched between the two phenylalanine 
residues providing aromatic/aromatic interactions also observed with salicylate. A host of 
hydrophobic interactions also stabilise TEI-6720 in the channel. The advantage of this 
inhibitor is that it binds tightly to both the oxidized and reduced forms and is not influenced 
by the oxidation state of the metal, whereas oxypurinol only binds to the reduced form and 
the oxypurinol inhibited enzyme can be reactivated at tl2 = 300 min by spontaneous 
reoxidation of the molybdenum cofactor. TEI-6720 is now in clinical use as Febuxostat13. 
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F 
(C) 
HO 
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73 648 
91 
e64 
Iniroduclion 
Figure 1.6 (A) Crystal structure of TEI-6720 bound in the XO active site'4; (B) 
Interaction of TEI-6720 with residues lining the access channel to Mo-pterin, colours 
correspond to atoms: carbon: mauve; nitrogen: blue; oxygen: red; sulfur: yellow; 
molybdenum: green; phosphorus: orange; (C) chemical structure of TEI-6720. Original 
in colour. 
In contrast, the inhibitor FYX-051 Figure 1.7. is slowly hydroxylated by the enzyme. 
This reaction is accompanied by an increase in absorption at 640 nm and a decrease at 430 
nm, corresponding to the formation of a charge transfer complex between the reduced Mo 
centre and the hydroxylated inhibitor. As previously, the inhibitor is bound in the solvent 
access channel to the molybdenum active site. In this instance, electron density is observed 
between the Mo centre and the pyridine ring, suggesting a covalent bond to the C2 of FYX- 
051, which is hydroxylated. Several hydrogen bonds and electrostatic interactions stabilise 
9 
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the inhibitor in the channel, as dercribed previously. Similarly the triazole ring is 
sandwiched between the two phenylalanine residues. 
CN 
NN G// 
iNý/ 
HN-N 
(s) 
(C) 
Figure 1.7 (A) FYX-051, (B) and 2-OH-FYX-051 produced by hydroxylation by the 
enzyme, (C) bound FYX-051 (purple) in the active site of XO16, colours correspond to 
atoms: carbon: mauve; nitrogen: blue; oxygen: red; sulfur: yellow; molybdenum: green; 
phosphorus: orange. Original in colour. 
Y-700 (1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-l H-pyrazole-4-carboxylic acid)" is a 
newly synthesized inhibitor of XO. Titration experiments showed that Y-700 bound tightly 
to the active site of the enzyme. Like TEI-6720, Y-700 closely interacts with the channel 
leading to the molybdenum-pterin active site but does not directly coordinate to the 
molybdenum ion. Y-700 is currently being investigated for its potential in clinical treatment 
of hyperuricemia and a number of other XOR-associated diseases. 
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Figure 1.8 Left: Crystal structure of XO bound Y-70018; Right: Y-700. Original in colour. 
Recently Krenitsky has demonstrated that XORs are useful for designing and utilising pro- 
drugs'9. Drugs which are not easily absorbed by the body can be administered in an inactive 
but easily absorbed form, which is converted (e. g. by XO) to the active drug. For example 
acyclovir { 9- [(2-hydroxyethoxy)methy! guanine }' an antiherpetic agent commercially 
known as Zovirax, has limited absorption in humans after oral administration. 6- 
Deoxyacyclovir {2-amino-9-[(2-hydroxyethoxy)methyl ]-9H-purine}, a congener, is 18 
times more water soluble but lacks the required activity. However, deoxyacyclovir is 
readily oxidised to acyclovir by XO and may therefore be used as a prodrug suitable for oral 
administration. 
In summary, XORs have enormous biological significance, which may be both beneficial 
and detrimental. It would be useful to study the molybdenum cofactor active site in detail to 
obtain further information on the structure, function and reaction mechanisms of these 
multi-substrate, multi-functional enzymes. Such information could include studying the 
reaction mechanisms, development of possible clinical inhibitors, substrate selectivity, 
11 
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cooperativity, mechanisms of drug action and metabolism, and provide insight into the 
circulatory and antibacterial activity of XORs. 
1.2. General Features of Luminescent Probes 
1.2.1. Structure 
Photochemical devices such as `sensors' or `probes' are used to transmit information about 
events occurring on a microscopic or nanoscopic scale via light signalling. They are 
designed to perform with high sensitivity, on-off switch-ability, ease of communication and 
a rapid response. They can be specifically constructed to suit a range of applications and 
2o target analytes, 21 
The general principle is to attach a signalling unit (luminophore) covalently to the binding 
unit via a bridge which will enable communication between the two22. Binding of a 
substrate to the receptor unit is communicated to the signalling unit by energy transfer or 
electron transfer and the information is reported as a change in the luminescent properties. 
Each of these distinct components can be specifically designed according to the intended 
application to maximise supramolecular interactions, tune the spectroscopic properties and 
redox potentials of the components and to achieve the required solubility of the molecule. 
A simple example reported by de Silva23 is the azacrown ether shown in Figure 1.9. 
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Figure 1.9 A potassium ion sensor reported by de Silva23. 
Introduction 
This molecule shows large fluorescence enhancements when `switched on' by incorporation 
of alkali metal ions, because quenching of the anthracene fluorescence by the nitrogen lone 
pair is prevented on binding of sodium or potassium ions. The sensor was selective as it did 
not respond to lithium ions. 
1.2.2. Mechanism of Communication 
Photochemical molecules often operate by means of photoinduced energy transfer24. The 
luminophore (L) absorbs a photon which promotes it to an excited state (1). 
L+hv -* 
(1) 
*L is a high energy species, which can decay by a number of pathways, such as 
photochemical reaction, radiative decay (emission of light or luminescence), non radiative 
decay (conversion of excitation energy to heat) or quenching processes by interaction with 
another molecule. The emission can be described as fluorescence or phosphorescence 
depending on whether it originates from an excited state of the same (spin allowed) or 
different (spin forbidden) spin as the ground state. Quenching of the luminescence can 
occur by energy transfer (2), which can be radiative or non-radiative, or electron transfer (3). 
*L+Q--*L+*Q 
(2) 
*L+Q-+L++Q- 
(3) 
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Radiative energy transfer (4) may occur over any distance, the emitted photon is simply 
intercepted: 
--L+hv' 
hv' +Q .+ 
(4) 
Non-radiative energy transfer can occur when there is an interaction between *L and Q 
where (*L + Q) is isoenergetic (i. e. at resonance) with (L + *Q). This mechanism is 
subdivided into electron exchange (Dexter mechanism25) and coulombic energy transfer 
(Förster mechanism26) which are illustrated in Figure 1.10. 
coulombic 1 30 
,ýýý interaction 
electron 
ý"-`ý exchange _, r 
L* QL Q* 
Figure 1.10 A schematic representation of the the Förster mechanism (top) and the Dexter 
mechanism (bottom) for a non-radiative energy transfer mechanism24. 
The electron exchange mechanism requires short donor-acceptor distances, i. e. contact, 
between *L and Q since it depends on orbital overlap. The electrons are simultaneously 
transferred when favourable overlap of the corresponding orbitals takes place on collision24. 
In order to compete with diffusion, long-lived excited states are required. Therefore, this is a 
common mechanism for energy transfer from inorganic chromophores for which the first 
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triplet excited state is sufficiently long lived22. Since overall spin is conserved, this 
mechanism enables processes to occur that would be spin-forbidden by direct conversion. 
The coulombic or electrostatic mechanism takes place via the electromagnetic field, so no 
contact between *L and Q is required, i. e it is a long range process. In simple terms, the 
electrons in *L cause a perturbation in the electrons in Q. Energy transfer then takes place 
when relaxation of the electron in *L occurs with corresponding excitation of an electron in 
Q24. The same selection rules apply as would for the independent relaxation of the 
individual chromophores. Therefore this mechanism is common for singlet-singlet energy 
transfer between aromatic molecules with high oscillator strength (such as chlorophylls) 22. 
This mechanism depends on distance according to (5). 
ße = µN4 
r3 (5) 
Where ße = the electronic coupling in cni 1, µL and µQ are the dipole moments of *L and Q 
and r is the distance between them24. 
The final process is outer-sphere electron transfer from *L to Q to give e. g. L+ and Q- for 
oxidative electron transfer shown in Figure 1.11. A molecule in its excited state is 
simultaneously a better oxidising and reducing agent than the ground state molecule because 
it is at higher energy. Therefore a photo-excited chromophore can subsequently transfer an 
electron to a second species, Q22. 
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Figure 1.11 Photoinduced electron transfer. (Left) Oxidative electron-transfer and (Right) 
reductive electron-transfer. 
Therefore *L may decay by a unimolecular pathway, radiative or nonradiative deactivation, 
or a bimolecular pathway, such as a chemical reaction or energy transfer. Following energy 
transfer *Q decays following the pathways described for *L. These are known as energy 
transfer sensitization processes24. Sensitization may induce bimolecular electron transfer 
reactions. Sensitizers may be chosen with the correct spectroscopic, redox and excited state 
properties to drive photochemical reactions, which may be thermodynamically 
unfavourable, i. e. they convert light energy into chemical energy. A light absorption 
sensitizer (LAS) absorbs light, promoting it to its excited state which reduces or oxidizes a 
reactant. The oxidized or reduced sensitizer then completes the redox reaction as it returns 
to its ground state (6). A light emission sensitizer (LES) uses the chemical energy to 
produce light. For example, if LES is oxidised by one of the reactants and the subsequent 
oxidised form then oxidises another reactant, the resulting excited state *LES can undergo 
radiative deactivation to the ground state, i. e. it luminesces (7). 
LAS 
A+B+ by --> A+ + B- 
(6) 
LES 
A-+B+--to+B+hv 
(7) 
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Both LAS and LES require a species which has sufficient stability to withstand the reaction 
without being consumed and the appropriate redox potentials in its ground and excited states 
for the process. An LAS requires a chromophore with intense absorption bands, whereas an 
LES requires a chromophore which has a high quantum yield of luminescence. The 
spectroscopic, energetic and redox properties are thus important in selecting the appropriate 
chromophore for a sensing device. 
1.2.3. Choice of Signalling Unit 
The properties which are of particular importance in choosing the relevant chromophore 
include the spectroscopic properties of the ground state: the frequency and molar absorption 
coefficient of the absorption. Similarly, the spectroscopic properties of the excited state 
must be considered: the efficiency of formation of the active excited state, the lifetime of 
that state (r) and the quantum yield of emission (c). 
i=1/(kr+knr+kp) 
(8) 
=krt 
(9) 
where kr is the rate constant for radiative decay, knr is the rate constant for radiationless 
decay and kp is the rate constant for chemical reaction22. 
The redox behaviour of the system is defined by the redox potentials for oxidation (Eo,, ) and 
reduction (Eyed) of the ground and excited state of the components and the energy of the 
exited state (E. ). For electron transfer, a one electron redox reaction between the ground 
state donor and the excited state acceptor component occurs. Therefore 
OG = E. X(D) - Ered(A) - Eoo 
(io) 
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1.2.3.1. Metal Complexes 
Introduction 
Metal complexes with aromatic ligands, such as polypyridyls, are frequently chosen as 
luminescent signalling units27,28. [Ru(bpy)3]2+, an example which has been extensively 
studied, is shown in Figure 1.1230 
7 2+ 
Nqp,,,, 
'Ru'**ý N 
N I Ný 
Figure 1.12 [Ru(bpy)3]2+ 
Metal complexes are suited to these applications because they exhibit metal-to-ligand charge 
transfer bands at relatively low energies (the MLCT is 2.1 eV above the ground state in the 
case of [Ru(bpy)3]2+)27. This means that they absorb in the visible and near UV region of 
the spectrum (e. g. 450 nm). The heavy metal atom leads to spin-orbit coupling which 
enables fast and efficient population of the lowest exited state (Si --+ TI)29. This is normally 
spin forbidden in organic molecules. In addition, the lowest excited state is usually 
luminescent in solution at room temperature. The metal complexes possess distinct redox 
centres. Each of these properties may be chosen or tuned for a specific process, such as 
signalling of the binding of a substrate by a sensor, by altering the metal or ligands. 
However, these types of complexes usually emit in the visible region. Since the absorption 
spectrum of XO is dominated by the strongly absorbing flavin and iron sulfur clusters, a 
photosensitiser with a high extinction coefficient is required'. 
18 
Chapter 1 
1.2.3.2. Porphyrins 
Introduction 
Another well documented class of luminophores is formed by free-base or metal containing 
porphyrins. Abundant in nature as chromophores31 and in electron transfer mechanisms32 
they are incorporated in enzyme active site models 33,34Porphyrin-based electron transfer 
systems are widely studied with respect to charge separated intermediates for possible 
photosynthesis mimics35. One of the most common systems is the porphyrin-quinone dyad 
due to its biological significance36. An example is that reported by Connolly et al., 
illustrated in Figure 1.1337. 
H3C 
Figure 1.13 Porphyrin-quinone dyad reported by Connolly et al. n=2,3,437. 
Biradical ion pairs (P'+-Q`) are generated upon irradiation, and can be observed by EPR. 
Photochemical electron transfer (> 10-8 s-1) occurs, in moderately polar solvents, from the 
excited singlet state and is quenched by up to 40 % upon attachment of a quinone compared 
to porphyrins without attached quinone, with hydroquinone or dimethyl benzene attached. 
In these flexible systems, the quinone moiety may fold over to interact with the 7r-system of 
the porphyrin causing broadening of the Soret band in the absorption spectra, but no other 
absorption spectral changes are observed. In these cases, broadening and red shifting of the 
emission bands and reduction of the quantum yields is attributed to enhanced radiationless 
decay. A long lived component (- 9 ns) of the decay is attributed to the `extended' 
conformer; a shorter lived component (- 2 ns) is attributed to the `folded' conformer. For 
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the optimal system, (fully oxidized quinone, n= 3) the fluorescence yields and lifetimes are 
as short as 1.7-1.9 and 7.5 ns. Quenching diminishes with lowering of temperature since 
rotation to give optimum orbital overlap is slowed and no longer occurs within the lifetime 
of the excited singlet state. 
The carotenoid-porphyrin-quinone triad38 in Figure 1.14 was shown to mediate 
photoinduced proton transfer across a lipid membrane, mimicking conversion of light 
energy into ATP chemical potential by photosynthetic bacteriaas. 
0 
OH 
ý 
(CH2)13CH3 
OH O 
+ Ca 2+ 
OO 
(CH2), 3CH3 
0 
Figure 1.14 Above: Carotenoid-porphyrin-quinone triad reported by Gust, Moore and 
Moore38; Below: photoactive compounds for active transport of Ca2+ across a lipid 
membrane. 
The group have modified the system to create a system which mimics active transport of 
calcium ions across a lipid membrane38. Ca2+ may bind to the quinone and hydroxyquinone 
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compounds in Figure 1.14 on the outer side of the membrane enabling it to diffuse across to 
the inner surface. Photoinduced electron transfer of the porphyrin triad produces a 
carotenoid radical cation which oxidises the complex releasing Ca2+ to the inner aqueous 
phase and diffuses back across where it can pick up another cation. 
Since fullerenes have first reduction potentials comparable to that of benzoquinone, small 
reorganisation energies (?, ) due to their rigidity, and ability to form short Van der Waals 
contacts with porphyrins (2.7-3.0 A), porphyrin-fullerene electron transfer has been 
extensively studied 39,40,41. Fullerenes are capable of accepting up to six electrons reversibly 
which makes these systems of particular interest for potential solar energy conversion and 
storage devices42. Such electron transfer may occur intermolecularly from the porphyrin 
triplet excited state to the C60 or C70, or intramolecularly from the porphyrin singlet state to 
the fullerene components in a supramolecular dyad, triad or larger assembly. The following 
examples serve to illustrate the different mechanisms by which porphyrins may coordinate 
to a second species, such as a fullerene, and the resulting changes in luminescence. 
A host of axially coordinated porphyrin-fullerene systems have been studied such as that in 
Figure 1.15 (A)43. Coordination to the metal is indicated by a red-shift in the absorption 
spectra of the porphyrin. The electron transfer rate is smaller in such systems than in the 
equivalent covalently bonded systems (B). Electron transfer occurs from the porphyrin 
excited singlet state in non-coordinating solvents or the excited triplet state in coordinating 
solvents. By covalently attaching the fullerene to one of the phenyl substituents as shown in 
Figure 1.15 (B), control over the distance and orientation between the donor and acceptor 
components can be achieved44. This can be used to tailor the electron transfer rates, 
lifetimes and higher order structures. 
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Figure 1.15 Porphyrin-fullerene dyads reported by D'Souza et a143'44. 
Introduction 
Stevenson and coworkers have used supramolecular interactions to construct the self- 
assembled supramolecular porphyrin-fullerene dyad shown in Figure 1.164'. Self assembly 
in non-coordinating solvents gave rise to a decrease in the fluorescence emission of the 
porphyrin with increasing concentration of fullerene. Watson-Crick hydrogen bonding 
between a porphyrin-appended cytidine and a fullerene-appended guanine brings the donor 
and acceptor moieties sufficiently close for through space electron transfer. Restoration of 
the fluorescence was observed on addition of a hydrogen bond disruptor (hexafluoro-2- 
propanol). Time resolved fluorescence studies revealed biexponential decay with a 
component for the uncomplexed porphyrin excited state (T1 = 2.1 ns) and for the 
photoelectron transfer (PET) quenching of the porphyrin by the hydrogen bonded fullerene 
(T2 = 0.6 ns). 
22 
Chapter 1 Introduction 
\\ electron transfer 
by 
OTBDMS 
R= 
TBDMSO OTBDMS 
-N 
H'N. 
H---p 
N_ \ 
`r y N, R 
\ N---- HNfN 
N 0----H' 'H 
Figure 1.16 Watson-Crick hydrogen bonded porphyrin fullerene dyad reported by 
Stevenson et al. 
Time-resolved infra-red spectroscopy (TRIR) can be used to study the photophysics of these 
systems as fullerenes have characteristic singlet-singlet and triplet-triplet absorptions in the 
visible and near infra red region. 7r-Radical anions (C60`, C70 -) show narrow bands in the 
near-IR (1080,1380 nm) which serve as a diagnostic tool in porphyrin-fullerene systems 
where the visible region is dominated by the porphyrin. The fullerene radical anion was 
observed at 1000 nm and the charge separated radical anion pair had a lifetime of 2.02 µs. 
In summary, porphyrins are able to report binding to a redox centre via direct coordination 
through the porphyrin metal centre, covalent attachment, or supramolecular interactions 
such as hydrogen bonding or 7r-stacking. Porphyrins are suitable signalling units since their 
absorption and luminescence spectra are altered by such binding. 
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1.2.3.3. Applications of Water Soluble Porphyrins 
For a biological application, such as the XO studies, water solubility is essential. Water 
soluble porphyrins have been investigated for their potential biological importance. 
Cationic porphyrins have been found to chelate to DNAas, 46,47 Polar porphyrins with long 
organic chains appended may interact with lipid membranes 48,49,5° and can be used in small 
molecule sensing due to their luminescent properties 51 
The most widely documented potential application of water soluble porphyrins is in 
photodynamic therapy52. A free base porphyrin acting as a photosensitiser may generate 
singlet oxygen by energy transfer from its excited state to molecular oxygen. The reactive 
oxygen species causes oxidative damage to biological material. Therefore this process may 
be utilized for antibiotic, antiviral and anticancer purposes in photodynamic therapy. If the 
photosensitiser accumulates in tumours cells, the surrounding area may be irradiated by 
visible light, selectively building up lethal reactive oxygen species which destroy the 
tumour. Retention of the sensitizer in tumour cells occurs as a result of its faster removal 
from healthy tissue than the malignant tissue. 
Lang et al. 53 comment on the photophysics involved and the requirements for the 
photosensitiser. Porphyrins are well suited to this purpose since they typically absorb at the 
required wavelengths (below 800 nm, avoiding competition from water, and above 400 mn, 
avoiding photosensitization of the skin). Fluorescence provides a means of detection. 
Porphyrin compounds are sufficiently stable to withstand the conditions and photochemical 
processes involved. 
Tailoring of the peripheral groups of the macrocycle to suit a particular host increases the 
selectivity. Charged groups introduce water solubility: cationic porphyrins such as TMPyP 
(Figure 1.17) are well documented54 due to their potential to intercalate between the 
guanine-cytosine base pairs in DNA. Negatively charged porphyrins such as TPPS55 interact 
with proteins with positively charged side chains such as protonated nitrogen atoms while 
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neutral sensitizers such as OEP may accumulate in lipid membranes56. A carrier such as a 
cyclodextrin57,57,58 may be required to administer the compound. 
B 
C 
H3 03S S03 
Figure 1.17 (A) Free base 5,10,15,20 Tetrakis(N-methylpyridinium-4-yl)porphyrin, 
TMPyP; (B) Free base meso-tetra(4-sulfonatophenyl)porphine, TPPS; (C) Free base 
octaethyl porphyrin, OEP. 
One of the advantages of using porphyrins in this way is that information may be gathered 
about the types of interactions involved between the photosensitiser and its local 
environment since they are capable of reporting host-guest interactions as described 
previously. In particular there are characteristic differences between absorption and 
emission spectra of monomeric porphyrins and those of aggregates, where the energy is 
dissipated, causing a reduction in fluorescence lifetimes and quantum yields. In some cases 
porphyrin aggregation is disrupted on interaction with a host, while in others aggregation is 
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caused by self-stacking on the host exterior59 or incorporation into a liposome60. The 
resulting shift in absorption maxima, for example, would report the corresponding 
mechanism. 
Cyclodextrins (CDs) are frequently used to demonstrate host-guest interactions in aqueous 
media because of their hydrophobic interior and water soluble periphery, as illustrated in 
Figure 1.18. The cavity can incorporate a range of guests, including some porphyrins. This 
makes cyclodextrins potential carrier molecules to transport hydrophobic compounds into 
the body 61,61,62 They are also known to disrupt aggregation of porphyrinS53, demonstrated by 
a red-shift of the Soret band and fluorescence emission bands. The intensity of the emission 
bands varies according to the porphyrin substituents and the nature of the connecting link 
between (3CDs. Excited triplet state lifetimes are increased because collisional quenching by 
solvent and diffusion-controlled quenching by oxygen is reduced by encapsulating the 
porphyrin within the CD. 
(6,6)HOCH2 
Primary Face 
(4)H 
(1)H H(5) 
(2)H 3). - - -, 
Figure 1.18 Schematic representation of cyclodextrins described by Lang et al.; aCD: n=6; 
ßCD: n=7; yCD: n=853. 
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1.2.4. The Bridge 
Introduction 
For bimolecular processes of excited states, the lifetimes of the excited chromophores must 
be sufficiently long lived (>10 ns) to overcome the kinetic restrictions (i. e. diffusion). For 
applications in supramolecular devices, such as sensors and luminescent probes, the 
luminophore and binding unit are not discrete, but tethered for efficient communication, as 
demonstrated by the examples so far. At the very least, the bridge serves to hold the 
components sufficiently close to enable communication by energy/electron transfer63. As in 
the previous examples, the linker may be anything from a covalent bond to a supramolecular 
interaction, but it defines the rigidity, length and conformationl behaviour of the system. A 
suitable choice of linkage may enable such rapid energy transfer that the first singlet and 
higher excited states may be quenched (8)22. 
*D-B-A --º D-B-A* (8) 
In order for long-range communication of events occurring at one site, the other must ideally 
be electronically coupled via the bridge. A certain degree of orbital overlap or electronic 
interaction is required for electron transfer or electron exchange. Consequently, the bridge 
may provide a through bond mechanism for the transfer of energy and therefore 
information. 
Examples of energy transfer systems, in which electron transfer is mediated by the bridge, 
have been investigated by Albinsson et al. The group have studied electron transfer within 
25 A `donor-bridge-acceptor' systems in order to monitor the influence of the bridging 
chromophore on the photoinduced electron/energy transfer64. In these systems, two 
porphyrins are incorporated: a zinc porphyrin is the donor and a gold(III) porphyrin is the 
acceptor. A third chromophore, the `bridge', makes up the triad. 
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Figure 1.19 Benzene and anthracene bridged porphyrin triads (ZnP-B-AuP) triads studied 
by Albinsson et alp". 
The largest quenching effect is observed in the anthracene bridged systems. In these 
examples long-range direct superexchange-mediated electron transfer processes65 compete 
independently with sequential electron transfer in polar solvents. In weakly polar solvents, 
such as 2-methyltetrahydrofuran, only direct electron transfer occurs66. It is believed that 
the electron tunnels through unoccupied orbitals, or `virtual low-lying excited states', of the 
bridge rather than travelling through space. The alternative, sequential electron transfer is 
said to go via a `hopping' mechanism67. The key difference between the two mechanisms is 
that superexchange mediated electron transfer results directly in the charge-separated state 
(D'+BA'-), whereas the sequential mechanism goes via a charge-separated intermediate 
(D'+B`A) where the electron is temporarily localised on the bridge, which in turn gives the 
charge separated state (D'+BA'-) (Figure 1.20). Both of these processes are widely 
discussed with respect to molecular wires68' 69,70. In these various bridging systems the 
superexchange phenomenon is often evaluated in terms of a distance-dependent `attenuation 
factor', ß (A). 
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Figure 1.20 The competing deactivation processes: sequential and superexchange- 
mediated electron transfer65. k1 - k6 are rate constants for each of the processes 
illustrated. 
It has been demonstrated that the mechanism can be controlled by tuning the energy gaps 
between the D-B-A primary excited state and the charge separated states 71.72 . Such systems 
are therefore sensitive to temperature, solvent, the metals coordinated within the porphyrins 
and the nature of the bridging chromophore. Consequently, the choice of bridge for a probe 
molecule may affect the mechanism and rate of communication (e. g. electron or energy 
transfer) between the binding unit and the signalling unit. 
1.3. Probing Enzyme Active Site 
Lo et al. have reported luminescent probes for indole-binding proteins which show protein- 
induced emission enhancement on binding to tryptophanase and bovine serum albumin 
(BSA) (Figure 1.21)73. Tryptophanase is a bacterial pyridoxal 5-phosphate (vitamin B6) 
dependent lyase that catalyses the breakdown of of L-tryptophan to indole, pyruvate and 
ammonia as well as a variety of a, ß-elimination and ß-replacement reactions on a number of 
other ß-substituted L-amino acid residues74. BSA is a large water-soluble globular protein 
which binds and transports lipids, fatty acids, amino acids and other small molecules75. 
Metal complexes were chosen over organic luminophores since the poor spectral overlap and 
mis-matched electrochemical properties with the enzyme prevent quenching by resonance 
energy transfer to the protein. 
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The dpga/dpq and pyridine ligands have intense absorption bands at 259-298 nm due to spin 
allowed a --+ 7c* intraligand ('IL) transitions and less intense bands at 355-393 nm due to 
metal-to-ligand charge-transfer ('MLCT) transitions. The absorption due to the indole is less 
intense. The luminescence wavelength (500-570 nm) depends on the nature of the ligand 
and the solvent. The emission of tricarbonylrhenium(I) indole complexes is concentration 
dependant (weak in polar solvents, e. g. aqueous buffer, stronger in less polar solvents, e. g. 
dichloromethane) and the presence of the indole lowers quantum yields and shortens 
lifetimes. This indicates self quenching of the rhenium(I)dipyridoquinoxaline by indole. 
CO (CF3SO3) 
OC ,, 
Re, 
L 
iý N/I N\ 
NýN 
J'1 
dpq 
IO 
N/I N) 
NH(CHZ)3CH3 
NN dpqa 
L= INS H 
N 
O NH 
py-3-CONHC2H4-indole /\ 
O 
N NH 
OH 
py-3-CONHC5H10CONHC2H4-indole 
N% 
H 
/ N,, ýCH3 
0 
py-3-CONH-Et 
Figure 1.21 Tricarbonylrhenium(I) dipyridoquinoxaline complexes reported by Lo et a1.73 
Lo et al. suggested that the quenching occurs by intermolecular electron transfer (9). 
Evidence for reductive quenching by indole comes from the redox potentials of the indole 
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free complexes and indole (E°[Re+*10] = +1.43, +1.48 V; E°[indole+'0], +1.06 V vs. SCE) 
and the self-quenching rate constants of the indole complexes (3.3 - 6.8 x 109 dm3 mol-1 s 
1) 
which are similar to the bimolecular quenching rate constant of the emission of the indole 
free complexes by indole (1.3 - 1.9 x 1010 dm3 mo17I s 
1). 
Re+* + indole -- Re° + indole+" (9) 
On titration with BSA, the absorption spectra for the tricarbonylrhenium(I) indole 
complexes were unchanged whilst the emission intensities and lifetimes were enhanced 
substantially. The decay remained single exponential. The emission for the indole free 
complexes remained unchanged. This suggests that the indole moiety binds to the protein, 
increasing the emission due to the hydrophobic environment and preventing intermolecular 
electron transfer between the complexes. The binding constant for the complexes with the 
longer alkyl chain (spacer) were larger than for those with a shorter spacer. 
Enzyme inhibition assays were carried out with tryptophanase. The conversion of L-serine 
to pyruvate was inhibited in the presence of indole (48 %, Km = 328 mM) and the 
tricarbonylrhenium(I) indole complexes (64-68 %, Km = 298 - 389 mM) in a non- 
competitive fashion. The binding affinity was not greatly affected by the length of the 
spacer. No inhibition was observed in the presence of the indole free complex with the dpq 
ligand, whereas inhibition was observed for the dpqa complex (44 %) possibly due to 
interaction of the amide substituent with the enzyme. 
Lo et al. have also developed luminescent biotin conjugates which bind to avidin. This 
tetrameric protein can bind up to four biotin molecules at two pairs of binding sites on each 
side of the structure, with a first dissociation constant Kd _ 10-15 M78. Because of this strong 
affinity, the system is a widely used biochemical tool for detection and isolation of 
biotinylated molecules. 
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Each of the probe complexes in Figure 1.22 exhibited solvent dependant triplet MLCT 
(db(Re) --º n* (N-N)) emission (500-570 nm) as observed for the indole systems. The 
exception was the Me4-phen complex, which exhibited long lived emission (7.3-14 ns) due 
to the low lying 3IL (Me4-phen) emissive state. The emission intensities were enhanced and 
the lifetimes extended on binding to avidin. As for the tricarbonylrhenium(I) indole 
complexes with BSA, the emission enhancement can be explained by increased rigidity and 
hydrophobicity of the protein binding pocket. The binding was investigated using a 
standard HABA (4'-hydroxyazobenzene-2-carboxylic acid) assay whereby absorption at 500 
nm corresponding to avidin-bound-HABA decreases on addition of the rhenium(I)-biotin 
complexes, indicating that HABA had been displaced by the probes. Each of the complexes 
bound with 4: 1 stoichiometry, as for biotin itself. The more hydrophobic (Me4-phen, Me2- 
phen) complexes showed greater enhancement than the others (phen, dpq) as did the 
complexes with the shorter spacer (py-4-CH2-NH-biotin). However, the binding was 
stronger for the complexes with the longer spacers. 
Similarly, the iridium complexes in Figure 1.23 (A) exhibited solvent dependant, long-lived 
(ns) 3MLCT (da(Ir) -- a* (bpy-CH2-NH-C2-NH-biotin)) luminescence (550-590 nm in 
degassed solution). The complexes in Figure 1.23 (B) exhibited even longer-lived (ms) 
luminescence (528-712 nm in degassed solution) with structured emission bands 
corresponding to 3IL (t -+ 7t*) (N-C) with some mixing of 
3MLCT (da(Ir) -+ 7c* (N-C")). 
On addition of avidin the emission is enhanced as for the rhenium complexes and the 
binding was investigated by HABA assays as described above. The complexes with the 
most hydrophobic ligands exhibited the most enhancement as for the rhenium(I)-biotin 
complexes. The complexes with the most significant emission enhancement and therefore 
greatest sensitivity were the biphenyl and naphthyl complexes in (B). The iridium 
complexes each bound several orders of magnitude more weakly (Kd - 10'10 to 10'8 M) than 
biotin itself. 
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Figure 1.23 Iridium complexes reported by Lo et al. 76 (A) [Ir(N-C)2(bpy-CHZNH-C2-NH- 
biotin)](PF6); (B) [Ir(N-C)2(bpy-CO-NH-C6-NH-biotin)](PF6). 
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Figure 1.24 Iridium(III) diimine bis(biotin) complexes reported by Lo et al. 77 
Another recently reported system is shown in Figure 1.24, in which the iridium complex 
contains two biotin units77. The solvent dependant emission (479 - 600 nm) was assigned to 
a 3MLCT (da(Ir) --> a* (N-N)) excited state (with some IL (a -+ 7r* (Me4phen) character for 
the Me4phen complex). HABA assays indicated that the complexes bound in a 2: 1 complex : 
protein ratio and that the binding was significantly stronger than HABA unlike the 
complexes in Figure 1.25. The emission intensities of each of the complexes was enhanced 
and the lifetimes increased on addition of avidin. The same relationship between spacer 
length and emission enhancement was observed. Kd = 3.9 x 10'9 to 4.8 x 10"8 M, several 
orders of magnitude lower than biotin. The complexes with the longer spacers (n = 6) are 
able to cross-link avidin (two avidin protein molecules bound to one iridium diimine 
bis(biotin) complex), whereas those with shorter spacers (n = 2) form intramolecular adducts 
with the same protein molecule. 
A range of probes for cytochrome P450c79 have been developed by Gray and co workers 
for heure active sites, such as those in Figure 1.2879. The binding is sufficiently strong to 
allow detection of the enzyme at submicromolar concentrations 81. 
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Cytochrome P450 enzymes catalyse monooxygen transfer to non activated hydrocarbons 
under physiological conditions. P450.,,, was the first member of this family to be 
structurally characterised by X-ray diffraction and its biochemistry is well understood. The 
substrate, camphor (A), is regio- and stereospecifically hydroxylated to 5-exo- 
hydroxycamphor (B) at a heure active site. The reaction scheme is shown in Figure 1.26. 
0 
H 
H 
A 
+O2+2H++e' 
B 
+ H2O 
Figure 1.26 Conversion of camphor (A) to 5-exo-hydroxycamphor (B) by P450C811,. 
A [Ru(bpy)3]2+ chromophore was linked to an enzyme substrate, imidazole, adamantane or 
ethyl benzene, through an aliphatic spacer Ru-C-Im/Ad/EB, or an aromatic fluorinated 
spacer Ru-FBbp-Im/Ad, (Figure 1.27)82. 
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Figure 1.27 (A) Structure of Ru-C9-Ad and (B) tmRu-F8bp-Im 79. 
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Firstly, binding of the probes to P450cam was signalled by quenching of the Ru`+ excited 
state (Ru"*). [Ru-substrate]2+* emission decay is normally monophasic (k0 = 2.1 X 106 s-1). 
In the presence of P450 it becomes biphasic, corresponding to the bound state, ki 
(quenched), and the free state, k,,, of the probe. The faster phase is due to energy transfer 
(Ru-Fsbp-Ad) or electron transfer (Ru-Fgbp-Im) to the heure. Figure 1.28 shows the crystal 
structures of the bound probes with a simplified adamantane substrate. 
A 
B 
Figure 1.28 (A) Structure of Ru-C9-Ad and (B) tmRu-FKbp-Ad bound P450ca... 79 
Original in colour. 
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Secondly, changes to the coordination of the heure active site are indicated by a shift in the 
P450cam Soret band at 417 nm. For the adamantane terminated probe, a blue shift in the 
porphyrin absorption indicates displacement of coordinated water, whereas for imidazole 
formation a red shift indicates binding to the heure itself. No such shift in the Soret band 
absorption was observed for the ethylbenzene probe, suggesting that it binds in the active 
site but not directly to the heure. For probes with the aliphatic spacer, the luminescence 
quenching was attributed to Förster-type energy transfer (Rut -º Fell' for Ru-Im, Rum--> 
Feu' for Ru-Ad and Ru-EB). The results are summarised in Table 1.1. The results for Ru- 
C,, -EB suggest that a direct bond to Fe is not required for electron transfer. 
ko kl , max heure kD 
(S-) (S-) (nm) (µM) 
Ru-C-Im 2.2 x 106 7.0 x 106 420 1.5 
Ru-Co-Ad 2.2 x 106 7.7 X 106 415 0.69 
Ru-C-EB 2.2 x 106 1.2 x 106 417 1.0 
Table 1.1 Summary of properties of P450, az-ligated probes by Gray et a179"85. 
The conjugated spacer enables the tmRu-FBbp-Im to reduce P450cam 103 times faster than 
the Ru-wire with an alkyl chain linker. The change in oxidation state of the heure was 
examined by transient absorption spectroscopy where a bleach at 420 nm and an increase in 
optical density at 445 nm was attributed to reduction of Fe with corresponding Ru11 to Ru" 
oxidation. Neither *Ru-F8bp-Ad nor *tmRu-F9bp reduces P450cam. 
The electron transfer processes are summarised in Figure 1.29. *Ru2+ reduces the heure (kf) 
or decays to the ground state through a combination of intrinsic decay (ko) and energy 
transfer to the heure (kE), which decays non-radiatively to the ground state. The charge- 
separated state (Ru3+"""Fe2) undergoes back electron transfer (kb) or decays to form a long- 
lived ferrous heure (ksep). 
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º Ru3+... Fe2+ 
kb 
º Ru2+... Fe3+ 
kE + kp ksep 
Rue+... Fe3+ Rue+... Fe2+ 
Figure 1.29 ET processes in photoexcited Ru-diimine: P450cam conjugates. 
Other probes contained a dansyl fluorophore (Figure 1.30)83,84. As for the [Ruii(bpy)3]2+ 
sensitiser, reduced dansyl luminescence was observed on binding to P450cam attributable to 
Förster type energy transfer. When the probes (D-4-Ad and D-8-Ad) were displaced by 
camphor (the natural substrate) the fluorescence was restored. 
N/ \ý 
0 A 
SH / 
HV N 
0 
N 
B- SSO 
H 
NN 
O 
Figure 1.30 Probes reported by Gray et al. (A) D-4-Ad; (B) D-8-Ad. 83 
The probes were held in the active sites by hydrophobic interactions and probes of different 
lengths could be incorporated due to the conformational flexibility of the surrounding B', F 
and G helices85. These range from an `open' conformation for the [Ru«(bpy)3]2+ sensitizer, 
to an intermediate conformation with the dansyl fluorophore, to a `closed' (camphor bound) 
form. Figure 1.31 illustrates the dansyl probe-bound conformations of P450c. 83. The D- 
4-Ad bound channel is more open than D-8-Ad bound channel, leading to a weaker affinity 
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for the D-4 molecule. The The D-4-Ad probe could be used to screen for potential 
inhibitors since it can easily be displaced. 
Figure 1.31 D-8-Ades (A) and D-4-Ad87 (B) bound P450ca,,,. Colours correspond to atoms: 
carbon and nitrogen: blue; sulfur: yellow; oxygen: red; zinc: orange. Original in colour. 
Recently, Gray et al. have reported a the Re(I)(imidazole-alkyl-nitroarginine) sensistiser. 
shown in Figure 1.32, to probe the active site of nitric oxide synthase (NOS) 89 NOSs are 
subdivided into cytokine-inducible (iNOS), endothelial (eNOS), and neuronal (nNOS) 
isozymes. Each oxidise L-arginine to the signalling molecule NO and citrulline at a heure 
88 active site (Figure 1.33). 
6 F4 
p= 
N_ý 0 NH 
(\\, 
N 
H HýNH NH2 NO2 
Figure 1.32 Structure of [ReCgargNO21[BF4] repoted by Gray er a1. R') 
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Binding of the probe to iNOS0,, y (inducible nitric oxide synthase with the reductase site 
cleaved at the interface of the two domains) caused a blue shift in the heure Soret peak from 
423 nm to 390 nm which is also observed when L-arginine is added to the enzyme. This is a 
result of partial displacement of water from the active site, as for the P450, ß system 
described above. Competitive binding studies were carried out by titrating iNOSo,, y and 
different concentrations of imidazole with [ReC8argNO21 [BF4] to show that there is 
competition between the probe and imidazole for the binding site. The luminescence from 
[ReC8argNO2][BF4]* is quenched on addition of iNOS... y and the maximum shifts from 570 
nm to 550 run. As for the probes for P450C81,,, biexponential decay was observed for the 
probe in the presence of the protein; the faster decay (r = 92 ns) for * [ReCBargNOZ]+ - bound 
iNOS... y; the slower component (i = 500 ns) for free *ReC8argN021[BF4]. 
In summary, the work by Gray and co-workers demonstrates that luminescent probes may 
be designed to be bound within the active sites of enzymes by hydrophobic interactions. 
The perfluorobiphenyl bridge improves the electronic coupling between *Ru2+(L2)L' and the 
heure, resulting in direct photoreduction with a time constant of 36 ns79-85. The work by Lo 
and co-workers has also shown that metal complexes linked to enzyme substrates can report 
binding within enzyme active sites. Lo et al. have demonstrated that careful design of 
hydrophobic complexes may lead to emission enhancement rather than quenching on 
binding to the protein. It has also been demonstrated that whilst the changing the length of 
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the arm may improve the binding affinity for the probe it may simultaneously reduce the 
emission enhancement and therefore a compromise must be made. 
1.4. Summary and Design of the Probe for Xanthine Oxidase 
1.4.1. Luminophore 
Porphyrins (em = 550-750 nm) are ideal for use in photochemical devices since they have 
high extinction coefficients as well as tunable fluorescence emission and redox potentials. 
This is essential if the chromophore is to avoid the region in the spectrum dominated by the 
enzymes, XORs, (k,,,. = 280 nm)1°90. The iron-sulfur clusters contribute absorption maxima 
at 420 nm, 470 nm and a shoulder at 550 nm and the absorption maxima of the flavin are at 
360 and 450 nm. In addition, porphyrins can be functionalised at the periphery to suit a 
particular function, such as water solubility in biological systems. 
1.4.2. Bridge 
The bridge should provide functionalities that allow the attachment of the substrate and 
luminophore. Amide bonds provide a means of connection whilst being able to encourage 
electron transfer via superexchange22.67. Other substituents may introduce hydrogen 
bonding within the molecule so that the system is more rigid to aid electron transfer. 
Aromatic groups have been shown to be particularly good bridges. 
The bridge should be of a suitable length to position the substrate close to the MoCo active 
site. Computer modelling could be used to check the length, although computer simulation 
from crystal structures can be an over-simplification since enzyme active sites can often 
change conformation considerably on substrate binding, as demonstrated in the cases for 
P450, ß,. 
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1.4.3. Substrate Analogues 
Introduction 
The purpose of the substrate is to bind within the channel of the active site and to 
communicate with the molybdenum cofactor. XO has an affinity for planar aromatic 
substrates containing five and/or six membered rings. The substrate should be bound in the 
channel by hydrogen bonds and a-stacking, as for the inhibitors described earlier. 
Biagi et al. 91 compared a series of inhibitors which were similar to xanthine or allopurinol. 
It was noted that the five-membered ring was more important than the six-membered ring in 
these complexes and therefore a reasonable initial simplification of the substrate would be 
pyrazole or imidazole as shown below. These should bind to the molybdenum in a similar 
manner to the natural substrates either through nitrogen (allopurinol) or via a carbon-oxygen 
bond formed by the enzyme (xanthine). 
Poor Inhibitors Best Inhibitors RO OH 
oo N RI NH KN I NH2 BD 
°SR' N NHR" 
HIN 
NH,, -, 2NH 
O0 
NH N :lO OH 
H NCR' NI 
%ýSR' 
N 
HC 1\ E 
N 
R=H, NHCHO R" = CO(CH2)4CH3 
HN 
R' = (CH2)CH3 or COCOO(CH2)CH3 
A n=3-5 
Figure 1.34 AA selection of substrates reviewed by Biagi et al. Right The simplified 
substrates B Pyrazole (Alloxanthine), C Imidazole (Xanthine), D Nicotinic acid, E 
Isonicotinic acid91 
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1.4.4. Overall system 
Introduction 
As demonstrated by Gray et al., combining a simplified substrate with a covalently attached 
luminophore may give rise to a novel device for reporting enzyme activity 
spectrophotometrically. The overall design incorporates a porphyrin luminophore, a 
simplified substrate and a planar bridge of the appropriate length, as shown in Figure 1.35. 
?i b 
I/ 
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NN 
H3C-N Zn\ 
hV 
NN 
\N 
Luminophore 
CH3 
Figure 1.35 An example of a probe for XOR. Original in colour. 
The following chapters will describe the synthesis and more detailed description of the 
components outlined above. Binding studies of the porphyrin derivatives with XO will also 
be described in conjunction with the important spectroscopic characteristics. 
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2. Synthesis and Characterisation of Substrate-Linker Conjugates 
2.1. Preparation of the Substrate-Linker Conjugates 
A series of substrate-linker compounds were synthesised in order to test their binding with 
XO. Commercially available 4-amino salicylic acid was chosen as the `linker'. As 
previously described, the enzyme active site accommodates planar aromatic compounds, 
such as salicylic acid. The acid and amine functionalities provide a means of attachment to 
the luminophore and substrate by amide coupling. The methoxy group introduces a potential 
hydrogen bond acceptor which could bind either intramolecularly, to improve rigidity, or 
intermolecularly to hydrogen bond donor residues lining the channel. Some preliminary 
computational models were examined to assess the suitability of the compounds. 
2.1.1. Computer modelling 
Computer simulations of the proposed system were constructed in collaboration with Dr C. 
Verma. QUANTA (QUANTA98; Accelrys INC, San Diego, CA). with CHARMM "2 was 
used to calculate the likely structure of the `docked' molecule. This provided confirmation 
of the depth of the channel and therefore the length of the bridging unit was decided. 
Residues lining the channel were examined so as to make use of any available stabilising 
interactions, such as hydrogen bonds, and to avoid any repulsive electrostatic interactions. 
The hydrophobic residues lining the channel are clearly shown in Figure 2.1. Aromatic 
stabilisation can be inferred from the manner in which the aromatic residues are aligned with 
the aromatic ring of the probe molecule. Two possible hydrogen bonds can be seen from the 
amine of the sensor to the hydroxyl ligand of the molybdenum and the nearby Glu 802. 
There is also the possibility of bonding between the nitrogen lone pair of the amine and the 
molybdenum on displacement of the hydroxyl ligand. 
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AB 
Figure 2.1 (A) Cross section of probe (purple) within XO channel. Colours correspond to 
atom types: Molybdenum, grey, sulfur, yellow, oxygen, red, nitrogen, blue, remaining atoms, 
green. (B) van der Waals' radii are shown dotted. Original in colour. 
2.1.2. Methyl 4-Amino-2-methoxybenzoate, 1. 
The acid group of 4-amino-2-hydroxy benzoic acid was first protected by methylation with 
dimethyl sulphate (Scheme 2.1) and then reacted with a series of acid functionalised 
substrates. 
O OH 01-1 
CH3 
OH KOH, Dimethyl Sulfate, Acetone 011-1 
CH3 
lip 
50% 
NH2 NH2 
1 
Scheme 2.1 Synthesis of methyl-4-amino-2-methoxy benzoate, 1. 
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Compound 1 was prepared as a beige powder using the method reported by Hewlett et al. in 
a similar yield to that stated in the literature3. This compound was characterised by 1H NMR, 
FTIR and EI-MS. The NMR data obtained are in good agreement with the literature. Three 
resonances were present in the aromatic region of the 'H NMR spectrum and 6 peaks were 
present in the 13C NMR spectrum, a broad peak at S 4.28 corresponds to the amine protons, 
two singlets, at S 3.86 and 3.83 in the 'H NMR spectrum were present corresponding to the 
methoxy protons and two peaks were present at 55.8 and 51.5 in the 13C NMR spectrum for 
the corresponding carbons. The FTIR spectrum contained bands at 3464 and 3362 cnz t 
corresponding to the N-H symmetric and asymmetric stretches and at 1604 cm -1 
corresponding to the N-H bending vibrations. The carbonyl C=O stretch was present at 1670 
cm 1. The mass spectrum gave the molecular ion at m/z = 181. 
2.1.3. Methyl4-[(2-methoxy-4-nitrocarbonyl)-amino]-2-methoxy benzoate, 2. 
+ 
DMAP, NsCI, TEA 
CH3CN 
75% 
2 
Scheme 2.2 Synthesis of methyl 4-[(2-methoxy-4-nitrocarbonyl)-amino]-2-methoxy 
benzoate, 2. 
Compound 2 was prepared by coupling 1 with 2-methoxy 4-nitrobenzoic acid (Scheme 2.2). 
These compounds were chosen in order to minimise the formation of side products. Estroff 
et a1.4 connected repeating units of a similar compound, 6-tert-butoxycarbonylmethoxy-5- 
nitro-pyridine-2-carboxylic acid, via the acid chloride, to the reduced, protected form 5- 
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amino-6-tert-butoxycarbonylmethoxy-pyridine-2-carboxylic acid methyl ester as illustrated 
in Scheme 2.3. The nitro group on the dimeric product was then reduced using hydrogen and 
palladium on carbon so that another repeating unit could be attached. 
COZCI2 
DMF (cat. ) 
CHZCI2 
_ 
U 
1) K2CO3 
Mel 
2) H2/Pd 
97% 
U 
DIEA 
90% 
Scheme 2.3 Coupling procedure reported by Estroff et a1.4 
The DMAP catalysed method by Lee et al. 5 was found to be the most efficient route in our 
case. Stirring the reactants overnight under argon gave 2 as a bright yellow feathery 
precipitate in 75% yield. 
Compound 2 was characterised by 'H NMR, FTIR and EI-MS. The 'H NMR spectrum in 
chloroform showed that the product was clean and did not require further purification after 
washing with cold acetonitrile. Amide bond formation was demonstrated in the 'H NMR 
spectrum by a singlet with a relative integration of 1 at S 9.76 corresponding to the amide 
proton and the FTIR spectrum contains an amide N-H stretch at 3355 and bend at 1589 cm 1. 
The rest of the 'H NMR spectrum consisted of three singlets at 8 4.20,3.97 and 3.88 
corresponding to three methoxy groups and six aromatic proton resonances. Other key peaks 
in the FTIR spectrum were two carbonyl peaks at 1699 and 1677 cm 1, one corresponding to 
the ester and the other to the amide and N=O stretches at 1522 and 1357 cm 1. The EI-MS 
corroborated this evidence by a substantial peak at m/z = 360. 
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'H-'H COSY (Figure 2.3) and 'H-13C HMQC and HMBC NMR spectra (Figure 2.4) were 
recorded to aid assignment of the spectra. d6-DMSO was used as the solvent in order to 
increase the concentration and improve the signal to noise ratio in the carbon spectrum, even 
though this solvent broadened the proton resonances. The assignments are summarised in 
Table 2.1 and Table 2.2; the numbers and letters correspond to those in Figure 2.2. 
CH3 J 
/17 
CH3 E0 Hi /9 
15 
C1 H3 A0 HD O 16 
O87 
ý 
11/14 
3ý 12 
13 
Oj HF HG HH 
4 
HB He 
Figure 2.2 2 with atom labels: letters assigned to protons and numbers assigned to carbons. 
ppm 
7.3 000 
7.4 v 
7.5 
7.7 
00ý VQ 
7.8- 
8.07.9 7.9 7.8 7.7 7.6 7.5 7.4 7.3 opm 
Figure 2.3 'H-'H COSY spectrum oft in DMSO. 
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Label 6 Integration Multiplicity Type COSY to H at 6 
A 3.76 3 s CH3 none 
B 7.71 1 d CH 7.36 
C 7.36 1 d CH 7.64,7.71 
D 7.64 1 s CH 7.36 
E 3.81 3 s CH3 none 
F 10.73 1 s NH none 
G 7.79 1 d CH 7.92 
H, I 7.92 2 m CH x2 7.79 
J 3.98 3 s CH3 none 
Table 2.1 Assignment of 'H NMR chemical shifts for 2 in d6_DMSO. 
ppm 
110 
120 
130 
140 
150 
160 
ppm 
50 
60 
PPM 
160 J 
4.0 3.9 3.8 3.7 Dpm 
Figure 2.4 'H-'3C HMQC spectrum(black) and HMBC spectrum (red) of 2 in d6-DMSO. 
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Label 6 Type HMQC to H at 8 HMBC to H at 8 
1 52.1 CH3 3.76 none 
2 165.9 Q none 7.71,7.64,3.76 
3 144.2 Q none 7.71,7.64 
4 132.6 CH 7.71 none 
5 111.3 CH 7.36 7.64 
6 115.0 Q none 7.64,7.36 
7 106.7 CH 7.64 7.36 
8 159.9 Q none 7.71,7.64,3.81 
9 56.1 CH3 3.81 none 
10 164.5 Q none 7.92,7.79 
11 149.9 Q none 7.92,7.79 
12 130.6 CH 7.79 7.92 
13 107.3 CH 7.92 none 
14 132.2 Q none 7.92 
15 116 CH 7.92 none 
16 157.3 Q none 7.92,7.79,3.98 
17 57.2 CH3 3.98 none 
Table 2.2 Assignment of 13C NMR chemical shifts for 2 in d6-DMSO. 
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2.1.4.4-[(2-Methoxy-4-nitrocarbonyl)-aminol-2-methoxy benzoic acid, 3. 
NaOH, EtOH 
I 
88% 
3 
Scheme 2.4 Hydrolysis of 2 to give 4-[(2-methoxy-4-nitrocarbonyl)-amino]-2-methoxy 
benzoic acid, 3. 
Since the acid functionality is required to couple the spacer to the porphyrin, 2 was 
saponified by refluxing with sodium hydroxide in ethanol to give 3 as an orange solid in 88% 
yield (Scheme 2.4). The product was characterised as for 2. The 'H NMR spectrum 
contained a singlet at S 11.20, shifted downfield compared to the ester, and only two singlets 
at S 3.85 and 3.80 corresponding to the methoxy protons. Broad peaks were observed at 
3271 cm7l and 1283 cm 1 in the FTIR spectrum corresponding to the acid functionality. The 
amide N-H stretch at 3336 cm 1 and bend at 1592 cm 1 confirmed that the amide bond was 
unaffected. A shift to the higher frequency of 1744 cm 7l of one of the carbonyl stretches was 
the only other significant change in the spectrum. The EI-MS contained a molecular ion 
peak at m/z = 346, a difference of 14 (CH2) compared to 2. 
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2.1.5. Methyl 4-[(2-methoxy-4-aminocarbonyl)-amino]-2-methoxy benzoate, 4. 
Reduction of 2 was also attempted since the amine functionality is required in the final probe. 
Reduction with stannous chloride and hydrochloric acid resulted in further hydrolysis of the 
ester and amide. Reaction with hydrogen and palladium on carbon also resulted in a range of 
products. A milder reaction was attempted with indium and ammonium chloride using the 
method of Pitts et a1.6 (Scheme 2.5). 
In, NH4CI, EtOH 
69% 
4 
Scheme 2.5 Reduction of 2 to give methyl 4-[(2-methoxy-4-aminocarbonyl)-amino]-2- 
methoxy benzoate, 4. 
The insolubility of the product meant that Soxhlet extraction with chloroform was required to 
remove the inorganic impurities. Compound 4 was formed in 69% yield as a yellow solid. 
The 1H NMR spectrum revealed that 2 had been selectively reduced to the amine with no 
hydrolysis of the ester. A singlet was observed at S 5.94 corresponding to the amine protons 
and three singlets at S 3.92,3.81 and 3.75 corresponding to the methoxy protons. A singlet 
with at 8 9.97 was assigned as the amide proton. The full assignments are listed in Table 2.3 
and Table 2.4; the numbering is shown in Figure 2.5. 
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CH3 J /17 
CH3 EO Hi /9 
15 C1 H3 A0 HD 0 16 
O8 
14 NH2 k 10 11\ / 
/23 
\6 
1 12 13 
05 HF HG HH 
HB He 
Figure 2.5 4 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Label 6 Integration Multiplicity Type COSY to 111 at 6 
A 3.75 3 s CH3 none 
B 7.67 1 d CH 7.30 
C 7.30 1 dd CH 7.67,7.70 
D 7.70 1 d CH 3.75,7.30 
E 3.82 3 s CH3 7.70 
F 9.97 1 s NH none 
G 7.63 1 d CH 6.26 
H 6.26 1 dd CH 7.63,6.30 
I 6.30 1 d CH 3.82,6.26 
J 3.92 3 s CH3 6.30 
K 5.94 2 s NH2 none 
Table 2.3 Assignment of 1H NMR chemical shifts for 4 in d6-DMSO. 
59 
Chapter 2 Synthesis and Characterisation of Substrate-Linker Conjugates 
Label a Type HMQC to 'H at 8 HMBC to 1H at 8 
1 51.0 CH3 3.75 none 
2 164.9 Q none 7.67,3.75 
3 143.9 Q none 7.67,7.70 
4 131.5 CH 7.67 none 
5 110.4 CH 7.3 9.97,7.70 
6 112.9 Q none 7.70,7.30 
7 102.6 CH 7.7 9.97,7.30 
8 159.1 Q none 7.67,3.82 
9 55.1 CH3 3.82 none 
10 163.5 Q none 9.97,7.63 
11 153.7 Q none 7.63,6.30 
12 132.2 CH 7.63 none 
13 106.0 CH 6.26 6.30,5.93 
14 108.2 Q none 6.30,6.26 
15 95.4 CH 6.3 6.26,5.93 
16 158.5 Q none 7.63,6.30,3.92 
17 55.2 CH3 3.92 none 
Table 2.4 Assignment of 13C NMR chemical shifts for 4 in d6-DMSO. 
As for the previous compounds, the N-H stretch at 3340 cm-1 and bend at 1585 cm I 
confirmed the presence of the amide bond. Further evidence for successful reduction of the 
nitro group was provided by peaks at 3428,3238 and 1526 cm-1 in the FTIR spectrum 
corresponding to the two stretching and one bending vibrations of the amine. The EI-MS 
spectrum contained a peak at m/z 330, a loss of 30 (2 x0-2x H) compared to 2. 
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2.1.6. Methyl4-[(nicotinoyl)-amino]-2-methoxy benzoate, 5. 
Since pyridyl compounds have been shown to be suitable substrates7'8, nicotinic acid was 
coupled to the linker in a similar way (Scheme 2.6). 
OO 
CH3 
(L(°CH3 
NH2 
O 
+ 
OH 
N 
DMAP, NsCI, TEA 
CH3OH 
34% 
5 
Scheme 2.6 Synthesis of methyl 4-[(nicotinoyl)-amino]-2-methoxy benzoate, 5. 
Compound 5 was purified by recrystallisation from ethyl acetate giving the pure compound 
in 34% yield. The 'H NMR spectrum contained 4 resonances for the pyridyl protons; a 
singlet at 6 9.11, two doublets at 8.77 and 8.22 and a doublet of doublets at 7.44. Two 
singlets corresponding to the methoxy protons at 6 3.92 and 3.86 and two doublets and a 
doublet of doublets at 6 7.84,7.74 and 7.06 for the phenyl protons were assigned similarly to 
the previous compounds. The amide proton at 6 8.77 was shifted less downfield than for the 
previous compounds possibly due to the absence of a hydrogen bonding methoxy group. The 
FTIR spectrum contained an amide N-H stretch at 3324 and a bend at 1591 cm 1. The two 
carbonyl stretches were located at 1687 and 1670 cm 1. 
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2.1.7. Methyl 4-[(isonicotinoyl)-amino]-2-methoxy benzoate, 6. 
It would be beneficial to compare the effect of the nitrogen position on binding to XO. 
Therefore the isonicotinic acid derivative 6 was prepared in 40% yield after recrystallisation. 
6 
Figure 2.6 Methyl 4-[(isonicotinoyl)-amino]-2-methoxy benzoate, 6. 
The 'H NMR spectrum for the isonicotinic acid derivative, 6, contained only two doublets at 
6 8.82 and 7.71 corresponding to the pyridyl protons. A singlet at 6 8.04 corresponded to the 
amide proton indicating weak hydrogen bonding, if any, in solution. The remaining aromatic 
resonances at 6 7.86,7.74 and 6.99 were assigned to the phenyl protons as previously, as well 
as the two singlets at 6 3.94 and 3.88 to the methoxy protons. The FTIR spectrum contained 
an amide N-H stretch at 3342 and a bend at 1591 cm 1. The two carbonyl stretches were 
located at 1690 and 1670 cm 1. The ESI-MS for both 5 and 6 contained a molecular ion 
peak at m/z =285.0. 
On slow evaporation of solvent from a concentrated solution of 6 in ethyl acetate, large 
transparent crystals formed. The molecular structure shown in Figure 2.7 was determined by 
X-ray diffraction. The bond lengths and angles are listed in Table 2.5. 
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ý_ 02 
C 
Figure 2.7 ORTEP view of 6 with 50 % thermal ellipsoids; colours correspond to atom 
types, carbon: black, nitrogen: blue, oxygen: red, hydrogen atoms not shown. Original in 
colour. 
Table 2.5 Bond lengths [A] and angles [°] for 6. 
C(1)-0(2) 1.215-3)(13)) 0(2)-C(1)-C(2) 123.21(9) 
C(1)-O(1) 1.3315(12) 0(1)-C(1)-C(2) 115.48(9) 
C(1)-C(2) 1.4817(14) C(7)-C(2)-C(3) 117.94(9) 
C(2)-C(7) 1.3991(14) C(7)-C(2)-C(1) 115.62(9) 
C(2)-C(3) 1.4120(13) C(3)-C(2)-C(1) 126.42(9) 
C(3)-0(3) 1.3583(12) O(3)-C(3)-C(4) 121.89(9) 
C(3)-C(4) 1.3974(14) O(3)-C(3)-C(2) 117.78(9) 
C(4)-C(5) 1.3951(14) C(4)-C(3)-C(2) 120.33(9) 
C(5)-C(6) 1.4004(14) C(5)-C(4)-C(3) 120.00(9) 
C(5)-N(1) 1.4042(13) C(4)-C(5)-C(6) 120.18(9) 
C(6)-C(7) 1.3765(14) C(4)-C(5)-N(1) 123.36(9) 
C(8)-0(4) 12194(13) C(6)-C(5)-N(1) 116.44(9) 
C(8)-N(1) 1.3627(13) C(7)-C(6)-C(5) 119.20(9) 
C(8)-C(9) 1.5064(14) C(6)-C(7)-C(2) 122.32(9) 
C(9)-C(10) 1.3896(15) 0(4)-C(8)-N(1) 124 21(9) 
C(9)-C(13) 1.3913(14) 0(4)-C(8)-C(9) 119.97(9) 
C(10)-C(11) 1.3875(15) N(1)-C(8)-C(9) 115.82(9) 
C(11)-N(2) 1.3373(16) C(10)-C(9)-C(13) 118.36(9) 
C(I2)-N(2) 1.3413(16) C(10)-C(9)-C(8) 116.83(9) 
C(12)-C(13) 1.3931(15) C(13)-C(9)-C(8) 124.78(9) 
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C(14)-O(1) 1.4450(12) C(11)-C(10)-C(9) 118.64(10) 
C(15)-O(3) 1.4311(12) N(2)-C(11)-C(10) 124.10(11) 
N(2)-C(12)-C(13) 123.88(10) 
C(9)-C(13)-C(12) 118.44(10) 
C(8)-N(1)-C(5) 127.50(9) 
C(11)-N(2)-C(12) 116.54(10) 
C(1)-O(1)-C(14) 114.62(8) 
C(3)-O(3)-C(15) 118.19(8) 
Table 2.6 Torsion angles [O] for 6. 
O(2)-C(1)-C(2)-C(7) -12.45(15) 
O(1)-C(l)-C(2)-C(7) 166.31(9) 
O(2)-C(1)-C(2)-C(3) 166.15(11) 
O(1)-C(1)-C(2)-C(3) -15.09(15) 
C(1)-C(2)-C(3)-O(3) 2.03(15) 
O(4)-C(8)-C(9)-C(10) 24.21(15) 
N(1)-C(8)-C(9)-C(10) -155.31(10) 
O(4)-C(8)-C(9)-C(13) -153.76(11) 
N(1)-C(8)-C(9)-C(13) 26.72(15) 
N(2)-C(12)-C(13)-C(9) 0.36(17) 
O(4)-C(8)-N(1)-C(5) 4.27(17) 
C(9)-C(8)-N(1)-C(5) -176.23(9) 
C(4)-C(5)-N(1)-C(8) 2.93(17) 
C(6)-C(5)-N(1)-C(8) -178.71(10) 
O(2)-C(1)-O(1)-C(14) -3.14(15) 
C(2)-C(1)-O(1)-C(14) 178.07(9) 
C(4)-C(3)-O(3)-C(15) -2.42(15) 
C(2)-C(3)-O(3)-C(15) 177.92(9) 
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As can be shown from Figure 2.8 and Table 2.6,6 is almost entirely planar apart from a 
small rotation around N(l)-C(8)-C(9)-C(13)of 26.72°. The dihedral angle between the fitted 
planes of the two aromatic rings deviates by 29.35 (0.04)° from co-planarity (see Appendix 
for calculation). 
Figure 2.8 Capped-stick representation of 6 showing twist of the pyridyl group relative to the 
rest of the molecule. Original in colour. 
A possible reason for this twist can be inferred from the higher order structure. A weak 
hydrogen bond between N(1) of one molecule and the ester carbonyl oxygen. 0(2), on 
another creates a supramolecular array of criss-crossed species. The steric bulk of carbonyl 
oxygen and the ester group appear to cause the twist of the pyridyl group, as shown in Figure 
2.9. The hydrogen bond lengths and angles are listed below in Table 2.7. 
Table 2.7. Hydrogen bonds for 6 [A and °] 
D-H... A d(D-H) d(H... A) d(D... A) <(DHA) 
N(1 )-H(1)... 0(2)41 0.868(15) 2.062(15) 2.9257(12) 173.4(14) 
Symmetry transformations used to generate equivalent atones: 
#1 -x+3/2, y-I/2, -z+3/2 
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Surprisingly, there seems to be the only hydrogen bond present. The pyridyl nitrogen does 
not act as a proton acceptor; instead it lies at some distance from any possible donors. There 
also does not appear to be any it-stacking between the aromatic groups as there is an 8A 
distance between each of them. 
C4 
Figure 2.9 Capped-stick representation of the higher order solid state structure of 6. colours 
correspond to atom types: carbon: grey; hydrogen: white; nitrogen: blue; oxygen: red. 
Original in colour. 
This is in agreement with the spectroscopic evidence. The relatively upfield location of the 
NH proton at 6 8.04 in the 1H NMR spectrum suggests weaker hydrogen bonding in solution 
than the previous compounds such as 2 for which the amide proton lies at 6 9.76. 
2.2. A crystalline derivative of 2 coupled to ruthenium bis-bipyridine 
phenanthroline 
The trimer synthesised by Estroff et al. 4 ( was shown by X-ray diffraction to have a planar 
structure stabilized by intramolecular hydrogen bonds from the amide NH's to the 
neighbouring pyridine and alkoxy groups. The N---N and N---O bond lengths were reported 
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as 2.6-2.7 A and the chemical shifts for the amide protons were shifted downfield to 6 10.12 
and 10.27 in the 1H NMR spectrum. 
02 
Me 
Scheme 2.7. The trimeric nitro derivative reported by Estroff et a1.4 
By comparison, the resonance corresponding to the amide proton of 2 is shifted downfield at 
8 9.76, more towards that reported by Estroff et al. than that of 6 (8 8.04), suggesting that 
this amide proton is involved in hydrogen bonding in solution. The single amide N-H stretch 
at 3355 and bend at 1589 cm-1 in the FTIR spectrum of 2 is not dissimilar to the 
corresponding frequencies at 3342 and 1591 cni 1 of 6 suggesting that intramolecular 
hydrogen bonding is present for both compounds in the solid state. 
Crystals of sufficient quality for x-ray diffraction were not obtained for compound 2. As an 
alternative approach, 1 was coupled to 1,10-phenanthroline-5-ylamine to give the 
phenanthrolinyl ligand 7, which could be attached to a ruthenium bis bipyridyl complex to 
give an analogue which could be readily crystallised. X-ray diffraction was used to obtain a 
crystal structure for 7, from which the hydrogen bond lengths could be measured. 
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Scheme 2.8. Preparation of 2-methoxy-4-nitro-N (1,10-piýci, wiuuolin-5-yl)benzamide, 7 
performed by Albrighton9. 
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Scheme 2.9. Synthesis of [Ru(bpy)2(2-methoxy-4-nitro-N-(1,10-phenanthrolin-5- 
y1)benzamide)]2+, [8][Cl]2, performed by Albrighton9. 
The synthesis was performed by Albrighton9. The ligand and complex both contained a 
downfield resonance at S 10.3 corresponding to the amide proton and consistent with the 
intramolecular hydrogen bond. Subsequently, the PF6 salt of 8 was crystallised from 
acetonitrile by slow evaporation of the solvent. Figure 2.10 shows the structure obtained by 
X-ray diffraction and Table 2.8 lists selected bond lengths and angles. The ruthenium centre 
has octahedral geometry, typical for such complexeslo 
T 2+ 
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Figure 2.10 ORTEP view of [8][PF6 ]2 with 50 % thermal ellipsoids; colours correspond to 
atom types, carbon: black, nitrogen: blue, oxygen: red, ruthenium: grey, hydrogen atoms 
(except NH) not shown. Original in colour. 
Table 2.8 Bond lengths [A] and angles [°] in the ruthenium coordination sphere for 
8[8][PF6 ]2. 
N(1)-Ru(1) 2.066(2) N(6)-Ru(1)-N(8) 93.59(10) 
N(2)-Ru(1) 2.071(2) N(6)-Ru(1)-N(5) 78.80(10) 
N(3)-H(3A) 0.80(4) N(8)-Ru(1)-N(5) 95.92(10) 
N(5)-Ru(1) 2.062(3) N(6)-Ru(l)-N(7) 95.84(10) 
N(6)-Ru(1) 2.059(2) N(8)-Ru(1)-N(7) 79.04(10) 
N(7)-Ru(1) 2.066(3) N(5)-Ru(1)-N(7) 172.48(10) 
N(8)-Ru(1) 2.061(3) N(6)-Ru(1)-N(1) 93.75(9) 
N(8)-Ru(1)-N(1) 169.81(10) 
N(5)-Ru(1)-N(1) 92.43(10) 
N(7)-Ru(1)-N(1) 93.19(10) 
N(6)-Ru(1)-N(2) 171.42(10) 
N(8)-Ru(l)-N(2) 93.56(10) 
N(5)-Ru(1)-N(2) 95.75(10) 
N(7)-Ru(1)-N(2) 90.17(10) 
N(1)-Ru(1)-N(2) 79.77(10) 
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Table 2.9 Selected torsion angles [°] for [8][PF6'2. 
0(1)-C(13)-C(14)-C(19) 
N(3)-C(13)-C(14)-C(19) 
0(1)-C(13)-C(14)-C(15) 
N(3)-C(13)-C(14)-C(15) 
C(14)-C(13)-N(3)-C(11) 
C(12)-C(11)-N(3)-C(13) 
C(10)-C(11)-N(3)-C(13 ) 
-7.7(4) 
172.4(3) 
171.8(3) 
-8.2(4) 
-179.0(3) 
15.7(5) 
-162.9(3) 
The phenanthroline ligand is almost entirely planar, apart from two small twists either side of 
the planar amide bond. The torsion angles are given in Table 2.9. The dihedral angle 
between the fitted planes of the coupled aromatic ring and the phenanthroline deviates by 
10.19 (0.20)° from co-planarity. The intramolecular hydrogen bond between the amide 
proton and the methoxy oxygen is clearly evident as expected. The bond lengths are listed in 
Table 2.10 alongside the weaker hydrogen bond between the same proton and a nearby 
anion. The N---O bond length is much shorter for this compound than that of 2 (2.93 A) 
corroborating the spectroscopic evidence. 
Table 2.10 Hydrogen bonds for [8][PF6-]2 [A and °]. 
D-H... A d(D-H) d(H... A) d(D... A) <(DHA) 
N(3)-H(3A)... O(2) 0.80(4) 1.97(4) 2.662(3) 144(3) 
N(3)-H(3A)... F(4)#1 0.80(4) 2.60(4) 3.097(4) 121(3) 
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The higher order solid state structure contains pairs of complexes surrounded by counter ions 
(not shown). as in Figure 2.11. The pairs are held together by 71-71-stacking interactions. 
The intermolecular distance between the oxygen atom positioned over the centre of the 1t- 
electrons of the aromatic rings and the centroid itself is 3.4 A for both the coupled ring to the 
amide carbonyl (01) and the phenanthroline to the nitro oxygen (04). This short distance 
suggests significant parallel-displaced aromatic-aromatic interactions' 
Figure 2.11 Ball and stick representation of [8][PF6 ]2, colours according to atom types, 
carbon: grey, nitrogen: blue, oxygen: red, ruthenium green (hydrogen not shown). Original 
in colour. 
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2.3. Summary 
2.3.1. Synthesis 
A number of linker-substrate compounds have been prepared using peptide coupling. A 
synthetic strategy to build up compounds of different lengths has been developed whereby an 
ester protected aniline derivative has been coupled with a nitro protected benzoic acid 
derivative. The most successful method found to couple aromatic acids and amines such as 
these was the DMAP catalysed method developed by Lee et a1.2. In order to couple a third 
compound, the ester can be saponified to give the corresponding acid or the nitro group can 
be selectively reduced to give the corresponding amine. The selectivity of the reduction, 
which uses indium and ammonium chloride, is crucial to the strategy6. The compounds have 
been designed to maximise supramolecular binding to the active site of xanthine oxidase. 
The binding affinity of these compounds can be assessed using an enzyme affinity bioassay 
with the enzyme. The final probe will be based on the most appropriate compound. 
2.3.2. Characterisation 
Compounds 1-6 have been characterised by 'H and 13C NMR, FTIR and UV-Vis 
spectroscopy and electron ionisation or electrospray mass spectrometry. Full assignment of 
the NMR spectra was aided by 2D experiments, 'H - 
'H COSY, 'H - 
13C HMQC and 
HMBC. A successful coupling reaction was indicated by a solvent dependent downfield 
signal corresponding to the amide NH. The signal was located more downfield for 
compounds 2-4 than for compounds 5 and 6 due to the presence of hydrogen bonding in 
solution. 
The intramolecular hydrogen bond between the methoxy oxygen of the linker to a 
neighbouring amide proton was confirmed by X-ray diffraction of a ruthenium bis bipyridyl 
complex which could be readily crystallised. The H... 0 bond distance was measured to be 
1.97 A, appropriate for a hydrogen bond. 
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The remaining functional groups were identified from the FTIR spectrum. The ester 
carbonyls (1,2,4,5,6) were located around 1670-1700 cm 1, the acid carbonyl (3) was 
located at higher frequency at 1744 cm 1 and the amide carbonyls at slightly lower frequency, 
1630 -. 1680 cm 
1 (2 - 6). The NH stretch for each was at 3320 - 3355 cm 
1, the amide NH 
deformation was around 1585 - 1595 and the amine (1,4) NH deformation was at lower 
frequency at 1525 - 1565 cm 
1. The nitro antisymmetric stretch (2,3) was located at 1522 
cm 1 and the symmetric stretch at 1357 cm 1. The acid OH stretch (3) was located at 3271 
cm 1, and bend at 1283 cm 1. 
Each of the compounds contained strong absorption bands in the UV region of the spectrum. 
For compounds 1-4, the M' ion was observed in EI-MS, and fragmenting mostly occurred 
by cleavage of the amide bond. In the ESI-MS the M+ H+ adducts were observed for 
compounds 2-6. 
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TETRAPHENYL PORPHYRIN DERIVATIVES 
Chapter 3 
3. Tetraphenyl Porphyrin Derivatives 
3.1. Synthesis 
Tetraphenyl Porphyrin Derivatives 
The synthesis of porphyrins is typically achieved by the Adler-Longo method of heating 
benzaldehyde and pyrrole in propionic acid at reflux in air6. By this method tetraphenyl 
porphyrin (TPP) can be prepared in around 20% yield (Scheme 3.1). Variation of the 
aldehyde enables porphyrins with different substituents at the 5,10,15 and 20 positions to be 
synthesised. Unsymmetrical porphyrins can be obtained in this way by using two different 
benzaldehydes. However, a statistical distribution of products is obtained which must be 
separated and therefore limits the overall yield2. 
0 N 
H 
OH 
Scheme 3.1 Formation of tetraphenyl porphyrin by the Adler-Longo method6. 
The Lindsey method enables synthesis of porphyrins from more sensitive aldehydes in 
smaller quantities but much higher yields (35-40%)3. Pyrrole, benzaldehyde, triethyl 
orthoacetate (water scavenger) and boron trifluoride (catalyst) are reacted at room 
temperature in chloroform under nitrogen (Scheme 3.2). After an hour, equilibrium between 
the staring materials and tetraphenylporphyrinogen is established at which point the oxidant 
2,3,5,6-tetrachlorobenzoquinone is added and the reaction heated at reflux. The oxidant 
irreversibly converts the porphyrinogen to porphyrin. The purification is more facile since 
the tarry by-products, which contaminate the products from the Adler-Longo procedure, are 
not present. However, a high dilution of the reaction mixture (10-2 M) is required which 
limits the scale. The advantage of the Lindsey method is that porphyrins with ortho and 
pyrrole substituents can be obtained. 
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Scheme 3.2 Formation of tetraphenyl porphyrin by the Lindsey method2. 
A thorough review by Shanmugathasan et al. describes several other routes including the `2 
+ 2' route whereby two dipyrromethanes are condensed and the `3 + 1' route, condensation 
of a tripyrrane and a diformyl pyrrole, which enable the preparation of more highly 
substituted porphyrins2. 
A far simpler route to monofunctionalised porphyrins is to perform substitution reactions 
around a pre-formed porphyrin periphery. 
3.1.1.5-(4-Aminophenyl)-10,15,20-triphenylporphyrin, 9. 
Previous work at York on the synthesis of porphyrin derivatives5'6 involved the selective 
monofunctionalisation of commercially available TPP according to the method by Kruper et 
al. 7 (Scheme 3.3). 
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CHCI3,0-5°C 
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SnCI2, Conc. HCI, 
65°C 
90% 
9 
NO2 
Scheme 3.3 Preparation of free-base 5-(4-aminophenyl)-10,15,20-triphenyl porphyrin, 9, 
according to the method by Kruper et al. 7 
This is a simpler route to prepare asymmetrically functionalised porphyrins than the 
traditional mixed condensation routes described above3. The advantage is that this method 
avoids the lengthy purification required, can be carried out on a relatively large scale and 
improves the yield substantially. 
In this research, the porphyrin was functionalised according to the improved method by 
Luguya et al., whereby TPP was stirred with sodium nitrite in trifluoroacetic acid at room 
temperature for a few minutes8. This gave the para nitrated porphyrin, which was reduced 
by tin (II) chloride in hydrochloric acid to the corresponding amino porphyrin (9) (Scheme 
3.4). 
Tetraphenyl Porphyrin Derivatives 
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Scheme 3.4 Preparation of 9 according to the method by Luguya et al. 8 
Treatment of TPP in trifluoroacetic acid with sodium nitrite leads to stepwise selective 
nitration of the aryl groups at the para position in moderate conditions which enables the 
mono functionalised porphyrin to be obtained with little damage to the macrocycle. 
Preparation of 5-(4-nitrophenyl)-10,15,20-triphenylporphyrin (8) proceeded as in Scheme 
3.4, and was monitored by tlc. The reaction was quenched after a few minutes, as soon as a 
second spot from the dinitroporphyrin was observed. This eased isolation of the product, 
which was achieved by column chromatography eluting with dichloromethane. Unreacted 
TPP, the first band to elute, was recovered and reused. 8 was then reduced to the amino 
porphyrin 9 as above with 86% yield (63% overall). 8 and 9 were characterised by 'H NMR, 
FTIR and EI-MS. The data obtained agreed with the literature. 
3.1.2. Coupling of the Linker 
Unfortunately the poor solubility of the acid, 3, (Chapter 2) meant that coupling to the 
porphyrin was not achieved using standard coupling techniques 6,9> 10, However, coupling of 
2-methoxy 4-nitrobenzoic acid to 9 was achieved in excellent yield by the anhydride 
methods 1. Therefore the strategy of coupling the linker, reducing the nitro group to give the 
amine followed by a second coupling step was developed in order to build up probes of 
different lengths and which could easily be modified to improve binding to the enzyme 
(Scheme 3.5). 
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Scheme 3.5 Coupling of spacer to luminophore, 9, to give 10. 
Stirring 2-methoxy 4-nitrobenzoic acid in a solution of dicyclohexylcarbodiimide in dry 
acetonitrile gave the acid anhydride which, once the insoluble urea byproduct had been 
removed by filtration, was heated under reflux with the porphyrin 9 in 50: 50 v/v 
acetonitrile/chloroform. This produced free base 5-[4-[(2-methoxy-4-nitro-phenylcarbonyl)- 
amino] phenyl]-10,15,20-triphenyl porphyrin 10, which was purified by column 
chromatography over silica, in 86% yield. Zinc was then inserted to give 11 (Section 3.1.6. ). 
3.1.3. Reduction of the Linker 
The nitro group was reduced selectively using the method shown in Scheme 3.6, which was 
described previously6. 
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Scheme 3.6 Reduction of nitro group to give 12. 
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The ESI-MS of the reduced porphyrin contained peaks corresponding to the indium 
coordinated porphyrin at m/z = 891.5 (57 %) and with methanol at m/z = 922.5 (100%). 
Therefore the porphyrin was stirred in 5% sulfuric acid in trifluoroacetic acid to remove the 
metal. This further purification step, in addition to the poor solubility of the product, reduced 
the yield to 35%. Zinc was inserted into 12 to give 13 (Section 3.1.6. ). 
3.1.4. Coupling of the Substrate-Analogue 
The whole procedure was repeated to link a second unit. 14 was prepared in 78% yield in the 
same way as 10, by heating 12 with the acid anhydride. 14 was poorly soluble in most 
common laboratory solvents, precipitating from DMSO and chloroform solutions on 
standing. The solubility was improved by incorporating zinc to give 15 (Section 3.1.6). 
O 
O N02 
NH 
NH O 
CH3 
CH3 
14 
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3.1.5. Reduction of the Substrate-Analogue 
Compound 14 was reduced with indium and ammonium chloride to give 16 in a similar yield 
to 12 (30%). Preparation of the zinc derivative 17 is described in the following section. 
16 
3.1.6. Insertion of Zinc 
The desired metalloporphyrins were prepared by heating a solution of free base porphyrin in 
dichloromethane and methanol with zinc acetate dihydrate at reflux. The progress of the 
reaction can be monitored by UV-visible spectroscopy where a change from four Q-bands to 
two is observed. The zinc porphyrins were then purified by column chromatography over 
silica, eluting with chloroform and methanol to reduce the aggregation in solution. 
Compounds 10,12,14, and 16 were heated at reflux with zinc acetate as described 
previously to give zinc porphyrins 11(80%), 13, (94%), 15 (90%) and 17 (83%). 
H2 
11 13 
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There is an increased tendency for zinc porphyrins to aggregate in solution and therefore the 
solubility of each decreased with respect to the free base porphyrins in organic solvents. 
However, solubility in coordinating solvents such as methanol improved. Such aggregation 
was demonstrated by substantial broadening of the peaks in the 'H NMR spectra of 13. 
Addition of a drop of ds-pyridine disrupted this, causing sharpening of the peaks. The 
presence of aggregates was also observed in the electrospray ionisation mass spectrum of 13. 
A peak at m/z = 1682.9 corresponds to 2M - H+. 
3.2. Characterisation 
Porphyrins 10 -17 have been characterised by NMR, FTIR, UV-Vis and ESI-MS. 
The characterisation of 9 by NMR, FTIR, UV-Vis and ESI-MS has been reported in the 
literatures' 6,7,8 and the data for the compound synthesised here are in good agreement with 
the previously reported data. 
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3.2.1. NMR Spectroscopy 
Tetraphenyl Porphyrin Derivatives 
The porphyrins 10 - 17 were characterised using 1D 'H and 13C NMR and 2D 'H -'H COSY 
and 'H - 
13C HMQC and HMBC experiments. 
The 1H NMR spectra each contained several characteristic features. The signal with the 
furthest downfield shift at 8- 10 corresponded to the amide resonance (G) (Figure 3.1) and 
was indicative of a successful coupling reaction. The resonance was sharp and shifted 
further downfield than had been observed for porphyrins synthesised previously in the group 
(8-8.5 5,6) suggesting the presence of hydrogen bonding. The porphyrin pyrrole resonances 
were located at 6-8.9. These resonances appeared as two doublets each corresponding to 
two protons and one singlet corresponding to four protons. The singlet can be assigned to the 
four (D) protons that experience pseudo-DO symmetry. The doublets (D', D") are shifted 
downfield with the biggest shift for D" due to its proximity to the functionalised phenyl 
group which has a stronger ring current. The resolution varied depending on the compound 
and solvent and therefore they have been treated as one multiplet in most cases to ease 
assignment. The porphyrin phenyl ortho-protons (C, E) were assigned to the two doublets 
with integration 2 (E) and 6 (C) at 6-8.2 - 8.3. The meta-protons closest to the amide (F) 
were assigned to the doublet due to two protons, slightly upfield at 6-8.1. The meta- and 
para-protons (A, B) appear as a multiplet further upfield at 8-7.7 - 7.9 since they are 
further away from the field generated by the porphyrin ring current than C. The shifts of the 
remaining aromatic protons on the linker and substrate phenyl groups depend on their 
environment; most upfield for amine, most downfield for nitro. The methoxy protons located 
at 8-4.0 - 4.3 are similarly affected by nature of the neighbouring groups. The spectra for 
the free base porphyrins each contain a resonance between 5--2.5 and - 2.3 which are 
absent for the zinc porphyrins. These are assigned to the inner N-H protons shifted upfield 
by the porphyrin ring current. 
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Figure 3.1 Labelling of significant porphyrin protons (FB = free-base). 
The 13C NMR spectra were similar for each compound. The type of carbon was determined 
by DEPT 45,90 and 135 experiments. A broad signal at 5 130 - 135 was observed in the 
spectra for the free base porphyrins, which was assigned to the ß-pyrrolic carbons. Sharp 
resonances in the same region were observed for the zinc porphyrins. 
2D experiments were used to aid assignment of the 'H and 13C NMR spectra. The 'H-'H 
COSY spectra contained cross-peaks between neighboring protons three bonds apart. Weak 
`W coupling' was observed between protons (I and J) four bonds apart. CH and CH3 carbons 
were assigned from the 1H - 
13C HMQC spectra which contained cross peaks between 
carbons and protons one bond apart. Quaternary carbons were assigned from the 'H -13C 
HMBC spectra which contained cross peaks for carbons and protons two to four bonds apart. 
The spectra for the zinc porphyrins contained cross peaks between the ß-pyrrolic protons and 
carbons whereas the spectra for the free base porphyrins did not. Since the zinc porphyrins 
were more soluble and therefore produced better spectra, apart from 10, the zinc porphyrins 
will be discussed in more detail. 
Tetraphenyl Porphyrin Derivatives 
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3.2.1.1. Free Base 5-1 4-I(2-Methoxy-4-nitro-phenylcarbonyl)-aminoI phenyl-- 
10,15,20-triphenyl Porphyrin, 10. 
As for the compounds in Chapter 2. the 'H NMR spectrum of 10 in CDC13 showed a singlet 
at 6 9.99 assigned to the amide proton (G). a singlet at 6 4.31 due to the methoxy protons (K) 
and a singlet at ö -2.74 assigned to the inner N-H protons (L) of the porphyrin (Figure 3.2). 
HA 
21/CH3 K 
0 Hj 
0 
20 
15 19 
NO2 
N 14 16\ 18 
17 HGHH Hi 
Figure 3.2 10 with atom labels: letters assigned to protons and numbers assigned to carbons. 
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Figure 3.3 'H-'H COSY spectrum of 10 in CDC13. 
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Label 6 Integration Multiplicity Type COSY to H at 6 
A 7.78 3 M CH x3 8.26 
B 7.79 6 D CH x6 8.26 
C 8.26 6 D CH x6 7.78,7.79 
D 8.89 8 M CH x8 none 
E 8.29 2 D CH x2 8.11 
F 8.11 2 d CHx2 8.29 
G 9.99 1 s NH none 
H 8.58 1 d CH 8.05 
I 8.05 1 dd CH 8.58,7.96 
J 7.96 1 s CH 8.05 
K 4.31 3 s CH3 none 
L -2.74 2 s NH x2 none 
Table 3.1 Assignment of 'H NMR chemical shifts for 10 in CDC13. 
Iý 
+1 
PPM 
60 
70 
80 
90 
100 
110 
120 
130 
140 
150 
160 
10 9 
s. . 
T" 
"a 
87 
I 
65 ppm 
Figure 3.4 1H-13C HMQC (black) and HMBC (red) spectra of 10 in CDC13. Original in 
colour. 
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The crowded aromatic region was assigned by comparison with the spectra of the starting 
compounds and from the IH - 
IH correlation spectra (Figure 3.3, Table 3.1). The carbon 
assignments are listed in Table 3.2. 
Label a Type HMQC to H at S HMBC to H at 8 
1 126.7 CH 7.78 7.79,8.26 
2 127.8 CH 7.79 8.26 
3 134.6 CH 8.26 7.78,7.79 
4 120.2 Q none 8.26 
5 142.2 Q none 7.79 
6 142.1 Q none 7.78 
8 120.3 Q none 8.89 
9 138.8 Q none 8.11 
10 119.3 Q none 8.29 
11 135.3 CH 8.29 8.11 
12 118.9 CH 8.11 9.99,8.29 
13 137.4 Q none 9.99,8.29,8.11 
14 161.5 Q none 9.99,8.58 
15 150.6 Q none 8.58,7.96,8.04 
16 133.9 CH 8.58 none 
17 116.5 CH 8.04 7.96,8.58 
18 127.3 Q none 8.04,7.96 
19 107.0 CH 7.96 8.05,8.58 
20 157.3 Q none 8.58,7.96,4.31 
21 57.2 CH3 4.31 none 
Table 3.2 Assignment of 13C NMR chemical shifts for 10 in CDC13. 
88 
Chapter 3 Tetraphenyl Porphyrin Derivatives 
3.2.1.2. Zinc 5-[4-[(2-Methoxy-4-nitro-phenylcarbonyl)-amino] phenyll- 
10,15,20-triphenyl Porphyrin, 11. 
The 'H NMR spectrum of 11 in d8-THF contained a peak at 6 10.11 for the N-H proton (G) 
and a peak at 6 4.24 for the methoxy protons. The phenyl protons of the coupled unit were 
assigned at 6 8.26,8.01 and 7.98. In CDC13, which is non-coordinating, the N-H proton (G) 
was shifted upfield with respect to that measured in the coordinating solvent, d8-THF, 
whereas the remaining protons remained relatively unchanged. The 1H and 13C assignments 
are listed in Table 3.3 and Table 3.4; the numbering system is shown in Figure 3.5. 
HA 
117 
18 N02 
N 
), 
14 
HG O Hj 
21 
K 
Figure 3.5 11 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Label S Integration Multiplicity Type COSY to H at S 
A, B 7.75 9 m CH x9 8.25 
C, E 8.25 8 m CHx8 7.75,8.01 
D 8.96 8 m CH x8 none 
F, I 8.01 3 m CH x3 8.25,8.46 
G 9.93 1 s NH none 
H 8.46 1 d CH 8.01 
J 7.95 1 s CH 8.01 
K 4.27 3 s CH3 none 
Table 3.3 Assignment of 'H NMR chemical shifts for 11 in CDC13. 
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Label 8 Type HMQC to H at 8 HMBC to H at 8 
1 126.3 CH 7.7 none 
2 127.1 CH 7.7 8.17 
3 134.6 CH 8.17 7.7 
4 143.7 Q none 7.7 
5 150.1 Q none 7.79,8.92,8.84 
6 120.6 Q none 8.92,8.84,8.17 
7 131.8 CH 8.92 none 
7 131.6 CH 8.83 none 
8 120.4 Q none none 
9 150.3 Q none none 
10 138.1 Q none 8.14 
11 135.2 CH 8.14 none 
12 118.3 CH 8.00 8.14,8.00 
13 138.9 Q none 8.00 
14 163.9 Q none 8.19,6.25 
15 151.6 Q none 8.19,6.25 
16 134.5 CH 8.19 none 
17 108.1 CH 6.41 6.25 
18 112.1 Q none 6.41,6.25,4.07 
19 97.4 CH 6.25 6.41,4.07 
20 159.2 Q none 8.19,6.25,6.41,4.07 
21 56.1 CH3 4.07 none 
Table 3.4 Assignment of 13C NMR chemical shifts for 11 in CDC13. 
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3.2.1.3. Zinc 5-[4-[(2-Methoxy-4-amino-phenylcarbonyl)-amino] phenyl] - 
10,15,20-triphenyl Porphyrin, 13. 
HA 
H2 L 
Figure 3.6 13 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Label S Integration Multiplicity Type COSY to H at S 
A, B 7.70 9 m CHx9 8.17 
C 8.17 6 d CHx6 7.70 
D 
D' 
D" 
8.92 
8.84 
8.83 
2 
2 
4 
d 
d 
s 
CH x8 
8.84 
8.92 
E 8.14 2 d CH x2 8.00 
F 8.00 2 d CHx2 8.14 
G 10.01 1 s NH none 
H 8.19 1 d CH 6.41 
I 6.41 1 dd CH 6.25,8.19 
J 6.25 1 s CH 6.41,4.07 
K 4.04 3 s CH3 none 
L 4.07 2 s NH2 6.25 
Table 3.5 Assignment of 'H NMR chemical shifts for 13 in CDC13, d5-pyridine. 
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The 1H NMR spectrum of 13 contained a peak at 5 10.01 for the N-H proton and a peak at 8 
4.04 for the methoxy protons. The phenyl protons of the coupled unit were assigned at 8 
8.19,6.41 and 6.25 (Table 3.5). The carbon assignments are listed in Table 3.6 and the 
numbering system is shown in Figure 3.6. 
Label 8 Type HMQC to 'H at 8 HMBC to H at 8 
1 126.3 CH 7.7 none 
2 127.1 CH 7.7 8.17 
3 134.6 CH 8.17 7.7 
4 143.7 Q none 7.7 
5 150.1 Q none 7.79,8.92,8.84 
6 120.6 Q none 8.92,8.84,8.17 
7 131.8 CH 8.92 none 
7 131.6 CH 8.83 none 
8 120.4 Q none none 
9 150.3 Q none none 
10 138.1 Q none 8.14 
11 135.2 CH 8.14 none 
12 118.3 CH 8.00 8.14,8.00 
13 138.9 Q none 8.00 
14 163.9 Q none 8.19,6.25 
15 151.6 Q none 8.19,6.25 
16 134.5 CH 8.19 none 
17 108.1 CH 6.41 6.25 
18 112.1 Q none 6.41,6.25,4.07 
19 97.4 CH 6.25 6.41,4.07 
20 159.2 Q none 8.19,6.25,6.41,4.07 
21 56.1 CH3 4.07 none 
Table 3.6 Assignment of 13C NMR chemical shifts for 13 in CDC13, d5-pyridine. 
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3.2.1.4. Zinc 5-[4-{(2-Methoxy-4-[(2-methoxy-4-nitro-phenylcarbonyl)- 
amino]-phenyl carbonyl)-amino) phenyl]-10,15,20-triphenyl Porphyrin, 15. 
HA 
29 
17 
N 28 -O 
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20 _ 
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H 
i92/26< 
O 
4 25 
CH3K HM HN 
21 
Figure 3.7 15 with atom labels: letters assigned to protons and numbers assigned to 
carbons. 
Label a Integration Multiplicity Type COSY to H at S 
A, B 7.75 9 m CH x9 8.21 
C, E 8.21 6 m CH x8 7.75,8.04 
D 8.94 8 m CH x8 none 
F 8.04 2 d CHx2 8.21 
G 10.14 1 s NH none 
H 8.34 1 d CH 6.91,8.24 
I 6.91 1 d CH 8.34,8.24 
J 8.24 1 s CH 8.34 
K 4.24 3 s CH3 none 
L 9.86 1 s NH none 
M 8.42 1 d CH 8 
N 8.00 1 d CH 8.42,7.9 
0 7.90 1 s CH 8 
P 4.21 3 s CH3 none 
Table 3.7 Assignment of 'H NMR chemical shifts for 15 in CDC13, ds-pyridine. 
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The 1H NMR spectrum of 15 contained peaks at 5 10.15 and 9.96 for the N-H protons and a 
peak at 5 4.22 and 4.14 for the methoxy protons. These signals were distinguished by their 
respective coupling to carbon atoms on different ring systems in the HMQC and HMBC 
spectra. The phenyl protons of the coupled units were assigned at 8 8.36,8.23,7.93,7.83, 
7.19 and 6.94 (Table 3.7). The carbon assignments are listed in Table 3.8 and the 
numbering system is shown in Figure 3.7. 
Label 8 Type HMQC to 'H at 8 HMBC to 1H at 8 
1 126.5 CH 7.75 7.75 
2 127.5 CH 7.75 8.21 
3 134.5 CH 8.21 8.21,7.75 
4 121.1 Q none 8.21 
5 143.0 Q none 7.75 
6 150.3 Q none 8.94 
7 132.0 CH 8.94 none 
8 150.2 Q none 8.94 
9 137.9 Q none 8.21 
10 120.6 Q none 8.21 
11 135.1 Q none 8.21 
12 118.5 CH 8.04 10.14 
13 138.8 Q none 8.04 
14 163.1 Q none 8.34 
15 142.3 Q none 8.34,8.24 
16 134.4 Q none none 
17 112.7 CH 6.91 8.24,9.86 
18 117.8 Q none 8.24,6.91 
19 103.8 CH 8.24 9.86,6.91 
20 158.4 Q none 8.34,8.24,4.24 
21 56.6 CH3 4.24 none 
22 161.5 Q none 8.42 
23 150.8 Q none 8.42,7.9 
24 131.9 Q none none 
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25 116.5 CH 8. oo 7.90 
26 126.7 Q none 8.00,7.90 
27 107.1 CH 7.90 none 
28 157.3 Q none 8.42,7.91,4.21 
29 57.3 CH3 4.21 none 
Table 3.8 Assignment of 13C NMR chemical shifts for 15 in CDC13, d5-pyridine. 
3.2.1.5. Zinc 5-[4-{(2-Methoxy-4-[(2-methoxy-4-amino-phenylcarbonyl)- 
amino]-phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl Porphyrin, 17. 
The lH NMR spectrum of 17 contained peaks at 8 10.08 and 9.74 for the N-H protons and a 
peak at 8 4.17 and 3.65 for the methoxy protons. The phenyl protons of the coupled units 
were assigned at 6 8.24,8.13,6.85,7.51,4.79 and 4.54, the latter three shifted upfield due to 
the amine function. 'H NMR spectra for both 15 and 17 did not contain peaks at negative 6, 
demonstrating that the inner protons have been displaced by zinc. The 'H and 13C 
assignments are listed in Table 3.9 and Table 3.10; the numbering system is shown in 
Figure 3.8. 
HA 
29 
1 H3P 
O Ho 
28 27 
2- 
26 NH2 a 
24 25 
HM HN 
Figure 3.8 17 with atom labels: letters assigned to protons and numbers assigned to 
carbons. 
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Label S Integration Multiplicity Type COSY to H at S 
A, B 7.75 9 m CH x9 8.22 
C 8.22 6 m CH x6 7.75 
D 8.95 2 d CHx2 8.91 
D', " 8.91 6 m CH x6 8.95 
E 8.09 2 d CH x2 7.91 
F 7.91 2 d CHx2 8.13,8.09 
G 10.08 1 s NH none 
H 8.24 1 d CH 6.85 
I 6.85 1 dd CH 8.24,8.13 
J 8.13 1 s CH 7.91 
K 4.17 3 s CH3 none 
L 9.74 1 s NH none 
M 7.51 1 d CH 4.79 
N 4.79 1 d CH 7.51 
0 4.54 1 s CH none 
P 3.65 3 s CH3 none 
Table 3.9 Assignment of 'H NMR chemical shifts for 17 in CDC13, ds-pyridine. 
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Label S Type HMQC 
to'HatS 
HMBC 
to 1Hat S 
1 126.6 CH 7.75 none 
2 127.4 CH 7.75 8.22 
3 134.6 CH 8.22 7.75,8.22 
4 126.5 Q none 7.75 
5 143.1 Q none 7.75 
6 150.0 Q none 8.91 
7 131.9 CH 8.91 8.95 
8 120.9 Q none none 
9 137.8 Q none 8.09 
10 120.8 Q none 8.09,8.22 
11 135.4 CH 8.09 8.13 
12 118.6 CH 7.91 10.08,8.09 
13 138.5 Q none 7.91 
14 163.6 Q none none 
15 143.6 Q none 8.13 
16 132.9 CH 8.24 none 
17 112.4 CH 6.85 9.74,8.13 
18 116.4 Q none 6.85,8.13 
19 103.4 CH 8.13 6.85,9.74 
20 158.4 Q none 4.17 
21 56.6 CH3 4.17 none 
22 163.4 Q none none 
23 150.4 Q none none 
24 132.1 CH 8.95 8.91 
25 97.2 CH 4.79 none 
26 127.4 Q none none 
27 108.0 Q none none 
28 157.9 Q none 3.65 
29 55.8 CH3 3.65 none 
Table 3.10 Assignment of 13C NMR chemical shifts for 17 in CDCl3i d5-pyridine. 
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3.2.2. Infrared Spectroscopy 
Tetraphenyl Porphyrin Derivatives 
The solid state infrared spectra of compounds 10-17 showed the same characteristic 
absorption bands. Broad bands at - 3300-3400 cm-1 were typical of an N-H stretch. The 
sharper N-H deformations were located at - 1590-1650 cm 1. Characteristically strong bands 
for the carbonyl stretches were observed at - 1675-1650 cm 1. Sharp bands at - 2925 and 
3025 cm -1 correspond to an asymmetric and symmetric stretch of the methoxy C-H bonds. 
These were matched by the corresponding asymmetric and symmetric deformations at 
1470 and 1400 cm 1. Compounds 10,11,14 and 15 contained peaks at - 1530 and 1340 
cm 1 typical of the asymmetric and symmetric stretching frequencies of a nitro group. The 
spectra for each were unsurprisingly crowded in the region 1200-1000 cm -1 were the C-N, C- 
0 and C-C vibrations would be located13. The significant peaks in the infrared spectra of 
compounds 10 - 17 are summarised in Table 3.11. 
Compound 10 11 12 13 14 15 16 17 
C=O 1677 1675 1655 1629 1676 1675 1662 1665 
stretch 1624 1650 
N=O 1529 1526 1527 1525 
stretch 1347 1340 1346 1341 
N-H 3437 3434 3422 3443 3446 3430 
stretch 
3448 3432 3341 3379 3328 3364 3357 3361 
N-H 1591 1594 1591 1594 1584 1588 1584 1585 
bend 1519 1522 1517 1519 
Table 3.11 Summary of infrared absorption frequencies in cm -1 for compounds 10-11. 
3.2.3. Electrospray Mass Spectrometry 
The majority of compounds followed the typical ionisation pathway for ESI-MS and the M+ 
H+ adduct was observed in the positive ion spectrum while the M- H+ ion was observed in 
the negative ion spectrum. For zinc porphyrins 11 and 17 the oxidation product M+ was 
detected. For each of the zinc porphyrins the typical isotope pattern was observed. 
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Compound 
Molecular 
Mass 
Observed 
+ve ion 
m/z 
Assignment 
Observed 
-ve ion 
mh 
Assignment 
10 808.9 809.5 M+H 807.4 M-H 
11 870.2 870.3 M 
12 778.3 779.4 M+H 777.3 M-H 
13 840.2 841.0 M+H 839.1 M- 
14 957.3 958.4 M+H 956.2 M-H 
15 1019.2 1020.3 M+H 1018.4 M-H 
16 927.4 928.4 M+H 
17 989.3 989 M 988 M-H 
Table 3.12 Summary of molecular ion peaks m/z for 10 - 11. Peaks are calculated for 
12c, 
64Zn 
and 
14N. 
3.2.4. Ground State Electronic Spectroscopy 
The absorption spectra of the free-base porphyrins14"5 contain a strong Soret or B band at 420 
nm, four weaker Q bands at 500-700 nm and some weaker bands at higher energy (N, L, M 
bands). The zinc porphyrins have similar spectra except for a 10 nm red-shift of the Soret 
band and a reduction to two Q bands between 550-625 nm. 
For metalloporphyrins with Doh symmetry (such as ZnTPP) the LCAO-MO four orbital 
model by Gouterman provides an explanation of the origin of the transitions16. 
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Figure 3.9 Left: The ground state electronic configuration (al)2(a2i)2; Right: The four 
`Gouterman' orbitals16'18. 
The B and Q bands are strong and low in energy since they arise from allowed t-ºý* 
transitions. The ground state electronic configuration is shown in Figure 3.9; the first 
excited state has either the '(alu, eg) or the '(a2u, eg) configuration, according to MO theory 16. 
The result is two degenerate pairs of states (Q,, Qy, B,,, By). The bands are split into one 
strong transition (B band) and one weak transition (Q band) due to a strong electronic 
interaction between the dipole transition moments which add to give the Soret band and 
nearly cancel to give the Q band. The Q band is split due to vibrations of these states (0-0,0- 
1). The free-base porphyrins are not fully symmetrical and therefore the Q band splits into 
Q. and Qy, each with fundamental harmonics (0-0) and harmonics (0-1). 
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3.2.4.1. Free-base Porphyrins 
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Figure 3.10 Ground state electronic absorption spectra of 10,12,14 and 16 in DMSO. 
Original in colour. 
Figure 3.10 shows the absorption spectra of the free base tetraphenyl porphyrin derivatives, 
10-16. 
There is little change in 4,,, for each band but there is some variation in extinction 
coefficient of the Soret band. The free base porphyrins were poorly soluble in other solvents. 
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3.2.4.2. Zinc Porphyrins 
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Figure 3.11 Ground state electronic absorption spectra of 11,13,15 and 17 in DMSO. 
Original in colour. 
Figure 3.11 shows the absorption spectra for zinc tetraphenyl porphyrin derivatives 11-17. 
Typically, a reduction of four Q-hands to two can be seen, with a slight narrowing of the 
Soret band. There is little difference between each spectrum apart from the slight difference 
in absorption coefficient as was observed for the free base porphyrins. A plot of absorption 
intensity against concentration gave a straight line suggesting the absence of aggregates at 
this micromolar concentration range. 
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Figure 3.12 Solvent dependence of the electronic absorption spectra of 11 (A), 13 (B). 17 
(D) and ZnTPP (E). Original in colour. 
Figure 3.12 shows the solvent dependence of the Soret hands of the zinc tetraphenyl 
porphyrin derivatives compared with ZnTPP itself. Each exhibits the characteristic red shift 
of the absorption maxima with increasing polarity of the solvent". The Q-hands behave in 
the same way. This is a consequence of coordination to the metal by the solvent resulting in 
a five coordinate species. Nappa and Valentine concluded that the red shift was a 
predominantly dependant on the amount of negative charge transferred from the ligand to the 
porphyrin ring via the metal19. The extinction coefficients of the longer probes (15 and 17) 
are lower but the trend follows that of the shorter ones (11 and 13). 
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Solvent 
MeOH DMSO CHCl3 THE 
SORET 424 (709000) 429 (573000) 420 (607000) 422 (649000) 
11 Q1 556 (32100) 560 (14800) 547 (25200) 557 (20400) 
Q2 596 (15900) 602 (5810) 584 (7400) 595 (7730) 
SORET 425 (748000) 429 (597000) 421 (502000) 422 (514000) 
13 Q1 556 (27400) 560 (25400) 548 (24400) 557 (20000) 
Q2 595 (12900) 603 (17100) 584 (7030) 595 (10900) 
SORET 425 (539000) 429 (525000) 421 (507000) 422 (40000) 
15 Q1 556 (26200) 561 (19400) 548 (22900) 557 (1180) 
Q2 596 (14100) 602 (10900) 584 (7170) 597 (459) 
SORET 425 (537000) 429 (477000) 421 (343000) 422 (495000) 
17 Q1 556 (20600) 560 (12100) 547 (16200) 557 (19700) 
Q2 595 (9080) 603 (8140) 583 (2700) 596 (10400) 
Table 3.13 Summary of porphyrin Q and Soret absorption maxima in nm 
(c in dm3mol-'cm ') for zinc porphyrins 11-17 
3.2.5. Steady State Fluorimetry 
Since steady state fluorimetry will be used to probe binding of the porphyrin to the XO active 
site, it is necessary to first fully characterise the spectroscopic properties of the porphyrin 
compounds. Spectra shown in the same graph were obtained from solutions optically 
matched at the excitation wavelength. 
3.2.5.1. - Free Base Porphyrins 
Figure 3.13 shows the emission spectra for the free base porphyrins 10 - 16. There is little 
difference between each. The relative quantum yields for the longer probes, 14 and 16, were 
slightly larger than for the shorter ones, 10 and 12. There is a very small blue shift associated 
with the nitro compounds, 10 and 14, compared to the amines, 12 and 16. 
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Figure 3.13 Emission spectra for free base porphyrins 10 - 16 in DMSO,, = 420 nm. 
Original in colour. 
3.2.5.2. Zinc Porphyrins 
Zinc porphyrins emit strongly from the first singlet-excited state. Porphyrins can be 
fluorescent, phosphorescent, luminescent or radiationless. Typically zinc porphyrins decay 
by fluorescence ((pti -0-2x 10-3, decay rate kt1 -- 6.0 ns) from the lowest excited state ('Q 
14 4. 
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Figure 3.14 Emission spectra of zinc porphyrins 11 - 17 in DMSO. Original in colour. 
Each of the zinc porphyrins displayed similar emission spectra (Figure 3.14). As for the free 
base porphyrins, the spectra for the nitro porphyrins (11 and 15) had lower emission intensity 
than the amino derivatives (13 and 17) and the spectra for the longer probes (15 and 17) were 
lower in intensity than those for the shorter ones (11 and 13). 
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Figure 3.15 Emission spectra for (A) 15 and (B) 17 in different solvents. Original in colour. 
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The emission spectra for the zinc porphyrins were solvent dependant as observed for the 
absorption spectra. Figure 3.15 shows the emission spectra for 15 and 17 in coordinating 
(dimethyl sulfoxide and tetrahydrofuran) and non coordinating solvents (chloroform). The 
emission bands were most intense for the porphyrins in tetrahydrofuran and significantly red 
shifted compared with the corresponding bands in chloroform. This is a result of 
coordination of the solvent to zinc, forming a five-coordinate species14 
3.3. Summary 
3.3.1. Synthesis 
Tetraphenyl porphyrin derived probes of different lengths have been prepared by 
systematically coupling 5-(4-aminophenyl)-10,15,20-triphenylporphyrin, with 2-methoxy-4- 
nitrobenzoic acid, followed by selective reduction of the nitro group with indium and 
ammonium chloride then repetition to give 5-[4-{(2-methoxy-4-[(2-methoxy-4-amino- 
phenylcarbonyl)-amino]-phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin. The 
zinc analogues were prepared by heating the free base porphyrins with zinc acetate in 
methanol. Each compound was successfully purified by column chromatography. The 
synthesis is summarised in Scheme 3.7. 
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Scheme 3.7 Total synthesis of porphyrins 10 -17 
3.3.2. Characterisation 
Porphyrins 10 -17 were characterised by 
'H, 13C NMR, FTIR and UV-Vis spectroscopy and 
ESI-MS. 
In the 'H NMR spectra signals characteristic of a porphyrin were observed. For each amide 
bond a signal at S- 10 was observed and for each methoxy group a chemical shift at 8-4 
was present. In the 13C spectra the methoxy carbons were located at 6- 55. The aromatic 
carbons were located at 6- 100 - 150 and the most downfield chemical shifts at 6- 160 - 
170 were assigned to the carbonyls. The spectra were fully assigned using 2D experiments 
including 'H-'H COSY, 'H-13C HMQC and HMBC carried out on the zinc porphyrins. 
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Aggregation was observed in the NMR and ESI mass spectra for the amines 13 and 17. 
Deuterated pyridine was added to the samples to disrupt this and resulted in sharpening of the 
signals. 
For each of the porphyrins a molecular ion peak was observed corresponding to M+ }1 
except for two of the zinc porphyrins, 11 and 17, which contained molecular ions at M+ 
corresponding to the oxidised compounds. 
The infrared spectra contained the same characteristic absorption bands for each porphyrin. 
Notably the carbonyl stretch, N-H stretch and deformation and for compounds 10,11,14 and 
15 the N=O symmetric and asymmetric stretch were all assigned. 
Each porphyrin displayed solvent dependent absorption bands in the visible region. The 
extinction coefficient of the intense Soret band varied with the nature of the functional 
groups i. e. nitro or amine, but X,. a, did not vary. The extinction coefficients for the zinc 
porphyrin were higher than for the free base porphyrins. 
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4. Water-Soluble Porphyrin Derivatives 
Water-solubility is essential for biological applications. Consequently, the synthetic 
procedure described in chapter 3 was applied to a porphyrin that was subsequently 
derivatised to produce a charged periphery. 
4.1. Synthesis 
Initially, coupling 5-(-4-aminophenyl)-10,15,20-tris (4-sulfonatophenyl)-porphyrin 
illustrated in Figure 4.1 to the linker was attempted. 
Figure 4.1 5-(-4-aminophenyl)-10,15,20-tris (4-sulfonatophenyl)-porphyrin reported by 
Kruper et all. 
Computer modelling (Chapter 2) had shown that regions of opposite charge criss-cross the 
opening of the channel. It is therefore possible for the sulfonate groups of the planar 
porphyrin to be aligned along the electropositive domains as shown in Figure 4.2. This 
would minimise electrostatic repulsion between the enzyme surface and a negatively charged 
porphyrin. 
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Figure 4.2 Enzyme surface with exposed sulfonated porphyrin. Red and blue shading 
corresponds to negative and positive electrostatics of surface residues respectively. Original 
in colour. 
Unfortunately the reaction was unsuccessful with both the sodium and more soluble 
ammonium salts and such a reaction was not found in the literature. 
Several commercially available water-soluble porphyrins were initially investigated (Figure 
4.3). Tetracarboxyphenyl porphyrin (TCPP) was chosen since the carboxyl groups could be 
coupled to the amine function of the linker. However, this porphyrin had limited solubility in 
water, preferring basic solution. Tetraaminophenyl porphyrin was found to be soluble in 
acidic solution as was tetrapyridyl porphyrin. However, these could be methylated to give 
the water soluble tetracationic porphyrins (TAPP and TMPyP). The advantage of 
tetracationic porphyrins is that they are found to be water soluble over the whole pH range 
and do not suffer from the aggregation phenomena associated with tetraanionic porphyrins 
like TPPS3. 
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TCPP Tetra (4-aminophenyl) porphyrin 
Figure 4.3 Commercially available porphyrins 
Li et al. have synthesised a series of meso-5,10,15-tris(N-methyl-4-pyridiniumyl)-20-(4- 
alkylamidophenyl) porphyrins shown in Figure 4.4 for use as DNA photomodifiers4. 
1R= NH2 
2R= NHCOCH3 
3R= NHCO(CH2)6CH3 
4R= NHCO(CF2)6CF3 
5R= NHCO(CH2)14CH3 
6R= NHCOCH=CH2 
Figure 4.4 Porphyrins reported by Li et a14. 
Whilst some success was achieved at mono-functionalising tetra(4-aminophenyl) porphyrin, 
the pyridyl and pyridiniumyl porphyrins were found to be easier to handle. Therefore the 
approach was taken whereby 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 
prepared using the method described by Li et al., was coupled to 2-methoxy-4-nitrobenzoic 
acid using the DCC mediated method described for TPP derivatives. 
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4.1.1 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 19. 
/\ 
N 
H 
N 
OH 
CH3 
O-ý- NH 
0H 
Propionic aci 
Acetic anhydri 
4% 
HNýO 
CH3 
18 
Scheme 4.1 Preparation of free base meso-5-10,15, -tris(4-pyridyl)-20-(4- 
acetamidophenyl)porphyrin, 18, reported by Li et al. 4 
Free base meso-5-10,15, -tris(4-pyridyl)-20-(4-acetamidophenyl)porphyrin, 18, was prepared 
by the Alder-Longo method as described by Li et al. 4 in 4.2% yield, a little lower than 
described by the authors (5%) due to the extra purification steps added. To ease purification 
by column chromatography, the tarry black residue resulting from the reaction illustrated in 
Scheme 4.1 was washed with methanol using Soxhlet apparatus for up to one week to 
remove the polymeric material. The remaining residue was dissolved in dichloromethane 
and passed through a short plug of Florisil® eluting with chloroform-methanol (10: 1, v/v) to 
remove any remaining polymer 149. 
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NH2 
19 
Scheme 4.2 Preparation of free base 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 
19, described by Li et aL'49 
Compound 18 was deprotected by heating a 1: 1 trifluoroacetic acid, hydrochloric acid 
solution of the porphyrin at 80°C for 36 h, followed by neutralisation of the cold solution 
with aqueous ammonia (Scheme 4.2). Amine 19 was purified by column chromatography 
over silica, eluting with chloroform-methanol (80: 1, v/v). The yield was comparable to that 
reported by the authors (80%). 
4.1.2 Coupling of the linker 
Compound 20 was prepared using the anhydride procedure described for 10 as illustrated in 
Scheme 4.3. Purification was aided by extracting 20 into dilute hydrochloric acid and 
washing the green aqueous layer with dichloromethane. This enabled removal of the 
unreacted organic reagents and, moreover, the urea byproduct which was difficult to remove 
from the TPP derivatives. The acid was neutralised with ammonia solution and the purple 
precipitate was extracted with chloroform and purified further by column chromatography. 
The yield was 79% for this step, a little lower than for 10. 
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H3C- CH3 
Oz N02 
19, CHCI3 
79% 
O 
NO2 
NH 
O1 
CH3 
20 
Scheme 4.3 Preparation of free base 5,10,15-tris(4-pyridyl)-20-[4-[(2-methoxy-4-nitro- 
phenylcarbonyl)-amino] phenyl] porphyrin, 20. 
4.1.3 N-methylation 
Nitro compound 20 was methylated with methyl iodide as described by Li et al. and 
illustrated in Scheme 4.4. Having stirred the DMF solution of 20 with an excess of methyl 
iodide overnight, the solvent was evaporated and the porphyrin dried in a vacuum oven for a 
few days. No further purification was carried out. Methylation in all three positions was 
shown to be complete by 'H NMR spectroscopy and ESI-MS (chapter 7). The iodide salt 
was reasonably soluble in water and ethanol. 
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Scheme 4.4 Preparation of free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2- 
methoxy-4-nitro-phenylcarbonyl)-amino] phenyl] porphyrin tris iodide, 21, described by Li 
et al. 149 
4.1.4 Reduction of the linker 
21 was reduced with indium and ammonium chloride as for the TPP derivatives, as 
illustrated in Scheme 4.5. The reaction mixture was acidified slightly to enable filtration 
through Celite®. The solvent was removed and the residue taken up in water. Ammonium 
hexafluorophosphate solution in water was added dropwise until [22][PF6]3 precipitated. The 
yield for this step was 64%, an improvement over the TPP derivatives, probably due to the 
increased solubility of the halide salts in ethanol and water. The 'H NMR spectrum and ESI- 
MS indicated that the free base compound, not the indium porphyrin, was present at this 
stage. Water solubility of the compound could be achieved by conversion to the chloride 
salt. Compound [22][PF6]3 was dissolved in acetonitrile and tetrabutyl or tetraethyl 
ammonium chloride solution in acetonitrile added dropwise until the chloride salt [22][Cl]3 
precipitated. The product could be further purified by passing an aqueous solution through 
Sephadex G-10 size exclusion gel and/or precipitation from an aqueous or methanolic 
solution by addition of acetone. 
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[22] [PF6]3 
O 
NH2 
NH 
\CH3 
Scheme 4.5 Preparation of free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2- 
methoxy-4-amino-phenylcarbonyl)-amino] phenyl] porphyrin, [22] [PF6]3. 
4.1.5 Coupling of the substrate 
Isonicotinic acid anhydride was chosen as the substrate since the linker-substrate complex, 6, 
had an appropriate IC50 for this application (chapter 5). Isonicotinic acid itself was not 
sufficiently soluble in the solvents appropriate for the DCC mediated method used so far. 
The acid chloride and DMAP catalysed reaction were inappropriate since triethylammonium 
chloride is produced which would exchange anions with [22] [PF6]3i precipitating the 
porphyrin from acetonitrile before the reaction had gone to completion. Therefore 
commercially available isonicotinic acid anhydride was used directly, as illustrated in 
Scheme 4.6. 
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N/I ,N 76% 
[22][PF6]3 
HN 0 
H3C'0 /1 
HN 0 
N 
[24] [C1]3 
H 
Scheme 4.6 Preparation of free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-{(2- 
methoxy-4-[(pyridine-4-carbonyl)-amino]-phenylcarbonyl)-amino} phenyl]-porphyrin, 
[24][Cl]3" 
As for [22] [Cl]3, the compound could be further purified by passing an aqueous solution 
through Sephadex G-10 size exclusion gel and/or precipitation from an aqueous or 
methanolic solution by addition of acetone. The overall yield after purification was 76 %. 
4.1.6 Insertion of zinc 
The porphyrins were metallated by a similar method to the TPP derivatives. Following the 
procedure reported by Myatani et al. 7, free base porphyrins [22] [Cl]3 and [24] [Cl]3 were 
heated at reflux with ten equivalents of zinc acetate dihydrate in methanol for two hours. As 
Water-Soluble Porphyrin Derivatives 
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previously, the progress of the reaction could be monitored by UV-Vis spectroscopy. The 
metalloporphyrins were purified by addition of ammonium hexafluorophosphate solution to 
precipitate [23][PF6]3 and [25][PF6]3 accordingly, enabling unreacted zinc acetate and other 
inorganic byproducts to be washed off with water. The water soluble derivatives could be re- 
obtained by adding tetrabutylammonium chloride to the acetonitrile solution as previously. 
[23][Cl]3 and [25][Cl]3 (Figure 4.5) could then be purified by gel permeation 
chromatography through Sephadex LH-20, eluting with methanol. 
[23] [Cl]3 
4.2 
Figure 4.5 Water-soluble metalloporphyrins [23][Cl]3 and [25][Cl]3. 
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4.2. Characterisation 
Porphyrins 18 - 25 have been characterised by NMR, FTIR and UV-Vis spectrometry and by 
ESI-MS. 
The characterisation of 18 and 19 by NMR, FTIR and UV-Vis spectrometry and by ESI-MS 
has been reported in the literature4 and the compounds synthesised here are mostly in good 
agreement with the previously reported data. However, there was a discrepancy between the 
1H NMR data reported by Li et al. for 18 and that characterised here and for completion the 
characterisation data for each compound, including 18 and 19, will be discussed for 
comparison. 
4.2.1 NMR spectroscopy 
As for the TPP derivatives, porphyrins 18 - 25 were characterised using 1D 
'H and 13C NMR 
and 2D 1H - 
'H COSY and 1H - 
13C HMQC and HMBC experiments. The spectra were 
similar to those of the TPP derivatives with some characteristic differences which will be 
discussed. The spectra of the water-soluble porphyrins were run using d6-DMSO as the 
solvent since protic solvents such as D20 and CD3OD exchange with the NH protons so they 
cannot be observed. Despite broadening of the peaks, the spectra were of higher quality for 
the chloride salts in d6-DMSO than the PF6 salts in CD3CN. 
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4.2.1.1. Free base meso-5-10,15; tris(4-pyridyl)-20-(4-acetamidophenyl) 
porphyrin, 18. 
G 
Figure 4.6 18 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Label 8 Integration Multiplicity Type COSY to H at 8 Lit 
A 9.05 6 m CH x6 8.14 9.05 
8.10, 
B, D 8.14 8 m CH x8 7.94,9.05 
8.00 
8.84 4 s CH x8 none 8.85 
C 8.94 2 d CHx2 8.81 
9.05 
8.81 2 d CHx2 8.94 
E 7.94 2 d CHx2 8.14 7.10 
F 7.74 1 s NH none none 
G 2.38 3 s CH3 none 1.95 
H -2.89 2 s NH x2 none -2.95 
Table 4.1 Assignment of 'H NMR chemical shifts for 18 in CDC13. 
Table 4.1 lists the 'H NMR signals for the spectra of 18 in CDC13 along side those reported 
by Li et a!. 4 in the same solvent. The numbering system is shown in Figure 4.6. Some of the 
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signals reported here appear to be shifted downfield relative to those reported in the 
literature. Li et al. did not report a signal corresponding to the amide NH. For this reason 
the spectra were fully assigned using 2D experiments as for the novel compounds to prove 
the structure. The carbon assignments are listed in Table 4.2. 
Label 8 Type HMQC to 'H at 8 HMBC to 'H at 8 
1 148.5 CH 9.05 8.14 
2 129.4 CH 8.14 9.05 
3 117.5 Q none 8.14 
4 117.1 Q none 8.14 
5 150.1 Q none 9.05 
7 150.0 Q none 9.05 
8 138.1 Q none 8.14 
9 121.2 Q none 8.14 
10 135.2 CH 8.14 8.14 
11 118.2 CH 7.94 7.74 
12 137.4 Q none 7.94 
13 168.8 Q none 2.38 
14 24.9 CH3 2.38 none 
Table 4.2 Assignment of13C NMR chemical shifts for 18 in CDC13. 
Despite the differences between the proton spectrum reported here and that published by Li 
et al., the compound has been more thoroughly investigated in this work, including two 
dimensional experiments and 13C NMR spectra. Compound 18 has also been characterised 
by ESI-MS, infra-red and UV-Vis spectroscopy (see experimental), and the corresponding 
data agree with the proposed structure. These data were not published by Li et al. for 
comparison. 
4.2.1.2. Free base 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 19. 
The 'H NMR spectrum for 19 agreed with the published data4. 
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4.2.1.3. Free base 5,10,15-tris(4-pyridyl)-20-[4-[(2-methoxy-4-nitro-phenyl 
carbonyl)-amino] phenyl] porphyrin, 20. 
02 
H 
Figure 4.7 20 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Label S Integration Multiplicity Type COSY to H at S 10 
A 9.05 6 d CH x6 8.17 7.78 
B 8.17 6 d CH x6 9.05 8.26 
C 
8.85 
8.97 
6 
2 
m 
d 
CHx6 
CH x2 
8.97 
8.85 
8.89 
D 8.23 2 d CH x2 8.11 8.29 
E 8.11 2 d CHx2 8.23 8.11 
F 10.02 1 s NH none 9.99 
G 8.58 1 d CH 8.04 8.58 
H 8.04 1 dd CH 7.98,8.58 8.05 
I 7.98 1 d CH 8.04 7.96 
J 4.29 3 s CH3 none 4.31 
K -2.88 2 s NH x2 none -2.74 
Table 4.3 Assignment of 'H NMR chemical shifts for 20 in CDC13. 
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The 'H NMR spectrum was similar to the spectrum for 10 discussed in chapter 2 (Table 4.3). 
The porphyrin signals are located at similar chemical shifts. The pyridyl protons are shifted 
downfield relative to the phenyl protons of 10. The inner NH protons are shifted upfield 
relative to those of 10. The protons for the coupled linker have almost identical chemical 
shifts to those for 10. For compound 18 the amide NH proton was located at 8 7.74. The 
downfield chemical shift corresponding to the amide NH protons OF - 10) for 10 and 20 
suggests hydrogen bonding as was discussed in chapters 2 and 3. 
Label a Type HMQC to H at 8 HMBC to H at 8 
1 148.3 CH 9.05 8.17 
2 129.4 CH 8.17 9.05 
3 117.5 Q none 8.17 
4 117.1 Q none none 
5 150.2 Q none none 
7 150.1 Q none none 
8 138.0 Q none none 
9 121.1 Q none 8.23 
10 135.3 CH 8.23 none 
11 119.1 CH 8.11 4.29 
12 137.9 Q none 8.23,8.11 
13 161.6 Q none 8.58 
14 150.8 Q none 8.58,7.98 
15 134.0 CH 8.58 none 
16 116.6 CH 8.04 7.98 
17 127.3 Q none 8.04,7.98 
18 107.1 CH 7.98 none 
19 157.4 Q none 4.29,8.58,7.98 
20 57.3 CH3 4.29 none 
Table 4.4 Assignment of 13C NMR chemical shifts for 20 in CDC13. 
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As for the 'H NMR spectrum, the 13C NMR spectrum for 20 was similar to that of 10 except 
for the pyridyl carbons which were located more downfield than the phenyl carbons of 10 
(Table 4.4). 
4.2.1.4. Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4- 
nitro-phenylcarbonyl)-amino] phenyl] porphyrin tris iodide, 21. 
02 
Figure 4.8 21 with atom labels: letters assigned to protons and numbers assigned to carbons. 
Table 4.5 lists the 'H chemical shifts for 21 and the numbering system is shown in Figure 
4.8. In general the signals for 21 were broader than for the previous spectra due to the 
solvent. The amide NH proton was shifted considerably downfield and the inner protons 
were shifted considerably upfield relative to 20, due to hydrogen bonding with the solvent6. 
The pyridyl protons, A and B, and porphyrin protons, C, were shifted downfield due to their 
proximity to the positive charge. The phenyl protons of the bridge were present at similar 
chemical shift as in the 'H NMR spectrum of 21. 
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Label 8 Integration Multiplicity Type COSY to 'H at 8 
A 9.49 6 d CH x6 4.73,9.01 
B 9.01 6 m CH x8 9.49 
C 
9.18 
9.10 
8 m CH x8 none 
D, E 8.25 4 m CH x4 none 
F 10.92 1 s NH none 
G 7.94 1 m CH none 
H 8.03 1 m CH 7.94 
I 8.03 1 s CH 8.03 
J 4.12 3 s CH3 none 
K 4.73 9 s CH3 x3 9.49 
L -2.98 2 s NH x2 none 
Table 4.5 Assignment of 'H NMR chemical shifts for 21 in d6-DMSO. 
Label 8 Type HMQC to H at 8 HMBC to 'H at 8 
1 144.7 CH 9.49 4.73,9.49,9.01 
2 132.6 CH 9.01 9.49,9.18,9.01 
3 115.8 Q none 9.01 
4 115.0 Q none none 
5 157.1 Q none none 
7 157.0 Q none 9.49 
8 139.7 Q none 8.25 
9 123.2 Q none none 
10 135.4 CH 8.25 none 
11 118.7 CH 8.25 10.92 
12 136.2 Q none 8.25 
13 164.5 Q none 10.92 
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14 150.0 Q none 8.03 
15 130.6 CH 7.94 none 
16 116.2 CH 8.03 none 
17 127.6 Q none none 
18 107.5 CH 8.03 none 
19 157.4 Q none 4.12,8.04,7.94 
20 57.3 CH3 4.12 none 
21 48.5 CH3 4.73 9.49 
Table 4.6 Assignment of 13C NMR chemical shifts for 21 in d6-DMSO. 
The signals in the '3C NMR spectra were not shifted to the extent of the protons (Table 4.6). 
The strong resonance at 8 48.5 was assigned to the pyridinium methyl groups (21). 
4.2.1.5. Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4- 
amino-phenylcarbonyl)-amino] phenyl] porphyrin, 22. 
21 CH3 K 
Figure 4.9 22 with atom labels: letters assigned to protons and numbers assigned to carbons. 
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Label S Integration Multiplicity Type COSY to 'H at S 
A 9.53 6 m CH x6 4.73,9.00 
B 9.00 6 m CH x6 9.53 
C 9.13 8 m CH x8 none 
D 8.21 2 d CHx2 8.19 
E 8.19 2 d CHx2 8.21 
F 10.21 1 s NH none 
G 7.74 1 d CH 6.33 
H 6.33 1 dd CH 7.74,6.40 
I 6.40 1 d CH 6.33 
J 4.01 3 s CH3 none 
K 4.73 9 s CH3 x3 9.53 
L 5.97 2 br s NH2 none 
M -2.99 2 s NH x2 none 
Table 4.7 Assignment of 'H NMR chemical shifts for [22][Cl]3 in d6-DMSO. 
On reduction of the nitro group the chemical shifts for the porphyrin protons remained 
unchanged (Table 4.7). The protons on the linker, including the amide proton and the 
methoxy protons, were shifted upfield significantly as for the TPP derivatives. The amine 
protons were located at 8 5.97, which is more downfield than 12 because of hydrogen 
bonding to the solvent. 
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Label a Type HMQC to H at 6 HMBC to 11-1 at 8 
1 144.7 CH 9.53 4.73,9,9.53 
2 132.6 CH 9.00 9.53 
3 115.8 Q none none 
4 114.9 Q none none 
5 157.1 Q none none 
7 157.0 Q none 9.53 
8 140.3 Q none 8.19 
9 123.6 Q none none 
10 135.4 CH 8.21 none 
11 118.8 CH 8.24 10.21 
12 135.7 Q none 8.21 
13 164.7 Q none none 
14 154.6 Q none 7.74 
15 133.2 CH 7.74 none 
16 107.0 CH 6.33 6.4 
17 109.7 Q none 6.33,6.4 
18 96.6 CH 6.40 none 
19 159.6 Q none 4.01,7.74 
20 56.3 CH3 4.01 none 
21 48.3 CH3 4.73 9.53 
Table 4.8 Assignment of 13C NMR chemical shifts for [22][C1]3 in d6-DMSO. 
As for the lH NMR spectrum, the 13C resonances were unchanged for the porphyrin carbons 
and shifted upfield for the linker carbons, 14-19 (Table 4.8). 
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4.2.1.6. Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-((2-methoxy-4- 
[(pyridine-4-carbonyl)-amino]-phenylcarbonyl)-amino} phenylj-porphyrin, 24. 
iv 21CH3K 
Hin HN 
2 
3 17 NHL 
19 18 
:: 
°>irJ 
20 
J 
Figure 4.10 24 with atom labels: letters assigned to protons and numbers assigned to 
carbons. 
The 111 NMR chemical shifts for [24][Cl]3 are listed in Table 4.9. The numbering scheme is 
shown in Figure 4.10. The additional doublets at 5 8.35 and overlapping with B at 6 9.01 
correspond to the pyridyl protons. Two amide signals are located at 6 11.35 and 10.58. F is 
shifted further upfield due to hydrogen bonding to the neighbouring methoxy compared to L 
for which there is no neighbouring hydrogen bond acceptor. L is shifted upfield compared to 
that recorded for 6 (6 8.04, chapter 2) possibly due to hydrogen bonding to the solvent (6 was 
recorded in CDC13). 
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Label 6 Integration Multiplicity Type COSY to 'H at 6 
A 9.55 6 m CH x6 4.75,9.01 
B, M 9.01 8 m CH x8 9.55 
C 9.10 8 m CH x8 none 
D 8.29 2 d CH x2 8.23 
E 8.23 2 d CH x2 8.23 
F 11.35 1 s NH none 
G 7.87 1 s CH 7.72 
H 7.72 1 d CH 7.87 
I 7.95 1 s CH none 
J 4.06 3 s CH3 none 
K 4.75 9 s CH3 x3 9.55 
L 10.58 1 s NH none 
N 8.35 2 d CH 9.01 
0 -2.95 2 d NH x2 none 
Table 4.9 Assignment of IH NMR chemical shifts for [24][Cl]3 in d6-DMSO. 
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4.2.2 Zinc Porphyrins 
4.2.2.1. Zinc 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4-amino- 
phenylcarbonyl)-amino] phenyl] porphyrin, 23. 
Figure 4.11 23 with atom labels: letters assigned to protons and numbers assigned to 
carbons. 
On addition of zinc, the chemical shifts for the linker protons remained unchanged (Table 
4.10). The protons on the porphyrin itself were shifted slightly. The signals were too broad 
to enable assignment from the 2D 13C_ 1H experiments. However, the majority of the peaks 
were unaffected by chelation of zinc. From the comparison with the spectra for the free-base 
compound (Table 4.8), these are likely to be the linker carbon resonances (see experimental). 
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Label a Integration Multiplicity Type COSY to H at 6 
A 9.41 6 m CHx6 4.70,8.88 
B 8.88 6 m CH x6 8.98 
C 8.98 8 m CHx8 none 
D 8.17 2 d CHx2 8.10 
E 8.10 2 d CHx2 8.17 
F 10.18 1 s NH none 
G 7.76 1 s CH 6.33 
H 6.32 1 d CH 7.76 
I 6.39 1 s CH none 
J 4.02 3 s CH3 none 
K 4.70 9 s CH3 x3 8.98 
L 5.95 2 br s NH2 none 
Table 4.10 Assignment of 'H NMR chemical shifts for [23][Cl]3 in d6-DMSO. 
4.2.2.2. Zinc 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-{(2-methoxy-4- 
[(pyridine-4-carbonyl)-amino]-phenylcarbonyl)-amino} phenyl]-porphyrin, 25. 
Figure 4.12 25 with atom labels: letters assigned to protons and numbers assigned to 
carbons. 
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As for 23, the resonances for the porphyrin protons were shifted slightly on incorporation of 
zinc (Table 4.11). However, the chemical shifts for the linker protons were also shifted 
upfield, possibly due to interaction of the pyridyl group on the linker interacting with the 
metal centre. As for the previous compound (23) the resonances were too broad to enable 
assignments of the13C signals by HMQC and HMBC experiments. However, the majority of 
signals were not greatly affected by chelation of zinc (see experimental). 
Label S Integration Multiplicity Type COSY to 'H at 8 
A 9.48 6 m CH x6 4.75,8.92 
B 8.92 6 m CH x6 8.47 
C 9.00 8 m CH X8 none 
D 8.23 2 d CHx2 8.14 
E 8.14 2 d CHx2 8.23 
F 11.18 1 s NH none 
G 7.82 1 s CH 7.69 
H 7.69 1 d CH 7.82 
I 7.91 1 s CH none 
J 4.05 3 s CH3 none 
K 4.75 9 s CH3 x3 9.48 
L 10.98 1 s NH none 
M 8.81 2 d CH 7.99 
N 7.99 2 d CH 8.81 
Table 4.11 Assignment of 111 NMR chemical shifts for [25][Cl]3 in d6-DMSO. 
4.2.3 Infrared spectroscopy 
The infrared spectra of 18 - 25 were similar to those of the TPP derivatives. Each contained 
broad bands at- 3300-3400 cm 1 corresponding to N-H stretching modes. The sharper N-H 
deformations were located at - 1590-1650 cm 1. These bands are located at lower frequency 
for 20 and 21, which may posess intramolecular hydrogen bonds, than those for 18 which can 
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only hydrogen bond intermolecularly. Compounds 24 and 25 contain one amide 
neighbouring a methoxy group which may hydrogen bond intramolecularly to the amide 
proton, and one which is not and can only hydrogen bond intermolecularly. As a result, a 
low frequency and a higher frequency deformation are observed as for the amine dervatives 
(22,23). The carbonyl stretch for compound 18 was observed at 1671 cm 1. The 
corresponding stretching frequencies for compounds 20 - 25 were red shifted (-1630 cm 7l) 
due to intramolecular hydrogen bonding which causes the carbon-oxygen bond to have more 
single bond character (Scheme 4.7). 
O :: x: 
A B 
Scheme 4.7 Possible amide resonance structures. Hydrogen bonding favours B. 
Sharp bands at - 2925 and 2850 cm-1 correspond to an asymmetric and symmetric stretch of 
the methoxy C-H bonds. These were matched by the corresponding asymmetric and 
symmetric deformations at - 1470 and 1350 cm 1. Compounds 20 and 21 contained peaks 
at - 1520 and 1340 cm 1 typical of the asymmetric and symmetric stretching frequencies of a 
nitro group. The significant peaks in the infrared spectra of compounds 18 - 25 are 
summarised in Table 4.12. 
Compound 18 19 20 21 22 23 24 25 
C=O 1671 1638 1638 1636 1636 1636 1637 
stretch 
N=O 1522 1521 
stretch 1346 1346 
e 3432 3439 3429 3430 3426 3428 3421 3443 
stC tch 
N-H 1597 1602 1597 1594 
bend 1594 1593 1589 1589 1509 1508 1521 1526 
Table 4.12 Summary of infrared absorption frequencies (KBr pressed disk in cml for 
compounds 18-25. 
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4.2.4 Electrospray mass spectrometry 
Water-Soluble Porphyrin Derivatives 
As for the TPP derivatives, the M+ H+ adduct was observed for most of the compounds 
(Table 4.13). The spectra for the pyridyl porphyrins also contained peaks for the [M + 2H+] 
and [M + 3H+] adducts (see experimental). A different ionisation pathway was observed for 
21. A peak at m/z = 856 corresponding to reduction of the porphyrin, possibly by iodide 
(M3+ + 2e-), was observed. Porphyrins 22 and 23 were already charged and therefore the 
corresponding M3+ ions were observed. 
Compound 
Molecular 
Mass 
Observed 
+ve ion m/z 
Assignment 
18 674 675 M+H 
19 632 633 M+H 
20 811 812 M+H 
21 856 856 M 
22 826 275 M 
23 888 296 M 
24 931 310 M 
25 993 331 M 
Table 4.13 Summary of molecular ion peaks m/z for 18 - 25. 
4.2.5 Ground state electronic spectroscopy 
4.2.5.1. Free-base porphyrins 
Table 4.14 lists the Soret and Q bands with corresponding extinction coefficients for the 
porphyrin absorption bands for the free base porphyrins 20 - 22, and 24. The spectra for each 
were characteristic of free base porphyrins. The Soret and QX bands of 20 are located closer 
to those of TMPyP than 21, the methylated derivative, whereas the Qy bands are located 
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closer to those of 21. The difference in the Qy bands between 20 and TMPyP could be a 
result of the substituent in the yz plane of 20 compared to the D2h symmetry of TMPyP 
(Figure 4.13). 
Compound 
s Q1 Q2 Q3 Q4 
). 
Max 
E Imax E x Mal E 
I 
max E 
Amax E 
20* 422 167000 516 8210 552 4140 590 2710 647 1790 
TMPyP 422 235000 518 16300 554 6430 585 7520 640 2000 
21 431 142000 524 12300 564 7710 592 6350 649 2630 
22 429 124000 522 9780 564 8750 595 5840 653 3510 
24 434 117000 524 11600 566 11800 598 8120 620 6520 
Table 4.14 Summary of porphyrin Q and Soret (S) absorption maxima in nm and c in 
dm3morlcm-1 for free base porphyrins TMPyP, 21, [22][CI]3 and [24][Cl]3 in 0.5 mM 
potassium phosphate buffer, pH 7.5. * 20 in chloroform. 
rl 
x 
Figure 4.13 20 with labelled axes. 
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Figure 4.14 Ground state electronic absorption spectra of 21,22 and 24 in 50mM potassium 
phosphate buffer, pH 7.5. Bottom: expansion to show the Q-hands. Original in colour. 
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The absorption spectra for 21,22 and 24 shown in Figure 4.14 were all substantially red- 
shifted compared to those of 20 and TMPyP. The extinction coefficient of the Soret band for 
each was similar, however, . varied slightly between compounds. 22 was slightly blue 
shifted compared to 21,24 was slightly red shifted compared to 21. The Q-bands varied in 
intensity and wavelength as shown in the expansion in Figure 4.14. 
4.2.5.2. Zinc porphyrins 
Figure 4.15 and Table 4.15 and summarise the absorption spectra of probes 23 and 25. The 
spectra are similar, apart from a slight red shift for compound 25 relative to 23. The spectra 
are both red-shifted relative to the corresponding free base compounds, causing their green 
colour. 
1.2x105 
1.0x105 
8.0x10` 
6. Ox104 
4.0x104 
2. Ox104 
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300 
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Figure 4.15 Ground state electronic absorption spectra of [23][CI]3 and [25][CI]3 in 50 mM 
potassium phosphate buffer, pH 7.5. Bottom: expansion to show the Q-bands. Original in 
colour 
Compound 
s QI Q2 
Amax E Amax £ Amax 
23 436 108000 565 10300 615 6040 
25 442 110000 569 11500 614 6520 
Table 4.15 Summary of porphyrin Q and Soret (S) absorption maxima in nm and c in 
dm3mol-'cm ' for zinc porphyrins [23][C1]3 and [25][C1]3 in 50 mM potassium phosphate 
buffer, pH 7.5. 
4.2.6 Steady State Fluorimetry 
4.2.6.1. Free-base porphyrins 
Figure 4.16 shows the emission spectrum of free base porphyrins 21, [22][Cl]3 and 
[24][C1]3. Spectra shown in the same graph are obtained from solutions optically matched at 
the excitation wavelength. The emission spectrum of 21 was similar to that of TMPyP in 
shape and the quantum yield was 50% of that of TMPyP. The quantum yields of 22 and 
24 were much lower and the spectra contained a more intense shoulder at shorter wavelength. 
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Figure 4.16 Corrected and optically matched emission spectra for 21, [22][CI]3 and 
[24][Cl]3 in 50mM potassium phosphate buffer, pH 7.5. X = 420 nm. Original in colour. 
4.2.6.2. Zinc porphyrins 
The emission spectra for the zinc porphyrins 23 and 25 are shown in Figure 4.17. The 
spectra are similar in intensity and kThe spectra are blue-shifted and more intense 
relative to the free base derivatives. 
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Figure 4.17 Corrected and optically matched emission spectra for [23][C1]3 and [25][C1]3 in 
50mM potassium phosphate buffer, pH 7.5. Xex = 435 nm. 
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4.3 Summary 
4.3.1 Synthesis 
A procedure modified from that used for the TPP derivatives, incorporating some of the 
methods reported by Li et al. was carried out to produce water-soluble porphyrins 21 to 25. 
5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, was prepared using the method 
described by Li et al., and coupled to 2-methoxy-4-nitrobenzoic acid using the DCC 
mediated method described for TPP derivatives. The pyridyl groups were then methylated 
using methyl iodide as reported by Li et al. The nitro group was reduced using indium and 
ammonium chloride and the substrate was coupled to the resulting amine. Indium was not 
introduced to the pyridinium porphyrin since the electron withdrawing groups reduce the 
basicity of the pyrrole nitrogens. Anion exchange was used to modify the solubility of the 
porphyrins and to purify the compounds at each stage. The application of the synthetic 
procedure (peptide coupling of a nitro substituted benzoic acid derivative to an amino 
porphyrin, reduction to give the amine, followed by coupling to a second unit) to both 
hydrophobic (TPP) and hydrophilic (TMPyP) porphyrins demonstrated the versatility of the 
reactions involved. A summary is illustrated in Scheme 4.8. 
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Scheme 4.8 Synthesis of water-soluble probe 25. 
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4.3.2 Characterisation 
Porphyrins 18 - 25 were characterised by 
'H, 13C NMR, FTIR and UV-Vis spectroscopy and 
ESI-MS. 
The 'H and 13C NMR spectra were similar to those for the TPP derivatives. 'H-'H COSY, 
'H-13C HMQC and HMBC experiments were carried out to enable full assignment of the 1H 
and 13C spectra. 
For each of the porphyrins, a molecular ion peak was observed corresponding to M+ H+ for 
compounds 18 - 20 and for the water-soluble porphyrins 22 - 25 the M3+ molecular ion was 
observed. The exception was compound 21 which appeared to be reduced, possibly by the 
iodide counter ions, for which a peak corresponding to the singly charged molecular ion (M3+ 
+ 2e-) was observed. 
The infrared spectra contained the same characteristic absorption bands for each porphyrin. 
Notably the carbonyl stretch, N-H stretch and deformation and for compounds 20 and 21 the 
N=O symmetric and asymmetric stretch were assigned. 
Each porphyrin displayed intense absorption bands in the visible region. The extinction 
coefficient and ),,,, of the intense Soret band as well as the Q-bands varied significantly with 
the nature of the functional groups i. e. nitro, amine vs pyridine. In contrast to the TPP 
derivatives, the extinction coefficients for the zinc porphyrin were lower than those of the 
free base porphyrins, possibly as a result of coordination to water. 
Compounds 18 - 25 each gave broad emission bands between 600 and 800 Mn upon 
excitation at 420 nm. The quantum yields were lower than that of TMPyP but were 
sufficiently high to compete with absorption from XO in assay conditions. 
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Chapter 5 
5 Enzyme Inhibition Studies 
5.1 Introduction 
Enzyme Inhibition Studies 
In order to compare the binding affinity of the compounds prepared, enzyme affinity 
bioassays were carried out. Understanding the kinetics of the enzyme of interest is essential 
when selecting the appropriate conditions for the bioassay. Therefore, some of the 
fundamentals will be discussed so as to highlight some general considerations and more 
specific issues relating to the XO activity assay. 
5.1.1 Historical Overview 
Early kinetic studies of unireactant enzymes led to the general rate equations shown below, 
(1), for the following reaction: 
E+S 
- 
ES 
kp 
- E+P 
k_I 
Where E is the free enzyme, S is the free substrate, ES is the enzyme substrate complex and 
P is the free product. 
The Henri equation': 
v= K[S] 
1+ [S]/Ks 
[S] =a fixed enzyme concentration 
v= initial velocity at the given [S] 
= d[P] / dt or - d[S] / dt 
kp = rate constant for the breakdown of ES to E+P 
Ks = the dissociation constant of the ES complex 
(1) 
=1-1 / k1= [E][S] / [ES] 
K=a constant, characteristic of the enzyme preparation 
kk[E]t / Ks 
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[E]t = the total concentration of enzyme 
= [E] + [ES] 
The Henri equation can be applied to a reaction for which a number of assumptions are valid. 
1) E is a catalyst. 
2) E and S react rapidly to form ES (k1 is fast). 
3) Only a single S and a single ES are involved and ES breaks down directly to form 
free E and P. 
4) E, S, and ES are at equilibrium: k. 1» kp. 
5) [S] » [E]: the formation of an ES complex does not alter [S]. 
6) The overall rate of the reaction is limited by the breakdown of the ES complex to 
form E and P. 
7) The velocity is measured during the very early stages of the reaction so that the 
reverse reaction is insignificant. 
To summarise, only the early components of the reaction are assumed to be at equilibrium. 
This is known as the rapid (quasi-) equilibrium assumption. Due to assumption 3, the rate is 
proportional to [ES], the only product forming species. This enables a kinetic expression to 
be obtained from an equilibrium expression ([E], = [E] + [ES]). Equation (1) is more 
commonly known in the form below (3): 
The Michaelis-Menten equation': 
kp [E]r [S] 
= 
Ks + [S] 
(2) 
v= kp[ES] 
kp[E]r = Vmax 
[S] 
Vmax KS + [S] 
(3) 
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Vmax = the limiting maximal velocity that would be observed when all the enzyme is present 
as ES. 
Therefore, providing assumption 4 holds, exact steady state treatment can be avoided and a 
simple kinetic system can be used to model the mechanism of the enzyme. 
Van Slyke derived a similar equation (4) based on the assumptions that the overall reaction 
occurred in two irreversible steps and that the time taken for the overall reaction was the sum 
of the times for each step. 
E+S 
ký 
ii- ES 
kp 
--33. - E+P 
kp [E]r [S] 
K+ [S] 
(4) 
This equation differs from the previous equations since K is the ratio of forward rate 
constants (kp/kl) instead of the equilibrium constant. 
A generalized method was derived by Briggs and Haldane. This approach does not require 
ES to be in equilibrium with E and S (assumption 4), nor the irreversible reactions (Van 
Slyke). Instead it allows [ES] to be obtained from steady-state equations instead of 
equilibrium expressions. 
E+S 
kl 
b ES 
ES 
kl 
> E+S 
k 
ES P> E+P 
1+ d[ S] = ki[E] [S] dt 
) 
d[ES] 
= k., [ES] + kp [ES] = (k., + kp) [ES] dt 
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Within a very short time after starting the reaction, ES builds up to a near constant ('steady- 
state') level. At this point ES is formed at the same rate as it decomposes. As the ratio of 
[S]o/[E]t (where [S]o is the initial substrate concentration) increases, the steady state 
assumption becomes more valid since the time taken to reach steady state conditions 
decreases and the duration under those conditions increases. Therefore, this approximation is 
appropriate for in vitro enzyme studies performed using a catalytic [E]. 
+ 
d[ES] )=(- d[ES] d[ES] 0 dt dt or dt = 
kl [E] [S] = k_1 [ES] + kp [ES] = (k. 1 + kp) [ES] 
As for the previous approach: 
[ES] _ 
(k 
1 
+SkP). 
[E] 
v= kp[ES] 
v kp[ES] 
[E]r [E] + [ES] 
kl [S] 
E 
v (k. l + kp) 
kp[E]r 
[EI + 
ki [S] 
[EI 
(k. 1 + kp) 
kp[E]r = Vm. 
kl [S] 
v (k. 1 + kp) 
VIZ, 
1+ 
k1 [S] 
(k_1 + kp) 
k. 1+kp 
Km 
k t 
1) [S] 
Vmax Km + [S] 
(5) 
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K,  is the Michaelis constant. It is a dynamic or pseudo-equilibrium constant which 
expresses the relationship between the actual steady-state concentrations rather than the 
equilibrium concentrations. When k» kp, K, n - k-1 / kl - Ks (the dissociation constant for 
ES). When k« kp, K, n - kp / kl (a kinetic constant). When more complex systems are 
examined, the final equation has the same form as that derived for rapid equilibrium 
conditions or steady-state conditions described here. The differences are the definitions of K, n 
and Vmax with respect to the rate constants. 
5.1.2 Significance of Km1 
" K, n relates the velocity of an enzyme-catalysed reaction to the substrate concentration: 
IS] 
Vmax 
K"'+[S] (6) 
" Km is numerically equivalent to the substrate concentration that yields half-maximal 
velocity: 
when [S] = Km 
= 
Km 
Vmax = 1/2 Vmax 
K, n + Kn, (7) 
" K, n is a means of comparing enzymes e. g. deduce those which are structurally 
different but catalyse the same reaction. 
" K. is a means of determining assay conditions where [S]» Kn from which Vm. and 
[E], can be estimated. 
" Monitoring the effects of different compounds on K. is a means of identifying new 
inhibitors/activators for a particular enzyme. 
The last point is the basis of enzyme affinity bioassays whereby an inhibitor is added to a 
solution of an enzyme and a known substrate. The effect on the observed value of K. 
compared to the inhibitor-free reaction indicates the relative binding strength of the inhibitor. 
Since K. is required in order to choose the appropriate [S] in the assay, it must be calculated 
for the XO catalysed reaction. 
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5.1.3 Plotting v against [S] 
Figure 5.1 shows a plot of v vs. [S] for an enzyme-catalysed reaction which obeys 
Michaelis-Menten kinetics. The curvature is fixed and independent of K,  and Vm.. There 
are three distinct regions which have different reaction orders. 
Vmar 
0.5 Vmax 
0 
Enzyme Inhibition Studies 
v_ IS] 
Vmax Km + [S] 
[S]0.5 = Km 
Km IS] (M) 
Figure 5.1 u vs. [S] plot for a reaction obeying Michealis-Menten kinetics: (Vm - v)(K, n + 
[S]) Km-V U max 
5.1.3.1 First-Order Region 
At low substrate concentrations ([S] < 0.01 Km), the curve is approximately linear (v 
proportional to [S]) (Figure 5.2) 
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Figure 5.2 Black: u vs. [S] plot where [S] «Km; Red: true first-order behaviour'. 
This is because when [S] « K,,,, [S] in the denominator in equation (6) can be ignored: 
[SI V may uk [s] K"' 
or (8) 
k= first order rate constant = Vn,. /K,,, (min-') (K,,, in moles x 1-1, u in moles x 1-1 x min-) 
i. e. k is the fraction of substrate converted to product per unit of time (e. g. minutes). 
The integrated form of the first order rate equation can be used to determine the amount of 
substrate used or product formed at time 1. 
[S] = [Sloe k' (9) 
A plot of [S] or [P] vs. time is shown in Figure 5.3. 
*I 
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Figure 5.3 Plot of [S] (solid line) and [P] (dashed line) vs. time for the first-order region of 
the velocity curvet. 
A linear plot can be obtained by taking log [S] vs. time as shown in Figure 5.4. 
[s], 
p %21og 
In 
Time 
Figure 5.4 Semilog plot of the integrated first-order velocity equation'. 
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5.1.3.2 Zero-Order Region 
Enzyme Inhibition Studies 
At very high substrate concentrations ([S] > 100 K,,, ), u is approximately independent of [S]. 
At this point the enzyme may be described as 'saturated' (Figure 5.5). 
1.0 
0.9 
0.00 
0 
Figure 5.5 Black: v vs. [S] plot where [S] > Km; Red: true zero-order behaviour 1,2 
This is because when [S]»K,,, the denominator of the Michaelis-Menten equation (5) may be 
ignored. 
u_ 
Vma, [s] 
[S] 
or u Vmax (10) 
A plot of [S] vs. time in the zero-order region of the velocity curve is shown in Figure 5.6. 
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Figure 5.6 [P] (Black) and [S] (Red) vs. time for the zero-order region of the velocity 
i curve . 
In between these regions (moderate [S]) the curve follows neither first-order nor zero-order 
kinetics. 
The hyperbolic u vs. time curve makes determination of Km and Vax impossible (they are 
asymptotes of the u vs. [S] hyperbolic curve). There are number of different ways of 
rearranging the Michaelis-Menten equation in order to simplify the estimation of K, n. 
A plot of u vs. log[S] according to equation (11) gives a sigmoidal curve. At the point of 
inflection [S] = K,,,. 
lo 
Vmax 
u 
When u=0.5 Vmax 
Vm/ v-1 =1 
log (Vmax/ U-1) =0 
log [S] = log Km 
-1= log Km - log [S] 
or [S] = K,,, 
(11) 
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The Lineweaver-Burk plot is based on the rearrangement of the Michaelis-Menten equation 
to give a linear form. 
1_ Km 1+1 
Vmax IS] Vmax 
(12) 
A plot of 1/v vs. 1/[S] gives a straight line of gradient Km/ Vmax and intercept on the 1/v axis 
of 1/ Vmax and on the 1/[S] axis of-1/K,,,. 
The nature of the hyperbolic u vs. time curve has implications on the conditions chosen for 
the assay. For a Lineweaver-Burk plot, the substrate concentrations must be carefully chosen 
to be in the intermediate range (0.3-0.7 Vm ), of similar magnitude to K,,,, and chosen to give 
evenly spaced reciprocals. For the sigmoidal plot, log[S] should be evenly spaced. 
5.1.4 Turnover Rate 
Vma., varies with enzyme concentration and enzyme concentration can be difficult to measure. 
Also, the true value of Vm. is impossible to determine experimentally (even at [S] = 10 K,, v 
< 10 % Vmax2). Therefore a means of describing the turnover rate of an enzyme in an assay 
cannot be described in terms of Vm. Instead, catalytic activity is often defined in terms of 
`units' (U). One unit is the amount of enzyme required to catalyse the transformation of one 
µmol of substrate into products in one minute under defined conditions (usually 25°C, pH 
7.5)1,2. 
5.1.5 Measuring Enzyme Inhibition 
Inhibitors reduce the rate of an enzyme catalysed reaction1' 2. Therefore they can be used as 
drugs, such as allopurinol as an inhibitor of XO. Irreversible inhibitors (catalytic poisons) 
reduce the enzyme activity to zero. Reversible inhibitors proceed by either a competitive 
(increased K,, ), non-competitive (decreased Vm ), uncompetitive (decreased Vm. and K. ) or 
a mixed (combination) inhibition mechanism. In these situations the enzyme-inhibitor 
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complex has no activity. Partial inhibition occurs when some activity is retained by the 
enzyme-inhibitor complex. Competitive inhibition occurs when the enzyme and substrate 
compete for the same site. In this situation, the inhibition constant, K; is a true equilibrium 
constant (13). 
Ks kp 
E+S l= ES -» E+P 
+ 
K; 11 EI 
Ki = [E] [I] / [EI] 
vi [I] 
vo [I] + K; (1 + [S]/K,, ) 
v; = initial velocity in the absence of an inhibitor 
vo = initial velocity in the presence of an inhibitor at the same [S] as v; 
5.1.5.1 The IC50 
(13) 
[I]0.5 is the concentration of inhibitor required to reduce the rate of the reaction by 50 %. 
[I]o. 5 = (1 + [S]/Km) Ki (14) 
A plot of (1-v; / uo), the percentage inhibition, vs. log [I] gives a sigmoidal curve. The point 
of inflection can be determined by non-linear regression analysis and is known as the IC50. 
The IC50 is the half maximal inhibitory concentration, [I10.5. It is dependent on enzyme 
concentration and therefore the assay conditions must be stated and values are usually quoted 
relative to a standard or well-characterised inhibitor. 
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5.1.5.2 The Double Reciprocal Plot 
An alternative method of comparing the effectiveness of an inhibitor uses the double 
reciprocal plot described previously (Figure 5.7). 
[I] 11 1 K. 
-=I +- -+ 
U Vmax Ki [S] Vmax 
ý15ý 
For a competitive system the intercept on the 1/u axis remains 1/ Vm but the gradient 
increases by the factor in the brackets (equation 15) as [I] increases and the intercept on the 
1/[S] axis moves towards the origin. K; can be extrapolated from a replot, as shown in 
Figure 5.81. 
= 3K, 
= 2K, 
= Kf 
=0.5K, 
=0 
Figure 5.71/u vs. 1/[S] in the presence of different concentrations of a competitive 
inhibitor'. 
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Figure 5.8 Replots of slope (Figure 5.7) vs. [I] 
Enzyme Inhibition Studies 
The conditions for the double-reciprocal plot must be carefully chosen. The concentration 
range must be in the intermediate region of the u vs. [S] curve (Figure 5.1). If [S] is in the 
zero-order region the intercept on the x axis will be too low (K,  deceptively high) and if [S] 
is in the first order region the intercept will be too close to the y axis (Km deceptively low). 
These restrictions may make the Lineweaver-Burk plot an unsuitable method for determining 
K; in some circumstances. Also, the nature of the double-reciprocal plot means that 
experimental errors are amplified. The slope of the plot is affected most at larger values of 
1/[S] for which the rates are slowest and the experimental error greatest. 
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5.1.6 Summary and Choice of Conditions 
Whilst the double-reciprocal plot method provides more information on the inhibition 
mechanism, the IC50 plot is a quick and simple method of comparing potential inhibitors. It 
also can be used without the extensive prior information required for the Lineweaver-Burk 
plot. Therefore for the purpose of this study, a selection of compounds was screened for 
inhibitory activity using the IC50 plot. 
The rate of formation of uric acid was measured spectrophotometrically at 295 nm using the 
method of Sweeney et al. with modifications3. Typical spectra are shown in Figure 5.9. 
0.12 
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io 
Figure 5.9 Difference spectra recorded at different times throughout a typical xanthine 
oxidase bioassay. 
All solutions were freshly prepared and stored in an ice bath before use. 100 µl enzyme 
solution (3 U ml-1) in phosphate buffer (50 mM, pH 7.5) was added to a 2900 µl solution of 
xanthine and inhibitor in phosphate buffer (50 mM, pH 7.5,25 °C) giving a final assay 
concentration of 0.050 mM xanthine (saturated) and 0.1 units enzyme. The reaction mixture 
+ 
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was stirred and maintained at 25 °C for the duration of the reaction (10 minutes). A blank 
was run in the absence of the inhibitor and a control reaction was carried out in the absence 
of XO. Three replicates were recorded for each [I]. The stock solutions of inhibitors that 
were not water soluble were made up in dimethyl sulfoxide. The final concentration of 
dimethyl sulfoxide (1%) was not sufficient to affect the assay. In those cases the control 
reactions were carried out with I% dimethyl sulfoxide in the final assay. 
0.12 
0.10 
E 
c 
0.08 
N 
co 0.06 
0.04 
0.02 
0.004 
0 
Time (s) 
Figure 5.10 Plot of change in absorption at 295 nm against time. 
The initial rate of formation of uric acid (absorption at 295 nm) (Figure 5.10) was plotted 
against log [I]. The IC50 was calculated using the sigmoidal fit tool in Origin 6.1 (OriginLab 
Coporation, Northampton, MA). Some of the inhibitors were not sufficiently soluble at 
concentrations that gave close to 100% inhibition. In those cases, the upper limit was fixed 
at 100%. X.. for the inhibitors was recorded over time to ensure no degradation reaction was 
taking place. 
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5.2 The Determination of the IC50 of Allopurinol 
In order to provide a means of comparison with literature data, the IC50 of allopurinol was 
measured as a control experiment. 
OH 
/N 
N 
N 
allopurinol 
100 
80 
60 
t 
40 
20 
0 
Figure 5.11 Plot of % inhibition vs. log [I] ([I] in . iM) where I= allopurinol. IC50 = 17.3 t 
4.5 MM. xz = 0.00434, R2 = 0.974. 
As expected, the point of inflection at 50% inhibition gave a value in the micromolar region 
(Figure 5.11)4. 
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5.3 ICso of Substrate-analogues and Linkers 
A number of substrate analogues and linkers were tested as potential inhibitors of XO. 
Below are the results obtained for methyl 4-amino-2-methoxybenzoate (the linker), 4-amino- 
2-methoxybenzoic acid (the deprotected linker), nicotinic acid, isonicotinic acid and 4- 
imidazolecarboxylic acid. 
5.3.1 Methyl 4-Amino-2-methoxybenzoate, 1. 
I 
100 
80 
60 
c 
0 
0 
40 
c 
ö 
20 
0 
Figure 5.12 Plot of % inhibition vs. log [I] ([I] in µM) where I=1. IC50 = 163 f5 µM. x2 
=10.1, R2=0.996. 
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1 inhibited the production of uric acid with an IC50 of 163 t5 µM (Figure 5.12). This is a 
reasonable value, suggesting that the aromatic linker can be accommodated in the active site. 
The moderate value is appropriate for a probe since it is sufficient to be measured. The 
binding, however, is sufficiently weak so that the compound can be displaced by a successful 
drug candidate with a higher IC; o value, such as allopurinol. Modification of the structure, 
such as attachment of the substrate, should improve the binding affinity. 
5.3.2 4-Amino-2-methoxybenzoic Acid. 
NH2 
4-amino-2-methoxybenzoic acid 
100 
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60 
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20- 
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1.9 
Figure 5.13 Plot of % inhibition vs. log [I] ([I] in µM) where I= 4-amino-2- 
methoxybenzoic acid. IC50 = 416 ±5 µM. x2 = 7.26, R2 = 0.996. 
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The IC50 of 4-amino-2-methoxybenzoic acid (Figure 5.13) was higher than that of the ester, 
1. This suggests that the acid functionality is less likely to be accommodated in the active 
site than the ester. The acid is likely to be deprotonated and anionic (the pKa of benzoic 
acids - 4-5), whereas the enzyme is known to accommodate neutral substrates. 
Alternatively, hydrogen-bonding may cause aggregation of the compound in solution. 
5.3.3 Nicotinic acid. 
HO 
\ 
nicotinic acid 
100 
80 
60 
0 
40 
ö 
20 
o+ 
1.5 
log [I] 
Figure 5.14 Plot of % inhibition vs. log [I] ([I] in µM) where I= nicotinic acid. IC50 = 
946±1 µM. x`=13.3, R2=0.991. 
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The ICso for nicotinic acid (Figure 5.14) is twice as large as 4-amino-2-methoxybenzoic 
acid. As for the previous compound, the acid functionality may be the reason for the 
relatively low affinity. 
5.3.4 Isonicotinic acid. 
O 
HO 
\ /N 
isonicotinic acid 
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Figure 5.15 Plot of % inhibition vs. log [I] ([I] in µM) where I= isonicotinic acid. IC50 
1269± 1 µM. x2=4.10, R2=0.997. 
The IC50 for isonicotinic acid (Figure 5.15) was slightly higher than for nicotinic acid. 
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5.3.5 4-Imidazolecarboxylic Acid. 
HO 0 
N 
`=NH 
4-imidazolecarboxylic acid 
90 
80 
70 
O 
60 
50 
40 
30 
0.6 
Figure 5.16 Plot of % inhibition vs. log [I] ([I] in µM) where I= 4-imidazolecarboxylic 
acid. ICso = 23.6 ± 1.4 µM. x2 = 0.196, R2 = 0.999. 
The IC50 of 4-imidazole carboxylic acid was relatively low (Figure 5.16) despite the acid 
functiontionality. This is in agreement with the data reported by Biagi el al.. who suggest 
that a simplified substrate with a five-membered ring rather than a six-membered ring would 
have a higher binding affinity for XO. 
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5.4 The Determination of the ICSO Values of the Substrate-Linker Conjugates 
The IC50 of 4-imidazole carboxylic acid was the most promising of all the substrates- 
analogues tested, however, the compound is poorly soluble in most solvents and therefore the 
coupling of the substrate to the linker was not achieved in a reasonable yield. The remaining 
`substrate-analogues' were successfully coupled to the linker (chapter 2). Of these only the 
nicotinic and isonicotinic acid derivatives were sufficiently soluble at the required 
concentrations for inhibition. 
5.4.1 Methyl 4-[(pyridine-3-carbonyl)-amino]-2-methoxy benzoate, 5. 
5 
100 
80 
C 60 
O 
40 
20 
0 
Figure 5.17 Plot of % inhibition vs. log [I] ([I] in µM) where I=5. IC50 = 179 ±I µM. x2 
=35.1, R2=0.986. 
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The IC50 of 5 (Figure 5.17) was much lower than that of nicotinic acid and closer to that of 
the linker, 1. 
5.4.2 Methyl 4-[(pyridine-4-carbonyl)-amino]-2-methoxy benzoate, 6. 
\ /N 
6 
100- 
80- 
60- 
40- 
20- 
0 
1.0 
ti 
Figure 5.18 Plot of % inhibition vs. log [I] ([I] in µM) where I=6. IC50 = 130 ±I µM. x` 
= 14.5, R2 = 0.992. 
The IC50 of 6 (Figure 5.18) was not only lower than that of isonicotinic acid, but also the 
linker, 1, and the nicotinic acid derivative, 5. This was the most promising substrate-linker 
conjugate and therefore isonicotinic acid was chosen as the substrate-analogue over nicotinic 
acid. 
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5.5 The Determination of the IC50 Values of the Probe Molecules 
5.5.1 Zinc 5,10,15-tris(N-methy1-4-pyridiniumy1)-20-14-1(2-methoxy-4-amino- 
phenylcarbonyl)-amino] phenyl] porphyrin, 1231ICI13. 
H 
[23][C1]3 
100 
80 
c 
60 
C 
40 
20 
0 
log [I] 
o 
NH2 
NH 
O 
CH3 
Figure 5.19 Plot of % inhibition vs. log [I] ([I] in µM) where I= [23][C1]3. ICs) = 81.2 ± 
'=0.0017, R=0.997. 3.6 µM. X-" ` 
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The IC50 of [23][Cl]3 (Figure 5.19) was approximately five times that of allopurinol, 
suggesting that the porphyrin-linker conjugate already has a reasonable affinity for xanthine 
oxidase. The value was half that of the linker alone, possibly due to improved water- 
solubility and additional interactions of the porphyrin with the enzyme surface. 
5.5.2 Zinc 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-{(2-methoxy-4-[(pyridine-4- 
carbonyl)-amino]-phenylcarbonyl)-amino) phenyl]-porphyrin, [25] [C]]3. 
CH3 c) 
H3C- 
[25] [C1]3 
O 
/N NH 
H 
CH3 
The IC50 of [25][Cl]3 (Figure 5.20) was a little higher than that of [23] [C113. This may be due 
to the longer length of the probe 'arm' compared to the porphyrin-linker compound. In 
addition, the amine group present in the latter may have formed stabilising hydrogen bonds 
with residues in the substrate-binding channel. Nonetheless an IC50 in the 100 µM scale is 
suitable for an application as a probe for XO since it is sufficient to be measured but low 
enough to allow displacement by strong inhibitors (IC50 <1 µM). 
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Figure 5.20 Plot of % inhibition vs. log [I] ([I] in µM) where I= [25][C1]3. IC; o = 113 ±I 
µM. x2 = 2.66, R2 = 0.999. 
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5.5.3 Summary of IC50 Data 
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Table 5.1 lists the IC50 determined for each of the compounds that were shown to inhibit XO. 
Compound IC50 (µM) 
Allopurinol 17.3: 1: 4.5 
1 163±5 
4-Amino-2- 
methoxybenzoic acid 
416±5 
Nicotinic acid 946 ±1 
Isonicotinic acid 1269 ±1 
4-Imidazolecarboxylic 
acid 
23.6 f 1.4 
5 179±1 
6 130±1 
[23][C1]3 81.2 f 3.6 
[25][C1]3 113 f1 
Table 5.1 IC50 values for each of the compounds with XO. 
5.6 Binding Constant, K. 
Since the ICso is dependent on the conditions of the assay, of which there is a great variation 
across published data, the binding constant, K; was calculated from equation 14. 
[110.5 = (1 + [S]/Km) Ki (14) 
Km was estimated for each assay using the double-reciprocal plot method described earlier 
(Figure 5.21 and Figure 5.22). 
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Figure 5.21 Example plot of u against [S] in the concentration range used to determine K,,,. 
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Figure 5.22 Example plot of 1/v against I /[S] used to determine K,,,. [S] in µM. 1/V,,, a, = 
537, Km/Vn, ax = 0.00164, Km = 3.05 µM. 
178 
05 10 15 20 25 30 
[S] µM 
Chapter 5 Enzyme Inhibition Studies 
Compound K; (pM) 
Allopurinol 1.37 ± 0.36 
1 21.5 ±-0.7 
4-Amino-2- 
methoxybenzoic acid 
48.6 ± 0.6 
Nicotinic acid 112.9 ± 0.1 
Isonicotinic acid 139.9 ± 0.1 
4-Imidazolecarboxylic 
acid 
2.63 f 0.16 
5 25.1 f 0.1 
6 18.3 ± 0.1 
[23][Cl]3 11.4: b 0.5 
[25] [C1]3 31.9 ± 0.3 
Table 5.2 K; values for each of the compounds with XO. 
K; for each of the compounds was in the micromolar range (Table 5.2). The binding affinity 
for the substrate-linker conjugates was much higher than that for the linker and substrate 
analogues themselves. K; for the reference compound, allopurinol, was found to be 1.4 ± 0.4 
µmol compared to the value reported by Ho et al., K; = 0.91 µmol. 
5.7 Affects of XO on the Probe Absorption and Emission Spectra 
Figure 5.23 shows the absorption and emission spectra for XO in phosphate buffer (50 mM, 
pH 7.5). The porphyrin absorption bands (chapter 4) occur at longer wavelength than 4 
for the enzyme (Figure 5.23 (A)). Similarly the emission bands are at longer wavelength for 
porphyrins 22 - 25 than that of XO (Figure 5.23 (B)). These properties are essential for an 
efficient probe. 
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Figure 5.23 (A) Absorption spectra for XO; (B) emission spectra for XO (, = 280 nm) 
10µ1 XO (bovine milk, grade III, 22 mg mr', 1.30 U mr') was added to each of the water- 
soluble porphyrins, 22 - 24. In each case the absorption decreased by - 30 % and was 
accompanied by a small red-shift (1-3 nm) (Figure 5.24 (A)). This was matched by a 30 % 
decrease in emission intensity (Figure 5.24 (B)). . This shows that the porphyrin does report 
the presence of XO by a change in luminescence and absorption. 
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Figure 5.24 Effect of adding XO to [22][CI]3 in phosphate buffer pH 7.5; (A) absorption 
spectra; (B) corrected emission spectra (4, = 420 nm). 
The absorption spectrum for [25][C113 was more substantially red-shifted on addition of XO 
(441 - 446 nm). The quantum yield was also reduced 
by 25 %. 
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Figure 5.25 Effect of adding XO to [25][Cl]3 in phosphate buffer pH 7.5; (A) absorption 
spectra; (B) corrected emission spectra (Xe, = 570 nm). 
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Addition of allopurinol did not result in restoration of the luminescence. Therefore it has not 
been conclusively proven that the quenching is due to binding to the active site and not just 
to the enzyme surface. However, neither of these effects were observed for TMPyP, 
suggesting that the quenching is not due to interaction with the enzyme surface alone. 
5.8 Summary 
The IC50 for the substrate-analogues and substrate-linker conjugates in xanthine oxidase 
affinity assays were measured by spectrophotometric rate determinations. The values 
obtained were used to aid design of the final compound, [25] [Cl]3. Each of the compounds 
had a binding affinity, K;, in the micromolar range. For [23][Cl]3, the K; = 11.4 ± 0.5 µM is 
lower than that of [25][Cl]3 (K; = 31.9 ± 0.3 AM). However [25][Cl]3 has the potential to 
bind closer to the molybdenum active site than [23] [Cl]3. The absorption spectra for the 
probe, [25][013, was red-shifted in the presence of XO and the quantum yield was 25 % 
lower than in the absence of the enzyme. 
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6. Conclusions and Future Work 
6.1 Conclusions 
Conclusions and Future Work 
Water-soluble zinc porphyrin derived probes, which report binding to xanthine oxidase (XO), 
have been prepared. The probes are composed of a porphyrin luminophore, a linker and a 
substrate. 
The porphyrin luminophore absorbed strongly in the visible region of the electromagnetic 
spectrum where there is little competition between the flavin and XO. The chloride salts of 
the pyridinium derivatives were highly water-soluble, which is required for the XO affinity 
bioassay. There is also a possibility for interaction of the cationic groups with the charged 
surface of the protein. Zinc was incorporated to give an electron donating metalloporphyrin. 
Electron transfer from the metalloporphyrin to the molybdenum cofactor active site on 
coordination of the probes would result in quenching of the luminescence and therefore 
signal binding. 
4-amino-2-methoxybenzoic acid was chosen as the linker since it is aromatic and contains 
possible hydrogen bond donor and acceptor substituents. Therefore, it can be stabilized 
within the hydrophobic channel leading to the active site. The neutral ester derivative (1) 
was shown to bind to XO with K1= 21.5 ± 0.71. M. 
The enzyme catalyses oxidation of aromatic, nitrogen containing heterocycles. Isonicotinic 
acid was shown to bind to the enzyme with K; = 112.9 ± 0.1 µM. However, when coupled to 
the linker (6) the binding was improved to K; = 18.3 ± 0.1 µM, making it a suitable choice as 
the substrate. 
A straightforward strategy was used to sequentially couple the aromatic units using peptide 
chemistry. The need for amine protecting groups was avoided by using the corresponding 
nitro compound and selectively reducing the coupled species with indium and ammonium 
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chloride to give the amine. This procedure was suitable for preparing the simple substrate- 
linker compounds in addition to neutral and cationic porphyrin-linker, extended porphyrin- 
linker-substrate compounds and extended ruthenium polypyridyl complexes. 
A range of standard characterisation techniques were used to identify the compounds, 
including NMR, FTIR, UV-visible absorption, luminescence spectroscopy and mass 
spectrometry. The compounds displayed behaviour characteristic of porphyrins, such as high 
extinction coefficients and stability, which are necessary for this application. The NMR and 
FTIR spectra indicated the presence of intra molecular hydrogen bonding which was 
confirmed by x-ray crystallography. Aggregation of the porphyrin compounds was 
occasionally observed in the NMR and mass spectra. At the low concentrations used in the 
xanthine oxidase assays and fluorescence studies, aggregation was not observed in the UV- 
Vis absorption spectra. 
Enzyme affinity bioassays were carried out on the porphyrin compounds to investigate their 
ability to bind to XO. The porphyrin-linker compound, 23, had a lower IC50 than the linker 
(1) alone. This could be due to a combination of improved water solubility compared to 
compound 1 and the cationic periphery lining up with the anionic residues around the 
channel. Since compound 23 was not displaced by allopurinol (IC5017 µM, K; 1.37 µM) the 
channel may be blocked by the porphyrin, preventing access. ZnTMPyP did not inhibit XO 
and, therefore, inhibition by compound 23 is likely to be associated coordination of the amine 
with an amino acid residue within or close to the channel. 
Compound 25 had a lower affinity for XO (IC50 = 113 ±1 µM, K; = 31.9 ± 0.3 µM) than 
compounds 23 and 1. Despite its weaker binding to XO, the longer probe should approach 
more closely or bind directly to the active site molybdenum. As a result there is more 
opportunity for quenching of the luminescence by electron transfer. Indeed, addition of XO 
to an aqueous solution of [25][Cl]3 did cause quenching of the porphyrin emission and a red 
shift in the absorption spectrum. The K; is in the low micromolar region which is suitable for 
use in screening for XO inhibitors, where the displacement of the probe by active analytes 
(such as febuxostat K; - nM) would restore the porphyrin luminescence. 
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6.2 Future work 
Conclusions and Future Work 
4-Imidazolecarboxylic acid had the highest affinity for XO (K; = 2.63 ± 0.16 µM). If this 
substrate could be coupled to the porphyrin-linker compound the resulting probe could bind 
more tightly to XO than [25][Cl]3. The synthetic procedure has been shown to be highly 
versatile; enabling synthesis of tetraphenyl porphyrin derivatives as well as water-soluble 
trimethylpyridiniumyl porphyrins. Further modification of the linker and substrate-analogue, 
such as substitution of 4-imidazolecarboxylic acid for isonicotinic acid, should be reasonably 
straightforward. Likewise, derivatisation around the porphyrin periphery is not restricted to 
methylation of the pyridyl nitrogens. 
Further investigation using a more rigorously purified enzyme solution should give more 
informative results. Nonetheless, the probe has been shown to bind to XO and to report 
interaction with the protein by a change in the absorption and luminescence properties as 
anticipated. The preliminary studies introduced here should provide the foundation for more 
extensive analysis of the kinetics involved and an indication of how the system can be 
improved. Such experiments could include transient absorption spectroscopy where the 
lifetimes of the excited state intermediates could be measured and used to confirm electron 
transfer from the porphyrin to the molybdenum cofactor. 
Further studies need to be carried out with a pure solution of XO. The enzyme solution 
purchased, whilst the highest grade available, is a mixture of active and inactive enzyme, 
which contains, amongst other impurities, free flavin. Titration with pure XO should give 
more reliable results. In addition, further investigation of the required incubation time should 
be completed. Inhibition by allopurinol is known to be time dependent (-. 2 hours for 
maximal inhibition) due to the time taken to form alloxanthine and this is not unusual. The 
spectra did not appear to vary over one hour but it would be desirable to measure the spectra 
over a longer time, maintained at a cool temperature to avoid degradation of the enzyme, 
with pure XO. Co-crystallisation of the probe with XO would give more structural 
information and assist with improvements to the system. 
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Chapter 7 
7. Experimental 
7.1. General Methods 
Experimental 
Chemicals came from the following suppliers: triethylamine, sodium carbonate, ammonium 
chloride, nicotinic acid (BDH); tetraphenylporphyrin (H2TPP) (Frontier Scientific); 4- 
aminosalicylic acid, 2-methoxy-4-nitrobenzoic acid, indium powder (100 mesh), tetrabutyl 
ammonium chloride, 4-acetamidobenzaldehyde, methyl iodide, nicotinic acid anhydride, 
sodium nitrite, imidazole-4-carboxylic acid, isonicotinic acid, potassium bromide, potassium 
phosphate, trifluoroacetic acid, EDTA (0.1 M in water), Celite®, Florisil®, xanthine oxidase 
(bovine milk, grade III, 22 mg mr', 1.30 U mr) (Sigma-Aldrich); ammonium carbonate, tin 
dichloride dihydrate, zinc (II) acetate, tetrabutylammonium hexafluorophosphate, allopurinol 
(Avocado); DCC (Acros Organics); ammonium hexafluorophosphate (Fluorochem) pyridine- 
4-carboxaldehyde, propionic acid, acetic anhydride, pyrrole, xanthine (Alfa Aesar) 
magnesium sulfate, sodium hydroxide, potassium hydroxide, dimethyl sulfate, sodium 
hydrogen carbonate, sodium carbonate, sodium sulfate, sodium chloride, hydrochloric acid 
(Fisher); ammonia solution (Fisons); silica gel 60, DMAP (Fluka); NsCI (Lancaster); 
Sephadex G-10 (Sigma); TLC plates F254 (Merck), [TMPyP][OTs]4 kindly donated by Prof. 
John Lindsey-Smith. 
Solvents for general use were obtained from Fisher and dried over calcium hydride 
(triethylamine, acetonitrile, chloroform) or Drierite ® (Aldrich) (acetone), distilled and stored 
under argon. Dichloromethane was dried using a PURE SOLV 400 solvent purification 
system3. 
All reactions were carried out under an argon atmosphere unless otherwise stated. 
Deuterated solvents were obtained from Aldrich or Cambridge Isotope Laboratories. 
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7.2. Physical Measurements 
Experimental 
UV-Visible Spectra were recorded on an Agilent 8453 diode-array spectrophotometer. Infra- 
red spectra were recorded on a Unicam RS 10 000E FTIR instrument. EI and FAB Mass 
Spectra were recorded on a VG Auto-Spec mass spectrometer, ESI-MS on a Finnigan LCQ 
instrument. NMR spectra were recorded on a Bruker AMX 300, Bruker AMX 500 or Bruker 
DMX 600 spectrometer. Fluorescence spectra were recorded on a Hitachi F-4500 
fluorescence spectrometer. Samples were measured using a 10 mm pathlength and constant 
slit width. The instrument was corrected for the wavelength dependent response of the 
detector system. For quantum yield determination the absorption at and above the excitation 
wavelength was below 0.1 absorbance units. 
Diffraction data were collected at 110 K on a Bruker Smart Apex diffractometer with Mo-Ka 
radiation (), = 0.71073 A) using a SMART CCD camera. Diffractometer control, data 
collection and initial unit cell determination was performed using "SMART" (v5.625 Bruker- 
AXS). Frame integration and unit-cell refinement software was carried out with "SAINT+" 
(v6.22, Bruker AXS). Absorption corrections were applied by SADABS (v2.03, Sheldrick). 
Structures were solved by direct methods using SHELXS-97 (Sheldrick, 1997) and refined 
by full-matrix least squares using SHELXL-97 (Sheldrick, 1997). All non-hydrogen atoms 
were refined anisotropically. Hydrogen atoms were placed using a "riding model" and 
included in the refinement at calculated positions. 
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7.3. Synthesis 
Methyl 4-Amino-2-methoxybenzoate, 1. 
OO 
CH3 
O%%CH3 
1 
NH2 
1 
4-Aminosalicylic acid (10.0 g, 65 mmol) was dissolved in acetone (200 cm3). Pellets of 
potassium hydroxide (9.2 g, 143 mmol) were added followed by dropwise addition of 
dimethyl sulfate (19.5 g, 155 mmol) at 25 °C. Stirring was continued at room temperature 
for 2.5 hours. The solvent was removed and the residue was diluted with water (150 cm3), 
extracted with ethyl acetate (2 x 150 cm3), washed with 5% sodium hydrogen carbonate 
solution (2 x 25 cm3) and dried with sodium sulfate. Evaporation of the solvent to 70 cm3 
gave 1 as a beige powder (5.0 g, 33 mmol, 45%). 
Rf (ethyl acetate): 0.65. Melting Point: 149-151 °C. 
1H NMR 8H (500 MHz; solvent CDC13): 7.74 (1H, d, J= 8.4 Hz, C-6 phenyl), 6.23 (1H, dd, 
J=8.5,2.1 Hz, C-5 phenyl), 6.22 (1 H, d, J=2.1 Hz, C-3 phenyl), 4.18 (2H, br s, NH2), 3.86 
(3H, s, OCHS), 3.83 (3H, s, OCH3) ppm. 
13C{1H} NMR 6c (125 MHz; solvent CDC13): 166.3,161.8,152.1,134.3,109.1,106.5,97.8, 
55.8,51.5 ppm. 
EI-MS: m/z = 181 (M+, 39%), 164 (5), 150 (100), 135 (6), 120 (9), 107 (12), 92 (10), 79 
(10), 65 (8), 52 (8), 44 (18). 
FTIR (KBr pressed disc) vm /cml: 3464s, 3363s, 3256w, 3219w, 3024w, 3006w, 2971w, 
2950m, 2841w, 1673s, 1628s, 1611s, 1593s, 1565s, 1513 m, 1470s, 1435s, 1344s, 1274s br, 
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1220s, 1183m, 1141s, 1090m, 1030m, 973w, 957w, 837m, 828m, 772m, 702w, 654w, 641w, 
551w, 474w. 
UV-Vis: X,,,,. /nm (DMSO) 282 (c/dm3 mol-1 cm 7l 15600), 303 (16900). 
Methyl 4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]-2-methoxy benzoate, 2. 
2 
Triethylamine (1.67 cm3,12.0 mmol) was added to a stirred solution of (1.00 g, 6.0 mmol), 
DMAP (0.14 g, 1.2 mmol) NsCI (1.34 g, 6.0 mmol) in acetonitrile (60 cm3) under argon. 
The solution was stirred for 20 minutes at which point a solution of methyl 4-amino-2- 
methoxybenzoate 1 (1.24 g, 6.8 mmol) in acetonitrile (10 cm) was added under an ice bath. 
Stirring was continued for 24 hours until a yellow precipitate developed. The reaction 
mixture was concentrated by 50% and then filtered. The feathery yellow powder was 
washed thoroughly with cold acetonitrile and dried under vacuum to give 2 (1.63 g, 4.5 
mmol, 75%). 
Melting Point: 185-190 °C 
'H NMR SH (500 MHz; solvent CDC13): 9.76 (1H, s, NH), 8.43 (1H, d, J= 8.6 Hz, phenyl), 
7.98 (1H, d, J= 8.6 Hz, phenyl), 7.92 (1H, s, phenyl), 7.87 (1H, s, phenyl), 7.85 (111, d, J= 
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8.3 Hz, phenyl), 6.88 (1H, d, J= 8.3 Hz, phenyl), 4.20 (3H, s, OCHS), 3.97 (3H, s, OCHi3), 
3.88 (3H, s, OCH3) ppm. 
13C{'H} NMR Sc (125 MHz; solvent CDC13): 166.0,161.6,160.7,157.4,150.8,142.8, 
133.7,132.8,127.0,116.5,115.6,111.35,107.1,104.1,57.3,56.2,52.0 ppm. 
EI-MS: m/z = 360 (M+, 63%), 329 (18), 180 (100), 150 (21), 134 (33), 122 (8), 107 (6), 91 
(5), 63 (8), 40 (61). 
HR ESI-MS: For C17H17N207 (M + H+), observed mass 361.1044, calculated 361.1030, 
difference 1.4 mDa. 
FTIR (KBr pressed disc) vm. /cm': 3470br w, 3355m, 3202w, 3155w, 3123w, 3103w, 
3011w, 2978m, 2944m, 2880w, 2840w, 2804w, 2758w, 2740w, 2678m, 2625w, 2605w, 
2530w, 2493m, (1719m), 1699s, 1677s, 1590s, 1533br s, 1472m, 1459m, 1439m, 1413m, 
1357s, 1294s, 1265s, 1256s, 1237s, 1194m, 1175m, 1152s, 1124m, 1113m, 1083s, 1036s, 
1020m, 967w, 868s, 858s, 823w, 806s, 769s, 736s, 697 m, 659s, 632m. 
UV-Vis: 4, /nm (DMSO) 275 (c/dm3 mol-1 cm 1 13900), 302 (10000), 340 
(5280). 
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4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]-2-methoxy benzoic acid, 3. 
H3 
3 
2M sodium hydroxide, (1.5 cm3,3 mmol) was added to a solution of methyl4-[(2-methoxy- 
4-nitro-phenylcarbonyl)-amino]-2-methoxybenzoate 2 (1.00 g, 2.8 mmol) in ethanol (50 cm3) 
and heated at reflux for 40 minutes under argon. The solvent was evaporated and the residue 
taken up in hot water and filtered. 12 M hydrochloric acid was added to alter the solution to 
pH 3. Cooling gave 3 as a feathery, pale orange solid (0.85 g, 2.5 mmol, 88%). 
Melting Point: >250'C 
1H NMR 8H (300 MHz; solvent DMSO): 11.20 (1H, s, NH), 8.35 (1H, d, J=8.4 Hz, 
phenyl), 8.14 (1H, s, phenyl), 8.12 (1H, s, phenyl) 7.93 (1H, dd, J=1.9,8.4 Hz, phenyl), 
7.78 (1H. d, J=2.0 Hz, phenyl), 7.64 (1H, dd, J=1.8,8.5 Hz, phenyl), 3.85 (3H, s, OCH3), 
3.80 (3H, s, OCH3) ppm. 
13C('H) NMR Sc (75 MHz; solvent DMSO): 166.5,163.9,159.4,156.8,149.4,143.4, 
132.3,131.8,130.0,115.5,110.7,106.8,103.0,56.7,55.6 ppm. 
EI-MS: m/z =346 (M+, 56%), 180 (100), 150 (6), 134 (32), 122 (7). 
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HR ESI-MS: For C16H15N207 (M + 1-1), observed mass 347.0877, calculated 347.0874, 
difference 0.3 mDa. 
FTIR (KBr pressed disc) vn,. /cml: 3336s, 3270 br m, 3120w, 3100w, 2998w, 2957w, 
2851w, 1744 s, 1679s, 1592s, 1520s, 1460m, 1415m, 1353s, 1283m, 1266m, 1238s, 1170m, 
1150m, 1126m, 1111w, 1079m, 1013s, 966m, 878s, 859s, 805s, 970s, 734s, 661s 
Methyl 4-[(2-methoxy-4-amino-phenylcarbonyl)-amino]-2-methoxy benzoate, 4. 
H3 
4 
Methyl 4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]-2-methoxybenzoate 3 (0.90 g, 2.5 
mmol), was dissolved in 100 cm3 methanol. Saturated ammonium chloride solution (3 cm3), 
and indium powder (100 mesh, 2.0 g), were added and the solution stirred for 72 h under 
reflex until the reaction was complete by tlc (dichloromethane/methanol v/v 5: 1). The 
reaction mixture was evaporated to dryness and the solid residue extracted with chloroform 
using Sohxlet apparatus to yield 4 as an orange solid. (0.62 g, 1.9 mmol, 69%) 
Melting Point: >250'C 
'H NMR 6H (500 MHz; solvent DMSO): 9.97 (1H, s, NH, exchangeable with D20), 7.70 
(IH, d, J=1.4 Hz, phenyl), 7.67 (IH, d, J=8.8 Hz, phenyl), 7.63 (IH, d, J=8.3 Hz, phenyl) 
7.30 (1H, dd, J= 1.9,8.8 Hz, phenyl), 6.30 (1H. d, J =1.9 Hz, phenyl), 6.26 (1H, dd, J=1.9, 
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8.8 Hz, phenyl), 5.93 (2H, s, NH2), 3.92 (3H, s, OCHS), 3.82 (3H, s, OCHS), 3.75 (311, s, 
OCH3) ppm. 
13C{'H} NMR Sc (175 MHz; solvent DMSO): 164.9,163.5,159.1,158.5,153.7,143.9, 
132.2,131.5,112.9,110.4,108.2,106.0,102.6,95.4,55.2,55.1,51.0 ppm. 
EI-MS: m1z =330 (M+, 25%), 299 (8), 164 (12), 150 (100), 107 (5). 
HR EST-MS: For C17H19N205 (M + H), observed mass 331.1293, calculated 331.1288, 
difference 0.5 mDa. 
FTIR (KBr pressed disc) vm., /cm 7l: 3427m, 3340s, 3238m, 3155w, 3121w, 3084w, 3009w, 
2946w, 2913w, 2865w, 2834w, 1714s, 1637m, 1609s, 1585s, 1528br s, 1467m, 1448m, 
1432m, 1408m, 1339m, 1329s, 1244br s, 1214w, 1205w, 1186w, 1175w, 1157m, 1085m, 
1031m, 975w, 861w, 838w, 821w, 764m, 747w, 696w, 678w, 665w, 548w, 525w. 
UV-Vis: X,,, /nm (DMSO) 329 (c/dm3 mol-1 cm' 27000). 
Methyl 4-[(pyridine-3-carbonyl)-amino]-2-methoxy benzoate, 5. 
0 NH 
N 
5 
Triethylamine (0.7 cm3,5.0 mmol) was added to a stirred solution of nicotinic acid (0.31 g, 
2.5 mmol), DMAP (0.061 g, 0.50 mmol) NsCI (0.55 g, 2.5 mmol) in acetonitrile (30 cm3) 
under argon. The solution was stirred for 20 minutes at which point a solution of methyl 4- 
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amino-2-methoxybenzoate, 1 (0.50 g, 2.8 mmol) in acetonitrile (10 cm3) was added under an 
ice bath. Stirring was continued for 24 hours until the reaction was complete by tlc (ethyl 
acetate). The reaction mixture was concentrated and extracted into 2M hydrochloric acid. 
The acid solution was washed with ethyl acetate, neutralised with sodium hydrogen 
carbonate and the resulting precipitate re-extracted into ethyl acetate. The organic fraction 
was washed with sodium hydrogen carbonate, water and brine and dried over magnesium 
sulfate. The solvent was removed in vacuo to give 5 as a pale yellow powder (0.27 g, 0.94 
mmol, 34 %). 
Rf (ethyl acetate): 0.32 Melting Point: 144 -146 °C 
1H NMR 6H (300 MHz; solvent CDC13): 9.11 (1H, s, pyridyl), 8.77 (1H, d, J=6.0 Hz, 
pyridyl), 8.33 (1 H, s, NH), 8.22 (1 H, d, i=7.3 Hz, pyridyl) 7.85 (1 H, d, J=8.6 Hz, phenyl), 
7.72 (1H, d, J= 1.8 Hz, phenyl), 7.44 (1H, dd, J= 4.6,7.7 Hz, pyridyl), 7.04 (1H, dd, J= 
1.7,8.6, phenyl), 3.91 (3H, s, OCH3), 3.87 (3H, s, OCH3) ppm. 
13C {'H) NMR Sc(75 MHz; solvent CDC13): 166.4,164.5,160.1,152.6,147.9,143.0,136.5, 
133.4,130.0,124.4,116.1,111.4,104.1,56.5,52.4 ppm. 
ESI-MS: m/z =285.0 (M - H+, 100%). 
HR ESI-MS: For C15H15N204 (M + IHt), observed mass 287.1025, calculated 287.1026, 
difference 0.1 mDa. 
FTIR (KBr pressed disc) vm. /cm 1: 3401w, 3342s, 3199w, 3150w, 3127w, 3090w, 3056w, 
3039w, 3012w, 2964w, 2935w, 2913w, 2863w, 2837w, 1687s, 1663s, 1593s, 1532s, 1479w, 
1466m, 1448m, 1429m, 1406s, 1341w, 1298s, 1257s, 1202w, 1187w, 1173w, 1147m, 
1117w, 1090m, 1026m, 976w, 958w, 886w, 860m, 839w, 827w, 780m, 734w, 704,682w, 
640w, 620w, 583w. 
UV-Vis: ý, /nm (DMSO) 284 (s/dm3 mo1-1 cm-1 14000) 308 (13000). 
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Methyl 4-[(pyridine-4-carbonyl)-amino]-2-methoxy benzoate, 6. 
6 
Experimental 
The procedure above was carried out using isonicotinic acid to give 6 as a pale yellow 
powder (0.30 g, 1.0 mmol, 40 %). 
Rf (ethyl acetate): 0.30 
Melting Point: 196-197 °C 
IH NMR SH (300 MHz; solvent CDC13): 8.82 (2H, dd, J= 4.5,1.6 Hz, pyridyl), 8.04 (111, s, 
NH), 7.86 (IH, d, J=8.5 Hz, phenyl), 7.74 (111, d, J=1.8 Hz, phenyl) 7.71 (211, dd, J=1.5, 
4.4 Hz, pyridyl ), 6.99 (1 H. dd, J=1.9,8.5, phenyl), 3.94 (3H, s, OCH3), 3.88 (311, s, OCH3) 
ppm. 
13C{1H} NMR Sc (75 MHz; solvent CDC13): 166.3,164.3,161.0,151.3,142.7,141.9,133.4, 
121.3,116.3,111.3,104.0,56.6,52.4 ppm. 
EST-MS: m/z =285.0 (M - H+, 100%). 
HR ESI-MS: For C15H15N204 (M + In, observed mass 287.1023, calculated 287.1026, 
difference 0.3 mDa. 
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FTIR (KBr pressed disc) vm /cm 1: 3468 br w, 3324s, 3199w, 3128w, 3098w, 3064w, 3049, 
3031w, 3001w, 2954w, 2934w, 2919w, 2833w, 1690s, 1670s, 1591s, 1532s, 1467m, 1451m, 
1413s, 1340m, 1297s, 1259s, 1206w, 1179w, 1147m, 1094m, 1068w, 1029m, 992w, 977w, 
96m, 893w, 860m, 848m, 829w, 781m, 756m, 694m, 663w, 644w, 547w. 
UV-Vis: Xm. /nm (DMSO) 280 (c/dm3 mo1-1 cm 7l 18000), 305 (14000). 
5-(4-aminophenyl)-10,15,20-triphenylporphyrin, 91. 
9 
Sodium nitrite (1.0 g, 14.5 mmol) was added to a solution of 5,10,15,20- 
tetraphenylporphyrin (5.0 g, 8.15 mmol) in trifluoroacetic acid (500 cm3) and the reaction 
was stirred at room temperature until the reaction was complete by tlc (3 mins). The reaction 
was quenched by pouring into cold water (5000 cm3). The mixture was extracted with 
dichloromethane (6 x 1000 cm3), which was washed with saturated sodium hydrogen 
carbonate and water, then dried over sodium sulfate. The solvent was removed in vacuo and 
the mixture was purified on a plug of silica (Si-60, dichloromethane). The solvent was 
removed and the purple product was dissolved in hydrochloric acid (500 cm3). Tin 
dichloride dihydrate (11.0 g, 48.8 mmol) was added with stirring and the reaction was heated 
to 65 °C for 1h under argon. The reaction mixture was poured into cold water (5000 cm3) 
and neutralized with ammonia solution (pH 8). The suspension was extracted with 
dichloromethane until colourless. The organic layer was died over sodium sulfate, 
concentrated in vacuo, and purified by column chromatography (Si-60, dichloromethane) to 
give 9 (3.21 g, 5.14 mmol, 63 %). 
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Rf (Chloroform) = 0.23 
Experimental 
1H NMR 6H (500 MHz; solvent CDC13): 9.01 (2H, d, J= 4.6 Hz, ß-pyrrole), 8.91 (611, s, ß- 
pyrrole), 8.29 (6H, m, o-phenyl), 8.05 (2H, d, J=8.3 Hz, o-aminophenyl), 7.81 (9H, m, m-/ 
p-phenyl), 7.07 (2H, d, J=8.3 Hz m-aminophenyl), 4.00 (2H, br s, NH2), -2.66 (2H, br s, 
inner NH) ppm. 
13C{'H} NMR SH (125 MHz; solvent CDC13): 146.2,142.5,142.4,135.9,134.8,132.6, 
128.0,126.9,126.8,121.1,120.2,113.7 ppm. 
FAB-MS: m/z = 630 (M+, 52%), 535 (9), 503 (5), 474 (6), 461 (16), 429 (10), 401 (6), 355 
(7), 327 (14), 281 (23), 267 (14), 221 (26), 207 (38), 191 (19), 177 (8), 147 (100) 
FTIR (KBr pressed disc) vn, /cml: 3455br w, 3317w, 3051w, 3023w, 1619m, 1510m, 
1470m, 1440m, 1349m, 1261m, 1177m, 965s, 844s, 731m, 700m. 
UV-Vis: X.. /nm (CHC13) 419 (c/dm3 mol-1 cm 1 439000), 516 (26900), 552 (15600), 590 
(9960), 647 (8680). 
Free base 5-[ 4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] phenyl]-10,15,20-triphenyl 
porphyrin, 10. 
O- 
N02 
NH 
O, 
CH3 
10 
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Dicyclohexylcarbodiimide (1.00 g, 4.85 mmol) was added to a stirred solution of 2-methoxy- 
4-nitrobenzoic acid (0.80 g, 4.05 mmol) in acetonitrile (25 cm3) at 0 °C. After 15 minutes the 
reaction was brought to room temperature and stirred until the reaction was complete by tlc 
(10: 1 chloroform: acetonitrile v/v) (-24 h). The solution was filtered and the solid by-product 
was washed thoroughly with acetonitrile and the washings added to the filtrate. Removal of 
the solvent yielded a pale yellow solid, which was used without any further purification. The 
anhydride residues were taken up in acetonitrile (20 cm3) and added dropwise to an ice cold 
solution of free base 5-(4-aminophenyl)-10,15,20-triphenylporphyrin, 9 (0.40 g, 0.635 mmol) 
in chloroform with stirring. The reaction was heated at reflux for 48 h. The solvent was 
removed and the purple residue was extracted into dichloromethane and washed with 2M 
sodium hydroxide (3 x 250 cm3), water and brine. The organic fraction was dried over 
sodium sulfate and the solution was then concentrated in vacuo and purified by column 
chromatography (Si-60,10: 1 chloroform: acetonitrile v/v) to give 10 (0.44 g, 0.544 mmol, 86 
%). 
Rf (10: 1 chloroform: acetonitrile v/v): 0.86. 
'H NMR SH (500 MHz; solvent CDC13): 9.99 (1H, s, NH), 8.89 (8H, m, ß-pyrrole), 8.58 
(1H, d, J= 8.4 Hz, phenyl), 8.29 (2H, d, J= 8.0 Hz, o-aminophenyl) 8.26 (6H, m, o-phenyl), 
8.11 (2H, d, J=8.2 Hz, m-aminophenyl) 8.05 (1 H, dd, J=2.3,8.8 Hz, phenyl), 7.78 (911, 
m, m-/ p-phenyl), 7.96 (1H, d, J=2.0 Hz, phenyl), 4.31 (3H, s, OCH3), -2.74 (21!, br s, 
inner NH) ppm. 
13C('H) NMR Sc (176 MHz; solvent CDC13): 161.5,157.3,150.6,142.2,142.1 138.8, 
137.4,135.3,134.6,133.9,127.8,127.3,126.7,120.3,120.2,119.3,118.9,116.5,107.0, 
57.2, ppm. 
ESI-MS: m/z = 809.5 (M + H+, 100%), 807.4 (M - H+, 100%). 
HR ESI-MS: For C52H37N604 (M + H+), observed mass 809.2895, calculated 809.2871, 
difference 2.4 mDa. 
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FTIR (ATR) v,,, ax /cm 
1: 1676s, 1589s, 1521 s, 1471 s, 1440m, 1400m, 1344s, 1311 m, 1259s, 
1177m, 1156m, 1101br s, 1056m, 1022s, 1002s, 981s, 964s, 867m, 798s, 750m, 728s, 699s. 
FTIR (KBr pressed disc) v,,, /cm 1: 3448br w, 3374br w, 3316br w, 3083w, 3061w, 3026m, 
2924s, 2852w. 
UV-Vis: Xm. /nm (DMSO) 420 (c/dm3 mol-1 cm 1 511000), 518 (20800), 552 (11200), 592 
(6130), 647 (5560). 
Zinc 5-[4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] phenyl]-10,15,20-triphenyl 
porphyrin, 11. 
o- 
N02 
NH 
O 
CH3 
11 
Free base 5-[ 4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] phenyl]-10,15,20-triphenyl 
porphyrin, 10 (0.16 g, 0.20 mmol) and zinc acetate dihydrate (0.20 g, 0.90 mmol) were 
dissolved in chloroform and methanol (25 cm3,5: 1, v/v) and heated at reflux for 1 h. The 
reaction mixture was cooled, diluted with dichloromethane (100 cm3) and washed with 
EDTA solution (2 g in 200 cm3 10 % sodium carbonate solution), water (3 x 200 cm3), dried 
over sodium sulfate and the solvent removed in vacuo. The residue was purified by column 
chromatography (Si-60,10: 1 chloroform: acetonitrile v/v) to give 11 (0.14 g, 0.16 mmol, 80 
%). 
Rf (10: 1 chloroform: acetonitrile v/v): 0.88. 
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1H NMR SH (500 MHz; solvent THF): 10.11 (1H, s, NH), 8.86 (8H, m, ß-pyrrole, o- 
aminophenyl), 8.26 (1H, d, J=9.9 Hz, phenyl), 8.22 (1OH, m, o-phenyl, m-aminophenyl), 
8.01 (IH, d, J=1.8 Hz, phenyl), 7.98 (IH, dd, J=8.6,2.2 Hz, phenyl), 7.77 (9H, m, m-/ p- 
phenyl), 4.24 (3H, s, OCH3) ppm. 
13C{'H} NMR 8c(125 MHz; solvent THF): 161.9,157.6,150.4,142.4,142.3,138.9,137.8, 
134.9,134.3,132.2,129.6,127.7,126.6,120.0,119.9,119.7,118.0,115.5,106.8,56.4, ppm. 
EST-MS: m/z = 870.3 (M+, 100%). 
HR ESI-MS: For C52H34N6O4Zn (M), observed mass 870.1929, calculated 870.1928, 
difference 0.1 mDa. 
FTIR (ATR) vm /cm I: 1675s, 1591s, 1525s, 1486s, 1439m, 1406m, 1339s, 1312m, 1259s, 
1205s, 1178m, 1156m, 1084s, 1018m, 1001s, 993s, 864m, 796s, 753m, 734m, 717m, 701s, 
660m. 
FTIR (KBr pressed disc) vm. /cm 1: 3432br w, 3084w, 3063w, 3026m, 2926m, 2852w. 
UV-Vis: X,,, /nm (DMSO) 429 (c/dm3 mol-' cm 
1573000), 560 (14800), 552 (5810). 
Free base 5-[4-[(2-methoxy-4-amino-phenylcarbonyl)-amino] phenyl]-10,15,20- 
triphenyl porphyrin, 12. 
NH2 
12 
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Free base 5-[ 4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] phenyl]-10,15,20-triphenyl 
porphyrin, 10 (1.1 g, 1.4 mmol), was dissolved in 100 cm3 ethanol. Saturated ammonium 
chloride solution (1.6 cm3), and indium powder (100 mesh, 1.1 g), were added and the 
solution stirred for 72 h under reflux until the reaction was complete by tlc 
(dichloromethane/acetonitrile v/v 5: 1). The reaction mixture was evaporated to dryness and 
the solid residue extracted with chloroform using Sohxlet apparatus. The solvent was 
removed in vacuo give a green/purple solid. This was taken up in the minimum amount of 5 
% sulfuric acid in trifluoroacetic acid and stirred at room temperature for 15 min. The 
solution was carefully neutralised with ice cold saturated sodium carbonate solution and the 
porphyrin was extracted with chloroform. The organic layer was separated, dried over 
sodium sulfate, concentrated in vacuo and purified by passing through a short silica column 
(Si-60,10: 1 chloroform: acetonitrile v/v) to give 12 (0.37 g, 0.48 mmol, 35 %). 
Rf (10: 1 chloroform: acetonitrile v/v): 0.41. 
1H NMR SH (500 MHz; solvent CDC13): 10.05 (1H, s, NH), 8.85 (8H, m, ß-pyrrole), 8.22, 
(1H, d, phenyl), 8.19 (6H, m, o-phenyl), 8.17 (2H, d, o-aminophenyl), 8.04 (2H, d, J=8.4 
Hz, m-aminophenyl), 7.74 (9H, m, m-/ p-phenyl), 6.45 (1 H, dd, J=2.5,8.4 Hz, phenyl), 
6.32 (1 H, d, J=2.5 Hz, phenyl), 4.12 (3H, s, OCH3), -2.78 (2H, br s, inner NH) ppm. 
13C{'H} NMR Sc (176 MHz; solvent CDC13): 161.5,157.3,150.6,142.1,138.8,137.4, 
135.3,134.6,133.8,128.0,127.3,126.7,120.3,119.4,118.7,118.2,117.4,116.6,107.1,57.5 
ppm. 
ESI-MS: m/z = 779.4 (M + H+, 100%), 777.3 (M - W, 100%). 
HR ESI-MS: For C52H39N602 (M + H), observed mass 779.3102, calculated 779.3129, 
difference 2.7 mDa. 
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FTIR (ATR) vm. /cm-1: 1663m, 1595s, 1516s, 1472s, 1441m, 1400m, 1349m, 1309s, 
1270s, 1245s, 1206m, 1178s, 1156m, 1134s, 1094m, 1072m, 1029s, 1002s, 981s, 965s, 
877m, 847m, 827m, 799s, 726s, 701s, 658s. 
FTIR (KBr pressed disc) vm /cm 1: 3437br m, 3341br m, 3056w, 3017w, 2975w, 2938w, 
2924m, 2899w. 
UV-Vis: ?,,, ax/nm (DMSO) 421 (c/dm3 mol-1 cm 
1 368000), 518 (19800), 552 (12300), 592 
(7140), 648 (8100). 
Zinc 5-[4-[(2-methoxy4-amino-phenylcarbonyl)-amino] phenyl] -10,15,20-triphenyl 
porphyrin, 13. 
O 
2-2-2 
O 
CH3 
13 
Free base 5-[4-[(2-methoxy-4-amino-phenylcarbonyl)-amino] phenyl]-10,15,20-triphenyl 
porphyrin, 12 (0.060 g, 0.077 mmol) and zinc acetate dihydrate (0.080 g, 0.36 mmol) were 
dissolved in chloroform and methanol (10 cm3,5: 1, v/v) and heated at reflux for 1 h. The 
reaction mixture was cooled, diluted with dichloromethane (40 cm3) and washed with EDTA 
solution (1 g in 100 cm3 10 % sodium carbonate solution), water (3 x 100 cm3), dried (Na- 
2SO4) and the solvent removed in vacuo. The residue was purified by column 
chromatography (Si-60,50: 1 chloroform: methanol v/v) to give 13 (0.060 g, 0.072 mmol, 
94 %). 
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Rf (50: 1 chloroform: methanol v/v): 0.5. 
Experimental 
'H NMR SH (500 MHz; solvent CDC13, do-pyridine): 10.01 (1H, s, NH), 8.92 (2H, d, J= 
4.25 Hz, o-aminophenyl), 8.84 (6H, m, ß-pyrrole), 8.19 (1H, d, J=8.3 Hz, phenyl), 8.17 
(6H, m, o-phenyl, ), 8.14 (2H, d, o-aminophenyl) 8.00 (2H, d, J=8.1 Hz, m-aminophenyl), 
7.70 (9H, m, m-/ p-phenyl), 6.41 (1 H, dd, J=2.1,8.5 Hz, phenyl), 6.25 (1 H, d, J=1.9 Hz, 
phenyl), 4.07 (2H, s, NH2), 4.04 (3H, s, OCH3) ppm. 
13C{'H} NMR Sc (125 MHz; solvent CDCl3): 163.9,159.2,151.6,150.3,150.1,143.7, 
138.1,138.9,135.2,134.6,134.5,131.8,131.6,127.1,126.3,120.6,120.4,118.3,112.1, 
108.1,97.4,56.1 ppm. 
ESI-MS: m1z = 839.1 (M - H, 100%), 1682.9 (2M - H+, 43%). 
HR ESI-MS: For C52H37N6O2Zn (M + H), observed mass 841.2282, calculated 841.2264, 
difference 1.8 mDa. 
FTIR: (ATR) vm. /cm l: 1629m, 1594s, 1559m, 1521s, 1490s, 1458m, 1441m, 1339m, 
1313s, 1275s, 1259s, 1244s, 1205s, 1176s, 1142m, 1096m, 1066s, 1029s, 1001s, 993s, 828m, 
809s, 796s, 760s, 752s, 732s, 717s, 700s, 660s, 644s. 
FTIR: (KBr pressed disc) vm. /cm 1: 3434br m, 3379br m, 3124w, 3094w, 3053w, 3018w, 
2924w, 2850w. 
UV-Vis: ý,,,, /nm (DMSO) 429 (c/dm3 mol-1 cm 1597000), 560 (25400), 603 (17100). 
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Free base 5-[4-((2-methoxy-4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino) phenylj-10,15,20-triphenyl porphyrin, 14. 
0 
O N02 
NH 
NH 
O CH3 
CH3 
14 
Dicyclohexylcarbodiimide (0.50 g, 2.42 mmol) was added to a stirred solution of 2-methoxy- 
4-nitrobenzoic acid (0.40 g, 2.03 mmol) in acetonitrile (15 cm3) at 0°C. After 15 minutes the 
reaction was brought to room temperature and stirred until the reaction was complete by tlc 
(10: 1 chloroform: acetonitrile v/v) (-24 h). The solution was filtered and the solid by-product 
was washed thoroughly with acetonitrile and the washings added to the filtrate. Removal of 
the solvent gave a pale yellow solid which was used without any further purification. The 
anhydride residues were taken up in acetonitrile (20 cm) and added dropwise to an ice cold 
solution of free base 5-[4-[(2-methoxy-4-amino-phenylcarbonyl)-amino] phenyl]-10,15,20- 
triphenyl porphyrin, 12 (0.25g, 0.32 mmol) in chloroform with stirring. The reaction was 
heated at reflux for 48 h. The solvent was removed and the purple residue was extracted into 
dichloromethane and washed with 2M sodium hydroxide (3 x 250 cm3), water and brine. 
The organic fraction was dried over sodium sulfate and the solution was then concentrated in 
vacuo and purified by column chromatography (Si-60,10: 1 chloroform: acetonitrile v/v) to 
give 14 (0.24g, 0.25 mmol, 78 %). 
Rf (10: 1 chloroform: acetonitrile v/v): 0.71. 
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'H NMR SH (500 MHz; solvent CDC13): 10.18 (1H, s, NH), 9.91 (1H, s, NH), 8.87 (8H, m, 
ß-pyrrole), 8.47 (1 H, d, J=8.7 Hz, phenyl), 8.42 (1 H, d, J=8.4 Hz, phenyl), 8.28 (1 H, d, J 
= 1.8 Hz, phenyl), 8.21 (8H, m, o-phenyl), 8.08 (IH, d, J= 8.4 Hz, phenyl), 8.00 (2H, d, J 
= 2.4,9.0 Hz, m-aminophenyl), 7.93 (IH, d, J=1.5 Hz, phenyl), 7.74 (9H, m, m-/ p- 
phenyl), 6.94 (1H, dd, J= 2.1,8.4 Hz, phenyl), 4.26 (3H, s, OCH3), 4.23 (31-1, s, OCHS), - 
2.79 (2H, s, inner NH) ppm. 
13C{'H} NMR Sc (125 MHz; solvent CDC13): 163.3,161.6,158.4,157.1,150.7,149.4, 
149.3,142.1,138.9,138.1,137.4,136.0,134.6,134.4,133.8,130.1,128.4,126.3,126.2, 
120.2,119.7,118.4,117.1,116.2,115.0,107.5.103.0,57.2,56.6 ppm. 
ESI-MS: m/z = 956.2 (M - H), 958.4 (M + ifl. 
HR ESI-MS: For C60H. 4N7O6 (M + In, observed mass 958.3323, calculated 958.3348, 
difference 2.5 mDa. 
FTIR: (ATR) vm. /cm-1: 1676s, 1624s, 1584s, 1559m, 1521 s, 1473m, 1414m, 1346s, 1312s, 
1263s, 1243s, 1176s, 1140m, 1089m, 1026m, 965s, 800s, 737s, 702s, 657w, 641w. 
FTIR: (KBr pressed disc) vm /cm 7l: 3422br m, 3328br m, 2928m, 2850m. 
UV-Vis: a,,, /nm (DMSO) 421 (c/dm3 mor' cm l 383000), 516 (37600), 552 (30100), 592 
(24800), 648 (25100). 
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Zinc 5-[4-{(2-methoxy-4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]-phenyl 
carbonyl)-amino) phenyl]-10,15,20-triphenyl porphyrin, 15. 
O- 
/ N02 
NH 
%H3 
15 
Free base 5-[4-{(2-methoxy-4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin, 14 (0.10 g, 0.10 mmol) and 
zinc acetate dihydrate (0.20 g, 0.90 mmol) were dissolved in chloroform and methanol (30 
cm3,5: 1, v/v) and heated at reflux for 1 h. The reaction mixture was cooled, diluted with 
dichloromethane (50 cm3) and washed with EDTA solution (1 g in 100 cm3 10 % sodium 
carbonate solution), water (3 x 100 cm3), dried (Na2SO4) and the solvent removed in vacuo. 
The residue was purified by column chromatography (Si-60,50: 1 chloroform: acetonitrile, 
v/v) to give 15 (0.092 g, 0.090 mmol, 90 %). 
Rf (50: 1 chloroform: acetonitrile v/v): 0.68. 
'H NMR 5H (500 MHz; solvent CDC13): 10.14 (1H, s, NH), 9.86 (1H, s, NH), 8.94 (811, m, 
ß-pyrrole), 8.42 (1 H, d, J=8.4 Hz, phenyl), 8.34 (1 H, d, J=8.4 Hz, phenyl), 8.24 (1 H, s, 
phenyl), 8.21 (8H, m, o-phenyl, o-aminophenyl), 8.04 (2H, d, J=8.0 Hz, m-aminophenyl), 
8.00 (1 H, d, 8.0 Hz, phenyl), 7.90 (1 H, s, phenyl), 7.75 (9H, m, m-/ p-phenyl), 6.91 (1 H, d, 
J= 7.0 Hz, phenyl), 4.24 (3H, s, OCHS), 4.21 (3H, s, OCH3) ppm. 
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13C{'H} NMR 6c (125 MHz; solvent CDC13): 163.1,161.5,158.4,157.3,150.8,150.3, 
150.2,143.0,142.3,138.8,137.9,135.1,134.5,134.4,132.0,131.9,127.5,126.7,126.5, 
121.1,120.6,118.5,117.8,116.5,112.7,107.1,103.8,57.3,56.6ppm. 
ESI-MS: m/z =1018.4 (M -H), 1020.3 (M + H). 
HR ESI-MS: For C60H42N7O6Zn (M + H+), observed mass 1020.2442, calculated 1020.2483, 
difference 4.0 mDa. 
FTIR: (KBr pressed disc) vm. /cm 1: 3443br s, 3364br s, 3115w, 3051w, 3019w, 2851w, 
1675br m, 1650m, 1588br s, 1526br s, 1486m, 1463m, 1450m, 1441m, 1409m, 1341s, 
1313m, 1262m, 1240m, 1204m, 1179m, 1138m, 1097m, 1071m, 1025m, 1003s, 994s, 970w, 
868w, 797s, 753m, 735m, 718m, 702s, 660w. 
UV-Vis: 7kß/nm (DMSO) 429 (c/dm3 mo1-1 cm' 525000), 561 (19400), 602 (10900). 
Free base 5-[4-((2-methoxy-4-[(2-methoxy-4-amino-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin, 16. 
O- 
NH2 
NH 
%H3 
16 
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Free base 5-[4-{(2-methoxy-4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin, 14 (0.050 g, 0.050 mmol), 
was dissolved in 200 cm3 ethanol. Saturated ammonium chloride solution (0.3 cm3), and 
indium powder (100 mesh, 0.050 g), were added and the solution stirred for 72 h under reflux 
until the reaction was complete by tlc (chloroform/acetonitrile v/v 5: 1). The reaction mixture 
was evaporated to dryness and the solid residue extracted with chloroform using Sohxlet 
apparatus. The solvent was removed in vacuo give a green/purple solid. This was taken up 
in the minimum amount of 5% sulfuric acid in trifluoroacetic acid and stirred at room 
temperature for 15 min. The solution was carefully neutralised with ice cold saturated sodium 
carbonate solution and the porphyrin was extracted with chloroform. The organic layer was 
separated, dried over sodium sulfate, concentrated in vauo and purified by passing through a 
short silica column (Si-60, chloroform, 10: 1 chloroform: acetonitrile v/v) to give 16 (0.015 g, 
0.015 mmol, 30 %). 
Rf (10: 1 chloroform: acetonitrile v/v): 0.42. 
1H NMR SH (700 MHz; solvent CDC13): 10.22 (1H, s, NH), 10.01 (1H, s, NH), 8.92 (2H, d, 
J= 6.0 Hz, ß-pyrrole), 8.83 (6H, m, ß-pyrrole), 8.39 (IH, s, phenyl), 8.36 (1H, d, J= 8.5 Hz, 
phenyl) 8.21 (8H, m, o-phenyl, o-aminophenyl), 8.10 (1H, d, J= 8.5 Hz, phenyl), 8.09 (2H, 
d, J=8.0 Hz, m-aminophenyl), 7.75 (9H, m, m-/ p-phenyl), 6.84 (1 H, dd, J=1.8,8.0 Hz, 
phenyl), 6.84 (1 H, dd, J=8.5,1.8 Hz, phenyl), 6.43 (1 H, d, J=8.5 Hz, phenyl), 6.27 (1 H, d, 
J= 1.8 Hz, phenyl), 4.24 (3H, s, OCHS), 4.12 (2H, s, NH2), 4.06 (3H, s, OCHS) ppm. 
13C{1H) NMR Sc (125 MHz; solvent CDC13): 164.0,163.5,158.9,158.2,149.4,144.5, 
142.1,138.3,136.4 134.9,134.3,127.7,127.4,126.4,125.9,122.1,119.7,118.4,116.8, 
112.2,108.0,103.1,97.1,56.3,56.1 ppm. 
ESI-MS: nVz = 928.4 (M + H+) 
HR ESI-MS: For C60H46N7O4 (M + H), observed mass 928.3592, calculated 928.3606, 
difference 1.4 mDa. 
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FTIR (KBr pressed disc) vm. /cm 1: 3446br s, 3356br s, 3040w, 3018w, 2960w, 2926w, 
2840w, 2685w, 2589w, 2520w, 1662br m, 1584br s, 1517br s, 1468m, 1441w, 1401m, 
1349w, 1311m, 1286m, 1243br s, 1209m, 1178m, 1163w, 1155w, 1131m, 1104w, 1072w, 
1027m, 1001w, 980w, 956s, 876w, 848w, 826w, 800s, 747m, 730m, 701s, 657w. 
UV-Vis: X,. /nm (DMSO) 421 (c/dm3 mol-1 cm 1 403000), 516 (21700), 552 (14200), 595 
(8500), 649 (11000). 
Zinc 5-[4-((2-methoxy-4-[(2-methoxy-4-amino-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin, 17. 
j)-N 
CH3 
NH2 
Oý 
CH3 
17 
Free base 5-[4-{(2-methoxy-4-[(2-methoxy-4-amino-phenylcarbonyl)-amino]- 
phenylcarbonyl)-amino} phenyl]-10,15,20-triphenyl porphyrin, 16 (0.24 g, 0.24 mmol) and 
zinc acetate dihydrate (0.4 g, 1.8 mmol) were dissolved in chloroform and methanol (25 cm3, 
5: 1, v/v) and heated at reflux for 1 h. The reaction mixture was cooled, diluted with 
chloroform (100 cm3) and washed with EDTA solution (2 g in 200 cm3 10 % sodium 
carbonate solution), water (3 x 100 cm3), dried (Na2SO4) and the solvent removed in vacuo. 
The residue was purified by column chromatography (Si-60,50: 1 chloroform: methanol v/v) 
to give 17 (0.20 g, 0.20 mmol, 83 %). 
Rf (50: 1 chloroform: methanol v/v): 0.19. 
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1H NMR 8H (500 MHz; solvent CDC13, d5-pyridine): 10.08 (1H, s, NH), 9.74 (111, s, NH), 
8.91 (8H, m, ß-pyrrole), 8.24 (1H, d, phenyl), 8.22 (6H, m, o-phenyl), 8.13 (1H, s, phenyl), 
8.09 (2H, d, J= 8.5 Hz, o-aminophenyl), 7.91 (2H, d, J= 8.5 Hz, m-aminophenyl), 7.75 (911, 
m, m-/ p-phenyl), 7.51 (1 H, d, J=8.5 Hz, phenyl), 6.85 (1 H, dd, J=8.5,1.8 Hz, phenyl), 
4.79 (1H, d, J=8.5 Hz, phenyl), 4.54 (1H, s, phenyl), 4.17 (3H, s, OCHS), 3.65 (311, s, 
OCHS) ppm. 
13C{1H} NMR Sc (125 MHz; solvent CDC13, d5-pyridine): 163.6,163.4,158.4,157.9, 
150.4,150.0,143.6,143.1,138.5,137.8,135.4,134.6,132.9,132.1,131.9,127.4,127.4, 
126.6,126.5,120.9,120.8,118.6,116.4,112.4,108.0,103.4,97.2,56.6,55.8 ppm. 
ESI-MS: m/z = 989 (M+, 100%), 988 (M - H+, 100%). 
HR ESI-MS: For C60H44N7O4Zn (M + IHl, observed mass 990.2675, calculated 990.2741, 
difference 6.6 mDa. 
FTIR: vmax /cm ' 1521 s (NH2), 1594s (NH), 1629m (CO). 
FTIR: (KBr pressed disc) vm/cm 1: 3430br m, 3361br m, 3051w, 3021w, 2922m, 2852m, 
1665m, 1585br s, 1519br s, 1466m, 1450m, 1441m, 1403m, 1339m, 1312m, 1285m, 1244br 
s, 1204m, 1178m, 1131m, 1069m, 1027m, 1002s, 994s, 797s, 753m, 717m, 702m, 661w, 
535w. 
UV-Vis: 4,, /nm (DMSO) 429 (c/dm3 mol-1 cm' 477000), 560 (12100), 603 (8140). 
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Free base meso-5-10,15; tris(4-pyridyl)-20-(4-acetamidophenyl)porphyrinf 182. 
18 
Pyridine-4-carboxaldehyde (16.07 g, 0.175 mol) and 4-acetamidobenzaldehyde (8.16 g, 0.05 
mol) were dissolved in propionic acid (600 cm3) and acetic anhydride (20 cm3) and heated to 
reflux under nitrogen. Pyrrole (13.42 g, 0.225 mol) in propionic acid (60 cm3) was added to 
the hot solution dropwise without heating. The final solution was heated at reflux for 1h in 
air. The solvent was removed in vacuo to give a purple sticky residue. This was poured into 
ice-water (1500 cm) and neutralised with aqueous ammonia solution to give a black solid. 
The solid was filtered, dried and extracted three times with chloroform. The solvent was 
removed in vacuo and the resulting dry solid was extracted with methanol using Soxhlet 
apparatus for 1 week. The remaining purple residue was passed through Florisil® (short 
plug, 10: 1 dichloromethane: methanol v/v). The solvent was removed and the crude product 
was purified by column chromatography (Si-60,60: 1 chloroform: methanol v/v) to give 18 as 
the major fraction (fifth) (1.41 g, 2.09 mmol, 4.2 %). 
'H NMR 6H (500 MHz; solvent CDC13): 9.05 (6H, m, m-pyridyl), 8.98 (2H, d, J= 8.9 Hz, ß- 
pyrrole), 8.94 (4H, s, ß-pyrrole), 8.81 (2H, d, J=8.8 Hz, ß-pyrrole), 8.15 (8H, m, o-pyridyl, 
o-aminophenyl), 7.94 (2H, d, m-aminophenyl), 7.74 (1H, s, NH), 2.38 (3H, s, OCHS), -2.89 
(2H, s, inner NH) ppm. 
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13C{'H} NMR Sc (125 MHz; solvent CDC13): 168.8,150.1,150.0,148.1,148.4,138.1, 
137.4,135.2,129.4,129.4,121.2,118.2,117.5,117.1,24.9 ppm. 
ESI-MS: m/z = 675 (M + H+, 25%), 338 (M + 2H+, 100%), 225 (M + 3H+, 30%). 
HR ESI-MS: For C43H30N80 (M +H), observed mass 675.2638, calculated 675.2615, 
difference 2.3 mDa. 
FTIR: (KBr pressed disc) vm. /cm 1 3432 br m, 3315m, 3096w, 3028m, 2970,2922m, 
2848w, 2708w, 2608w, 1671m, 1594s, 1559w, 1526m, 1508m, 1473m, 1402m, 1384m, 
1351m, 1313m, 1294w, 1255w, 1227w, 1181w, 1155w, 1112w, 1068m, 1022w, 997w, 
981w, 970s, 882m, 851m, 799s, 728s, 660m, 642w. 
UV-Vis: X.. /nm (CHC13) 419 (E/dm3 mol-1 cm l 99200), 515 (4880), 550 (2100) 592 
(1860), 648 (1430). 
Free base 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 192. 
NH2 
19 
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Free base meso-5,10,15-tris(4-pyridyl)-20-(4-acetamidophenyl)-porphyrin, 18 (0.10 g, 0.15 
mmol) was dissolved in trifluoroacetic acid (10 cm3) and concentrated hydrochloric acid (10 
cm3). The solution was heated and stirred at 80°C for 36 h. The pH of the resulting solution 
was adjusted to 9.0 with dilute cold aqueous ammonia solution. The solution was extracted 
with chloroform (3 x 50 cm3). The chloroform extracts were combined, washed with 10% 
sodium hydrogen carbonate solution and water and dried over magnesium sulfate. The 
solvent was removed in vacuo and the residue was purified by column chromatography (Si- 
60, chloroform: methanol, 80: 1 v/v) to give 19 (0.074 g, 0.12 mol, 79 %). 
'H NMR SH (300 MHz; solvent CDC13): 9.05 (8H, m, m-pyridyl, ß-pyrrole), 8.83 (611, m, ß- 
pyrrole), 8.16 (6H, m, o-pyridyl), 7.98 (2H, d, J=8.0 Hz, o-aminophenyl), 7.08 (2H, d, J= 
7.0 Hz, m-aminophenyl), 1.89 (2H, br s, NH2), -2.86 (2H, s, inner NH) ppm. 
13C{'H} NMR Sc(75 MHz; solvent CDC13): 150.3,150.2,148.4,146.6,135.9,131.7,131.2, 
129.5,122.7,118.8,116.74,113.65 ppm. 
ESI-MS: m/z = 633 (M + H+, 100%). 
HR ESI-MS: For C41H29N8 (M + Ham), observed mass 633.2507, calculated 633.2510, 
difference 0.3 mDa. 
FTIR: (KBr pressed disc) vm /cm 1 3439 br m, 3321m, 3200w, 3135w, 3026w, 2957w, 
2922w, 2852w, 2712w, 2611 w, 2535w, 1721w, 1613m, 1593s, 1561w, 1540w, 1511w, 
1473w, 1404w, 1384w, 1351w, 1292w, 1257w, 1215w, 1178w, 1157w, 1070w, 1058w, 
1027w, 982w, 970m, 882w, 837w, 802s, 784w, 732m, 660w, 642w. 
UV-Vis: X. /nm (CHC13) 420,516,552,592,649. 
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Free base 5,10,15-tris(4-pyridyl)-20-[4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] 
phenyl] porphyrin, 20. 
N02 
20 
Dicyclohexylcarbodiimide (1.4 g, 6.8 mmol) was added to a stirred solution of 2-methoxy-4- 
nitrobenzoic acid (1.2 g, 6.1 mmol) in acetonitrile (25 cm3) at 0 °C. After 15 minutes the 
reaction was brought to room temperature and stirred until the reaction was complete by tlc 
(10: 1 chloroform: acetonitrile v/v) (-24 h). The solution was filtered and the solid by-product 
was washed thoroughly with acetonitrile and the washings added to the filtrate. Removal of 
the solvent yielded a pale yellow solid, which was used without any further purification. The 
anhydride residues were taken up in acetonitrile (20 cm3) and added dropwise to an ice cold 
solution of free base 5,10,15-tris(4-pyridyl)-20-(4-aminophenyl)porphyrin, 19 (0.64 g, 1.01 
mmol) in chloroform with stirring. The reaction was heated at reflux for 48 h. The solvent 
was removed and the purple residue was extracted into 1M hydrochloric acid and washed 
with chloroform (3 x 100 cm). The green solution was neutralised with ammonia solution 
and the purple precipitate was extracted with chloroform. The organic fraction was dried 
over sodium sulfate and the solution was then concentrated in vacuo and purified by column 
chromatography (Si-60,10: 1 chloroform: methanol v/v) to give 20 (0.71 g, 0.88 mmol, 87 
%). 
1H NMR SH (500 MHz; solvent CDC13): 10.02 (1H, s, NH), 9.05 (6H, d, o-pyridyl), 8.97 
(2H, d, ß-pyrrole), 8.85 (6H, in, ß-pyrrole), 8.58 (1H, d, J= 8.6 Hz, phenyl), 8.23 (2H, d, J= 
8.5 Hz, o-aminophenyl), 8.17 (6H, d, J=8.7 Hz m-pyridyl), 8.11 (2H, d, J=8.5 Hz, m- 
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aminophenyl), 8.04 (1H, dd, J= 2.0,8.5 Hz, phenyl), 7.98 (1H, d, J=2.0 Hz, phenyl), 4.29 
(3H, s, OCHS), -2.88 (2H, br s, inner NH) ppm. 
13C{'H) NMR Sc (176 MHz; solvent CDC13): 161.6,157.4,150.8,150.2,150.1,148.3, 
138.0,137.9,135.3,134.0,129.4,127.3,121.1,119.1,117.5,117.1,116.6,107.1,57.3 ppm. 
ESI-MS: m1z = 812.3 (M + H+, 100%), 406.6 (M + 2H+, 15%). 
HR ESI-MS: For C49H34N904 (M + H+), observed mass 812.2708, calculated 812.2728, 
difference 2.1 mDa. 
FTIR (KBr pressed disc) vm /cm 1: 3429br m, 3314m, 3077w, 3023w, 2925w, 2854w, 
2756w, 2615w, 2536w, 2400w, 2349w, 1716w, 1662m, 1638s, 1589m, 1567w, 1522s, 
1480w, 1459m, 1401m, 1383w, 1346m, 1321m, 1279w, 1251m, 1210w, 1182s, 1158w, 
1123w, 1085m, 1018m, 999m, 981m, 968s, 897w, 885m, 856m, 801s, 729s, 664w, 639w. 
UV-Vis: . /nm (DMSO) 422 (c/dm3 mol"1 cm 7l 167000), 516 (8210), 552 (4140), 590 
(2710), 647 (1790). 
Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-mcthoxy-4-nitro- 
phenylcarbonyl)-amino] phenyl] porphyrin tris iodide, 21. 
CH3 
02 
21 
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Free base 5,10,15-tris(4-pyridyl)-20-[4-[(2-methoxy-4-nitro-phenylcarbonyl)-amino] phenyl] 
porphyrin, 20, (0.067g, 0.082 mmol) was dissolved in dimethylformide (5 cm3). Excess 
methyl iodide (0.1 cm3) was added and the solution was stirred at room temperature for 12 h. 
The solvent was removed in vacuo to give 21 which was dried in a vacuum oven at 70°C for 
48 h (0.11 g, 0.086 mmol, 96 %). 
'H NMR SH (500 MHz; solvent d6-DMSO): 10.92 (1H, s, NH), 9.49 (6H, d, m-pyridyl), 9.01 
(6H, m, o-pyridyl), 9.18 (4H, s, ß-pyrrole), 9.10 (4H, m, ß-pyrrole), 8.25 (411, m, 0, m- 
aminophenyl), 8.03 (2H, m, phenyl), 7.94 (1H, m, phenyl), 4.73 (9H, s, NCH3), 4.12 (311, s, 
OCH3), -2.88 (2H, br s, inner NH) ppm. 
13C{'H} NMR Sc (176 MHz; solvent CDC13): 164.5,157.4,157.1,157.0,150.0,144.7, 
139.7,136.2,135.4,132.6,130.6,127.6,123.2,118.7,116.2,115.8,115.0,107.5,57.3,48.5 
ppm. 
ESI-MS: m/z = 856.3 (M3+ + 2C, 25%), 427.7 (M3+ - H+, 15%). 
HR ESI-MS: For C52H41N904 (M3+ - H), observed mass 427.6627, calculated 427.6635, 
difference 0.8 n0a. 
FTIR (KBr pressed disc) vm /cm 1: 3430br m, 3314w, 3077w, 3023br m, 2925br m, 2854w, 
2756w, 2615w, 2536w, 2400w, 2349w, 1662m, 1638s, 1589m, 1567w, 1521s, 1479w, 
1459m, 1401m, 1383w, 1346m, 1322m, 1279w, 1251m, 1210w, 1182s, 1158w, 1123w, 
1083m, 1018m, 999m, 981m, 968s, 897w, 885m, 856m, 801s, 719s, 664m, 639m. 
UV-Vis: a,,,, /nm (pH 7.5 phosphate buffer) 431 (c/dm3 mor' cm 1 142000), 524 (12300), 
564 (7710), 592 (6350), 649 (2630). 
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Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-mcthoxy-4-amino- 
phenylcarbonyl)-amino] phenyl] porphyrin, 22. 
CH3 
H3C- 
22 
Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4-nitro- 
phenylcarbonyl)-amino] phenyl] porphyrin tris iodide, 21 (0.10 g, 0.082 mmol), was 
dissolved in 25 cm3 ethanol. Saturated ammonium chloride solution (0.1 cm3), and indium 
powder (100 mesh, 0.05 g), were added and the solution stirred for 72 h under reflux. The 
reaction mixture was diluted with water, adjusted to pH 3 with 0.1 M hydrochloric acid and 
filtered through celite. The solvent was removed in vacuo give a green/purple solid. The 
crude porphyrin was taken up in water and ammonium hexafluorophosphate added to 
precipitate the 22 as the hexafluorophosphate salt. This was filtered, washed with cold water 
and dried to give [22] [PF6]3 (0.070 g, 0.055 mmol, 64 %). 
To obtain the water soluble chloride salt, tetrabutyl ammonium chloride solution in 
acetonitrile was added dropwise to an acetonitrile solution of the [22][PF6]3 precipitate the 
[22] [Cl]3. This was further purified by passing an aqueous solution through Sephadcx G 10 
size exclusion gel and precipitation from aqueous solution by addition of acetone. 
1H NMR SH(500 MHz; solvent d6-DMSO): 10.21 (1H, s, NH), 9.53 (6H, d, m-pyridyl), 9.13 
(8H, m, ß-pyrrole), 9.00 (6H, m, o-pyridyl), 8.21 (2H, d, J=8.2 Hz, m-aminophenyl), 8.19 
(2H, d, J=8.2 Hz, o-aminophenyl), 7.74 (1 H, d, J=9.0 Hz, phenyl), 6.40 (111, d, J-1.9 
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Hz, phenyl), 6.33 (1H, dd, J=9.0,1.9 Hz, phenyl) 4.73 (9H, s, NC113), 4.01 (311, s, 
OCHS), -2.99 (2H, br s, inner NH) ppm. 
13C{IH} NMR 6c (176 MHz; solvent CDC13): 164.7,159.6,157.1,157.0,154.6,144.7, 
140.3,135.7,135.4,133.2,132.9,132.6,123.6,118.8,115.8,114.9,109.7,107.0,96.6,56.3, 
48.3 ppm. 
ESI-MS: m/z = 412.7 (M3+ - H+, 15%), 275.5 (M3+, 100%), 206.8 (M3+ + 1i+, 10%) 
HR ESI-MS: For C52H44N6O2 (M3), observed mass 275.4526, calculated 275.4534, 
difference 0.8 mDa. 
FTIR (ATR) vm. /cm I: 1636s, 1597s, 1588s, 1559m, 1509s, 1468s, 1460s, 1400m, 1359w, 
1349w, 1329w, 1312s, 1271s, 1245s, 1211m, 1182s, 1155m, 1136m, 1094m, 1054w, 1024s, 
1014s, 998m, 968s, 945w, 927w, 883m, 853s, 793s, 764s, 710s, 663s. 
FTIR (KBr pressed disc) vm,. /cm 1: 3426br s, 2961w, 2926w, 2855m, 1638 s, 1599s, 1590s, 
1511s, 1463s, 1400m, 1384s, 1311s, 1271s, 1244s, 1210m, 1182sm 1135m, 1094m, 1052w, 
1023s, 1014s, 999m, 981w, 968s, 885w, 821m, 797s, 763m, 729m, 710s. 672m. 
UV-Vis: (DMSO) 429 (c/dm3 mor, cm 7l 124000), 522 (9780), 564 (8750), 595 
(5840), 653 (3510). 
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Zinc 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4-amino- 
phenylcarbonyl)-amino] phenyl] porphyrin, 23. 
CH-t 
NH2 
23 
Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-[(2-methoxy-4-amino- 
phenylcarbonyl)-amino] phenyl] porphyrin, 22 (0.050 g, 0.054 mmol) and zinc acetate 
dihydrate (0.11 g, 0.50 mmol) were dissolved in ethanol (25 cm3) and heated at reflux for 2 
h. The reaction mixture was cooled and diluted with water (50 cm). Ammonium 
hexafluorophosphate was added to precipitate the 23 as the hexafluorophosphate salt, 
[23][PF6J3 (0.058 g, 0.044 mmol, 82%). This was filtered, washed with cold water and 
dried. To obtain the water soluble chloride salt, tetrabutyl ammonium chloride solution in 
acetonitrile was added dropwise to an acetonitrile solution of the [23][PF6]3 to precipitate the 
[23][C1]3. This was further purified by passing a methanol solution through Sephadex L1120 
size exclusion gel and precipitation from aqueous solution by addition of acetone to give 
[23][Cl]3 (0.040 g, 0.041 mmol, 76 %). 
'H NMR SH (600 MHz; solvent d6-DMSO): 10.18 (1H, s, NH), 9.41 (611, m, m-pyridyl), 
8.98 (8H, m, ß-pyrrole), 8.88 (6H, m, o-pyridyl), 8.17 (2H, d, J=6.0 Hz, m-aminophcnyl), 
8.10 (2H, d, J=6.0 Hz, o-aminophenyl), 7.76 (IH, d, J=7.5 Hz, phenyl), 6.39 (111, s, 
phenyl), 6.32 (1 H, d, J=7.5 Hz, phenyl) 5.95 (2H, br s, NH2), 4.70 (911, s, N+C113), 4.02 
(3H, s, OCH3) ppm. 
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13C{'H} NMR Sc (150 MHz; solvent d6-DMSO): 164.6,159.0,154.6,150.1,148.8,148.6, 
148.3,144.1,135.0,133.8,133.2,132.6,132.4,131.9,123.8,115.9,118.5,113.9,109.7, 
106.9,96.6,56.3,48.2 ppm. 
HR ESI-MS: For C52H42N9O2Zn (M3+), observed mass 296.0891, calculated 296.0912, 
difference 2.1 mDa. 
FTIR: (KBr pressed disc) vmax/cm 1: 3428 br m, 3110w, 3044w, 2963w, 2921m, 2851m, 
1636s, 1602s, 1559w, 1518s, 1508s, 1457m, 1400w, 1385m, 1359w, 1341w, 1311w, 1264m, 
1241m, 1202w, 1182m, 1129m, 1108w, 1093m, 1016m, 992s, 855w, 797s, 759m, 713m, 
673m. 
UV-Vis: ý, /nm (pH 7.5 phosphate buffer) 436 (e/dm3 mor, cm 1 107000), 565 (11200), 
615 (6890). 
Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-((2-methoxy-4-[(pyridine-4- 
carbonyl)-amino]-phenylcarbonyl)-amino} phenyl]-porphyrin, 24. 
CH. 3 
H3C- 
24 
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The isonicotinic acid anhydride (0.050 g, 0.18 mmol) was taken up in acetonitrile (50 cm3) 
and added dropwise to an ice cold solution of free base 5,10,15-tris(N-methyl-4- 
pyridiniumyl)-20-[4-[(2-methoxy-4-aminocarbonyl)-amino] phenyl] porphyrin tris 
pentafluorophosphate, [22][PF6]3 (0.068 g, 0.054 mmol) in acetonitrile with stirring. The 
reaction was heated at reflux for 48 h. Tetrabultylammonium chloride solution in acetonitrile 
was added dropwise to the cool solution until a precipitate of [24][Cl]3 formed. This was 
filtered, washed with acetonitrile and dried. The product was further purified by passing an 
aqueous solution through Sephadex G10 size exclusion gel and precipitating from aqueous 
solution by addition of acetone to give [24][Cl]3 (0.043 g, 0.041 mmol, 76 %). 
'H NMR SH (600 MHz; solvent d6-DMSO): 11.35 (IH, s, NH), 10.58 (1H, s, NH), 9.55 (611, 
m, m-pyridyl), 9.10 (8H, m, ß-pyrrole), 9.01 (81-1, m, o-pyridyl, m-pyridyl), 8.35 (211, d, J= 
5.3 Hz, o-pyridyl), 8.29 (2H, d, J=7.8 Hz, m-aminophenyl), 8.23 (2H, d, J=7.9 biz, o- 
aminophenyl), 7.95 (1 H, s, phenyl), 7.87 (1 H, d, J=8.6 Hz, phenyl), 7.72 (111, d, J=8.6, 
phenyl) 4.75 (9H, s, NCH3), 4.06 (3H, s, OCHS), -2.95 (2H, br s, inner NH) ppm. 
13C{1H} NMR 5c (150 MHz; solvent CD3CN): 164.0,163.4,159.4,158.3,149.6,148.3, 
144.0,143.4,138.7,138.4,135.2,132.8,132.7,132.3,131.6,123.8,121.3,118.7,118.3, 
114.9,114.0,112.2,103.4,56.3,48.4 ppm. 
ESI-MS: m/z = 465.2 (M3+ - H+, 10%), 310.5 (M3+, 100%). 
HR ESI-MS: For C58H47N1003 (M3', observed mass 310.4596, calculated 310.4605, 
difference 0.9 mDa. 
FTIR: (KBr pressed disc) vm/cm 1: 3421s, 3109w, 3018w, 2958w, 2917w, 2837w, 1636br 
s, 1559w, 1539w, 1521m, 1506m, 1521m, 1507m, 1475w, 1457w, 1437w, 1401s, 1384s, 
1323w, 1260w, 1232w, 1213w, 1182w, 1145w, 1090m, 1072m, 1026s, 964w, 882w, 856w, 
794m, 763m, 698m, 668s, 659w, 617w. 
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UV-Vis: )qn,, /nm (pH 7.5 phosphate buffer) 434 (c/dm3 mol-1 cm 1 117000), 524 (11600), 
566 (11800), 598 (8120), 620 (6520). 
Zinc 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-((2-methoxy-4-[(pyridine-4- 
carbonyl)-amino]-phenylcarbonyl)-amino) phenyl]-porphyrin, 25. 
CH3 
N+ 
CH3 
25 
Free base 5,10,15-tris(N-methyl-4-pyridiniumyl)-20-[4-{(2-methoxy-4"[(pyridine-4- 
carbonyl)-amino]-phenylcarbonyl)-amino} phenyl]-porphyrin, 24 (0.043 g, 0.041 mmol) and 
zinc acetate dihydrate (0.075 g, 0.41 mmol) were dissolved in methanol (25 cm3) and heated 
at reflux for 2 h. The reaction mixture was cooled and diluted with water (50 cm3). 
Ammonium hexafluorophosphate was added to precipitate the 25 as the hexafluorophosphate 
salt. This was filtered, washed with cold water and dried. To obtain the water soluble 
chloride salt, tetrabutyl ammonium chloride solution in acetonitrile was added dropwise to an 
acetonitrile solution of the [25][PF6]3 giving a precipitate of [25][Cl]3. This was further 
purified by passing a methanol solution through Sephadex LH2O size exclusion gel and 
precipitation from aqueous solution by addition of acetone to give [25][Cl]3 (0.030 g, 0.028 
mmol, 67 %). 
'H NMR SH (600 MHz; solvent d6-DMSO): 11.18 (IH, s, NH), 10.98 (IH, s, NH), 9.47 (611, 
m, m-pyridyl), 9.00 (8H, m, ß-pyrrole), 8.92 (6H, m, o-pyridyl), 8.81 (211, d, J=6.01lz, m- 
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pyridyl), 8.23 (2H, d, J=8.2 Hz, m-aminophenyl), 8.14 (2H, d, J=8.2 Hz, o-aminophenyl), 
7.99 (2H, d, J=6.0 Hz, o-pyridyl), 7.91 (1H, s, phenyl), 7.82 (1H, d, J=8.2 Hz, phenyl), 
7.69 (1H, d, J=8.2, phenyl) 4.75 (9H, s, NCH3), 4.05 (3H, s, OCH3) ppm. 
13C{'H} NMR Sc (150 MHz; solvent d6-DMSO): 164.8,164.7,159.0,157.6,150.9,150.8, 
148.6,148.3,144.1,142.0,137.5,135.0,133.8,132.8,131.8,131.2,126.6,123.7,122.2, 
118.5,115.9,115.0,112.8,104.4,55.6,48.1 ppm. 
ESI-MS: iWz = 496 (M2+9100%), 331 (M3+, 80%). 
HR ESI-MS: For C58H45N1O3Zn (M3), observed mass 331.0971, calculated 331.0984, 
difference 1.2 mDa. 
FTIR (KBr pressed disc) vm /cm 1: 3443br w, 3116w, 3043w, 2963w, 2920w, 2849w, 
1637s, 1594m, 1526m, 1514w, 1461m, 1453m, 1402m, 1384s, 1342w, 1314m, 1288w, 
1262w, 1247w, 1185m, 1129w, 1092m, 1019w, 994s, 853w, 797s, 750w, 715w, 673w, 
616w. 
UV-Vis: ý,, n,, /nm (DMSO) 442 (c/dm3 mors cm 
1 111000), 569 (12500), 614 (7520). 
Enzyme assay of XO 
50 mM Potassium phosphate buffer, pH 7.5. 
Potassium phosphate, monobasic, anhydrous (1.36 g, 10 mmol) was dissolved in deioniscd 
water (190 cm3). A solution of EDTA (0.1 M, 0.2 cm) was added and the pH of the solution 
was adjusted to 7.5 at 25 °C with 1M potassium hydroxide solution. The volume of the 
solution increased to 200 cm3 with deionised water. 
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0.15 mM Solution of Xanthine 
Experimental 
Xanthine (2.3 mg, 0.0 15 mmol) was dissolved in the minimum volume of aqueous potassium 
hydroxide (1 M). The solution was diluted to 90 cm3 with deionised water and the pH was 
adjusted to 7.5 with dilute hydrochloric acid. The solution was made up to 100 cm3 with 
deionised water. 
Solution of Xanthine Oxidase 
17 pl of a stock solution of xanthine oxidase (bovine milk, grade III, 22 mg mV-', 1.30 U ml- 
1) was diluted to 5 cm3 with 50 mM potassium phosphate buffer and stored over ice. 
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APPENDIX 1 
X-ray Crystallography Data for 6 
Table 1. Crystal data and structure refinement for 6. 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(000) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 28.30° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
C15H14N204 
286.28 
110(2) K 
0.71073 A 
Monoclinic 
P2(1)/n 
a =13.6031(9) A 
b=8.0726(5) A 
c= 13.6339(9) A 
1321.17(15) A3 
4 
1.439 Mg/m3 
0.106 mm-1 
600 
0.37 x 0.32 x 0.22 mm3 
a= 90°. 
b= 118.0610(10)°. 
g=90°. 
1.74 to 28.30°. 
-18<=h<=18, -10<=k<=10, -18<=1<=18 
13200 
3270 [R(int) = 0.0194] 
99.7 % 
Semi-empirical from equivalents 
0.980 and 0.906 
Full-matrix least-squares on F2 
3270 /0/ 196 
1.033 
R1 = 0.0364, wR2 = 0.0979 
R1 = 0.0403, wR2 = 0.1011 
0.377 and -0.186 e. Ä-3 
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Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(A2x 103) for 6. U(eq) is defined as one third of the trace of the orthogonalized Uil tensor. 
xyz U(eq) 
C(1) 6631(1) 5650(1) 9285(1) 16(1) 
C(2) 7553(1) 4646(1) 9308(1) 15(1) 
C(3) 8545(1) 4194(1) 10262(1) 14(1) 
C(4) 9367(1) 3290(1) 10158(1) 16(1) 
C(5) 9207(1) 2819(1) 9108(1) 15(1) 
C(6) 8217(1) 3230(1) 8158(1) 17(1) 
C(7) 7420(1) 4141(1) 8271(1) 17(1) 
C(8) 11022(1) 1408(1) 9716(1) 16(1) 
C(9) 11745(1) 626(1) 9280(1) 16(1) 
C(10) 12541(1) -502(1) 9972(1) 19(1) 
C(11) 13221(1) -1256(1) 9600(1) 24(1) 
C(12) 12423(1) 180(2) 7970(1) 22(1) 
C(13) 11692(1) 990(1) 8259(1) 19(1) 
C(14) 5753(1) 6860(2) 10225(1) 22(1) 
C(15) 9652(1) 4173(2) 12242(1) 23(1) 
N(1) 10010(1) 1967(1) 8933(1) 16(1) 
N(2) 13176(1) -943(1) 8616(1) 24(1) 
0(1) 6638(1) 5833(1) 10259(1) 20(1) 
0(2) 5898(1) 6252(1) 8440(1) 27(1) 
0(3) 8667(1) 4674(1) 11268(1) 19(1) 
0(4) 11354(1) 1500(1) 10715(1) 25(1) 
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Table 3. Bond lengths [A] and angles [°] for 6. 
C(l)-O(2) 1.2153(13) 
C(1)-O(1) 1.3315(12) 
C(1)-C(2) 1.4817(14) 
C(2)-C(7) 1.3991(14) 
C(2)-C(3) 1.4120(13) 
C(3)-O(3) 1.3583(12) 
C(3)-C(4) 1.3974(14) 
C(4)-C(5) 1.3951(14) 
C(4)-H(4) 0.9500 
C(5)-C(6) 1.4004(14) 
C(5)-N(1) 1.4042(13) 
C(6)-C(7) 1.3765(14) 
C(6)-H(6) 0.9500 
C(7)-H(7) 0.9500 
C(8)-O(4) 1.2194(13) 
C(8)-N(1) 1.3627(13) 
C(8)-C(9) 1.5064(14) 
C(9)-C(10) 1.3896(15) 
C(9)-C(13) 1.3913(14) 
C(10)-C(11) 1.3875(15) 
C(10)-H(10) 0.9500 
C(11)-N(2) 1.3373(16) 
C(11)-H(11) 0.9500 
C(12)-N(2) 1.3413 (16) 
C(12)-C(13) 1.3931(15) 
C(12)-H(12) 0.9500 
C(13)-H(13) 0.9500 
C(14)-O(1) 1.4450(12) 
C(14)-H(14A) 0.9800 
C(14)-H(14B) 0.9800 
C(14)-H(14C) 0.9800 
C(15)-O(3) 1.4311(12) 
C(15)-H(15A) 0.9800 
C(15)-H(15B) 0.9800 
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C(15)-H(15C) 0.9800 
N(1)-H(1) 0.868(15) 
O(2)-C(1)-O(1) 121.30(9) 
O(2)-C(1)-C(2) 123.21(9) 
O(1)-C(1)-C(2) 115.48(9) 
C(7)-C(2)-C(3) 117.94(9) 
C(7)-C(2)-C(1) 115.62(9) 
C(3)-C(2)-C(1) 126.42(9) 
O(3)-C(3)-C(4) 121.89(9) 
O(3)-C(3)-C(2) 117.78(9) 
C(4)-C(3)-C(2) 120.33(9) 
C(5)-C(4)-C(3) 120.00(9) 
C(5)-C(4)-H(4) 120.0 
C(3)-C(4)-H(4) 120.0 
C(4)-C(5)-C(6) 120.18(9) 
C(4)-C(5)-N(1) 123.36(9) 
C(6)-C(5)-N(1) 116.44(9) 
C(7)-C(6)-C(5) 119.20(9) 
C(7)-C(6)-H(6) 120.4 
C(5)-C(6)-H(6) 120.4 
C(6)-C(7)-C(2) 122.32(9) 
C(6)-C(7)-H(7) 118.8 
C(2)-C(7)-H(7) 118.8 
O(4)-C(8)-N(1) 124.21(9) 
O(4)-C(8)-C(9) 119.97(9) 
N(1)-C(8)-C(9) 115.82(9) 
C(10)-C(9)-C(13) 118.36(9) 
C(10)-C(9)-C(8) 116.83(9) 
C(13)-C(9)-C(8) 124.78(9) 
C(11)-C(10)-C(9) 118.64(10) 
C(11)-C(10)-H(10) 120.7 
C(9)-C(10)-H(10) 120.7 
N(2)-C(11)-C(10) 124.10(11) 
N(2)-C(11)-H(11) 117.9 
C(10)-C(11)-H(11) 118.0 
X-ray Crystallography Data for 6 
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N(2)-C(12)-C(13) 123.88(10) 
N(2)-C(12)-H(12) 118.1 
C(13)-C(12)-H(12) 118.1 
C(9)-C(13)-C(12) 118.44(10) 
C(9)-C(13)-H(13) 120.8 
C(12)-C(13)-H(13) 120.8 
O(1)-C(14)-H(14A) 109.5 
O(1)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
O(1)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
O(3)-C(15)-H(15A) 109.5 
O(3)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 
O(3)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15B)-C(15)-H(15C) 109.5 
C(8)-N(1)-C(5) 127.50(9) 
C(8)-N(1)-H(1) 118.5(10) 
C(5)-N(1)-H(1) 113.8(10) 
C(11)-N(2)-C(12) 116.54(10) 
C(1)-O(1)-C(14) 114.62(8) 
C(3)-O(3)-C(15) 118.19(8) 
X-ray Crystallography Data for 6 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A2x 103) for 6. The anisotropic 
displacement factor exponent takes the form: -2p2[ h2 a*2U11 +... +2hk a* b* U12 ] 
Ull U22 U33 U23 U13 U12 
C(1) 14(1) 17(1) 16(1) 0(1) 8(1) -1(1) 
C(2) 14(1) 17(1) 15(1) 1(1) 7(1) 0(1) 
C(3) 15(1) 17(1) 12(1) 0(1) 7(1) -1(1) 
C(4) 13(1) 19(1) 13(1) 1(1) 5(1) 0(1) 
C(5) 14(1) 17(1) 16(1) 0(1) 7(1) 0(1) 
C(6) 17(1) 22(1) 12(1) -1(1) 6(1) 1(1) 
C(7) 14(1) 22(1) 13(1) 2(1) 5(1) 1(1) 
C(8) 15(1) 17(1) 16(1) -1(1) 8(1) 0(1) 
C(9) 14(1) 17(1) 17(1) -3(1) 8(1) -3(1) 
C(10) 19(1) 19(1) 22(1) 2(1) 12(1) 0(1) 
C(11) 23(1) 20(1) 33(1) 4(1) 17(1) 4(1) 
C(12) 20(1) 30(1) 20(1) -5(1) 12(1) -3(1) 
C(13) 15(1) 25(1) 16(1) -2(1) 7(1) -1(1) 
C(14) 20(1) 25(1) 22(1) -2(1) 11(1) 7(1) 
C(15) 18(1) 36(1) 12(1) 1(1) 6(1) 5(1) 
N(1) 14(1) 22(1) 11(1) -2(1) 6(1) 1(1) 
N(2) 23(1) 25(1) 30(l) -4(1) 17(1) -1(1) 
0(1) 19(1) 25(1) 16(1) 1(1) 9(1) 8(1) 
0(2) 21(1) 42(1) 18(1) 9(1) 10(1) 13(1) 
0(3) 16(1) 28(1) 12(1) -1(1) 6(1) 4(1) 
0(4) 22(1) 37(1) 14(1) 0(1) 6(1) 10(1) 
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Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2x 10 
3) 
for 6. 
xyz U(eq) 
H(4) 10035 2996 10802 19 
H(6) 8096 2886 7444 21 
H(7) 6757 4436 7622 20 
H(10) 12618 -752 10686 23 
H(11) 13750 -2044 10072 28 
H(12) 12386 439 7273 26 
H(13) 11170 1773 7770 23 
H(14A) 5847 7997 10031 33 
H(14B) 5778 6852 10956 33 
H(14C) 5033 6427 9666 33 
H(15A) 9683 2961 12286 34 
H(15B) 9638 4623 12902 34 
H(15C) 10309 4592 12204 34 
11(1) 9794(12) 1722(18) 8241(13) 25(4) 
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Table 6. Torsion angles [°] for 6. 
O(2)-C(1)-C(2)-C(7) -12.45(15) 
O(l)-C(1)-C(2)-C(7) 166.31(9) 
O(2)-C(1)-C(2)-C(3) 166.15(11) 
O(1)-C(1)-C(2)-C(3) -15.09(15) 
C(7)-C(2)-C(3)-O(3) -179.40(9) 
C(1)-C(2)-C(3)-O(3) 2.03(15) 
C(7)-C(2)-C(3)-C(4) 0.94(15) 
C(1)-C(2)-C(3)-C(4) -177.63(10) 
O(3)-C(3)-C(4)-C(5) 179.86(9) 
C(2)-C(3)-C(4)-C(5) -0.48(15) 
C(3)-C(4)-C(5)-C(6) -0.87(16) 
C(3)-C(4)-C(5)-N(1) 177.43(9) 
C(4)-C(5)-C(6)-C(7) 1.73(16) 
N(1)-C(5)-C(6)-C(7) -176.68(9) 
C(5)-C(6)-C(7)-C(2) -1.28(16) 
C(3)-C(2)-C(7)-C(6) -0.05(16) 
C(1)-C(2)-C(7)-C(6) 178.67(10) 
O(4)-C(8)-C(9)-C(10) 24.21(15) 
N(1)-C(8)-C(9)-C(10) -155.31(10) 
O(4)-C(8)-C(9)-C(13) -153.76(11) 
N(1)-C(8)-C(9)-C(13) 26.72(15) 
C(13)-C(9)-C(10)-C(11) -2.17(15) 
C(8)-C(9)-C(10)-C(11) 179.72(10) 
C(9)-C(10)-C(11)-N(2) 1.39(18) 
C(10)-C(9)-C(13)-C(12) 1.36(15) 
C(8)-C(9)-C(13)-C(12) 179.31(10) 
N(2)-C(12)-C(13)-C(9) 0.36(17) 
O(4)-C(8)-N(1)-C(5) 4.27(17) 
C(9)-C(8)-N(1)-C(5) -176.23(9) 
C(4)-C(5)-N(1)-C(8) 2.93(17) 
C(6)-C(5)-N(1)-C(8) -178.71(10) 
C(10)-C(11)-N(2)-C(12) 0.30(17) 
C(13)-C(12)-N(2)-C(11) -1.20(17) 
O(2)-C(1)-O(1)-C(14) -3.14(15) 
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C(2)-C(1)-O(1)-C(14) 178.07(9) 
C(4)-C(3)-O(3)-C(15) -2.42(15) 
C(2)-C(3)-O(3)-C(15) 177.92(9) 
Symmetry transformations used to generate equivalent atoms: 
Table 7. Hydrogen bonds for 6 [A and °]. 
D-H... A d(D-H) d(H... A) d(D... A) <(DHA) 
N(1)-H(1)... 0(2)#1 0.868(15) 2.062(15) 2.9257(12) 173.4(14) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+3/2, y-1/2, -z+3/2 
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Table 1. Crystal data and structure refinement for [8][PF6-]2. 
Empirical formula C44.66 H37 F12 N10.33 04 P2 Ru 
Formula weight 1173.40 
Temperature 110(2) K 
Wavelength 0.71073 A 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a= 11.9956(10) Aa= 69.116(2)°. 
b= 14.3953(12) Ab= 78.306(2)°. 
c= 14.9670(12) Ag= 80.187(2)°. 
Volume 2350.9(3) A3 
Z 2 
Density (calculated) 1.658 Mg/m3 
Absorption coefficient 0.506 mm-1 
F(000) 1183 
Crystal size 0.23 x 0.15 x 0.15 mm3 
Theta range for data collection 1.52 to 28.31 °. 
Index ranges -13<=h<=15, -19<=k<=14, -19<=1<=16 
Reflections collected 16853 
Independent reflections 11445 [R(int) = 0.0217] 
Completeness to theta = 28.31 ° 98.3 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.927 and 0.787 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11445 / 15 / 759 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0498, wR2 = 0.1164 
R indices (all data) R1 = 0.0626, wR2 = 0.1232 
Largest diff. peak and hole 1.453 and -1.003 e. A-3 
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Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(A2x 103)for [8] [PF6-]2. U(eq) is defined as one third of the trace of the orthogonalized Uij 
tensor. 
xyz U(eq) 
C(1) 4951(3) 8228(2) 5075(2) 26(1) 
C(2) 3914(3) 8809(2) 5229(2) 27(1) 
C(3) 3780(3) 9309(2) 5877(2) 27(1) 
C(4) 4689(2) 9244(2) 6372(2) 22(1) 
C(5) 5694(2) 8644(2) 6182(2) 21(1) 
C(6) 6632(2) 8532(2) 6674(2) 20(1) 
C(7) 8440(3) 7740(2) 6956(2) 27(1) 
C(8) 8474(3) 8256(2) 7582(2) 27(1) 
C(9) 7565(3) 8917(2) 7760(2) 24(1) 
C(10) 6594(2) 9070(2) 7304(2) 21(1) 
C(11) 5552(2) 9707(2) 7471(2) 21(1) 
C(12) 4637(2) 9766(2) 7033(2) 23(1) 
C(13) 4613(3) 10654(2) 8560(2) 22(1) 
C(14) 4826(3) 11181(2) 9209(2) 24(1) 
C(15) 5877(3) 11173(2) 9497(2) 26(1) 
C(16) 5938(3) 11714(2) 10092(2) 32(1) 
C(17) 4936(4) 12237(2) 10396(2) 35(1) 
C(18) 3895(3) 12257(2) 10139(2) 35(1) 
C(19) 3853(3) 11718(2) 9552(2) 29(1) 
C(20) 7901(3) 10675(3) 9392(3) 38(1) 
C(21) 8791(3) 8852(2) 4311(3) 35(1) 
C(22) 9332(3) 9477(3) 3441(3) 49(1) 
C(23) 9178(3) 9402(3) 2588(3) 50(1) 
C(24) 8514(3) 8705(3) 2599(3) 39(1) 
C(25) 8002(3) 8091(2) 3486(2) 26(1) 
C(26) 7331(2) 7288(2) 3583(2) 24(1) 
C(27) 7062(3) 7106(3) 2805(2) 35(1) 
C(28) 6474(3) 6301(3) 2962(3) 40(1) 
C(29) 6180(3) 5680(3) 3907(3) 33(1) 
C(30) 6461(3) 5897(2) 4653(2) 25(1) 
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C(31) 
C(32) 
C(33) 
C(34) 
C(35) 
C(36) 
C(37) 
C(38) 
C(39) 
C(40) 
N(1) 
N(2) 
N(3) 
N(4) 
N(5) 
N(6) 
N(7) 
N(8) 
0(1) 
0(2) 
0(3) 
0(4) 
Ru(1) 
C(41) 
C(42) 
N(9) 
C(43A) 
C(44A) 
N(1 OA) 
C(43B) 
C(44B) 
N(l OB) 
C(43 C) 
C(44C) 
N(IOC) 
F(1) 
5500(3) 
5092(3) 
5862(4) 
7010(4) 
7375(3) 
8575(3) 
9485(3) 
10581(4) 
10748(3) 
9820(3) 
5824(2) 
7546(2) 
5549(2) 
4993(4) 
8131(2) 
7008(2) 
6615(2) 
8745(2) 
3636(2) 
6795(2) 
4108(3) 
5914(4) 
7324(1) 
1914(5) 
1378(5) 
2322(7) 
8973(11) 
9170(20) 
8794(10) 
7679(13) 
8485(15) 
7074(14) 
8450(15) 
7804(19) 
8943(15) 
6791(3) 
5999(3) 
5200(3) 
4417(3) 
4436(3) 
5252(2) 
5335(2) 
4644(3) 
4791(3) 
5610(3) 
6271(2) 
8128(2) 
7869(2) 
10219(2) 
12790(2) 
8172(2) 
6696(2) 
6033(2) 
6154(2) 
10632(2) 
10607(2) 
13239(2) 
12742(3) 
7176(1) 
4725(4) 
4602(4) 
4790(6) 
839(9) 
1662(15) 
338(7) 
3201(14) 
2470(30) 
3713(19) 
2248(13) 
2880(20) 
1742(15) 
3683(2) 
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7088(2) 
7860(3) 
8259(3) 
7900(2) 
7124(2) 
6653(2) 
6991(3) 
6502(3) 
5677(3) 
5368(3) 
5544(2) 
6506(2) 
8112(2) 
11048(2) 
4336(2) 
4507(2) 
6721(2) 
5851(2) 
8457(2) 
9195(2) 
11322(2) 
11306(3) 
5565(1) 
-268(5) 
696(4) 
-1072(6) 
4686(8) 
3759(12) 
5473(8) 
2904(12) 
2550(20) 
3260(20) 
3268(15) 
2489(15) 
3868(14) 
6131(2) 
30(1) 
39(1) 
43(1) 
37(1) 
26(1) 
26(1) 
40(1) 
49(1) 
43(1) 
31(1) 
22(1) 
23(1) 
22(1) 
49(1) 
26(1) 
22(1) 
24(1) 
24(1) 
29(1) 
26(1) 
61(1) 
77(1) 
19(1) 
76(2) 
70(2) 
149(3) 
45(3) 
97(9) 
49(3) 
63(5) 
152(18) 
164(12) 
290(30) 
227(15) 
310(20) 
71(1) 
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F(2) 
F(3) 
F(4) 
F(5) 
F(6) 
P(1) 
F(7A) 
F(8A) 
F(9A) 
F(1 OA) 
F(7B) 
F(8B) 
F(9B) 
F(1 OB) 
F(11) 
F(12) 
P(2) 
7647(5) 
5977(3) 
7625(2) 
6782(2) 
8410(3) 
7203(1) 
10952(17) 
9083(14) 
9077(14) 
10980(11) 
11189(9) 
9376(17) 
8743(11) 
10505(19) 
9864(3) 
10122(2) 
9992(1) 
2551(3) 
2253(2) 
1342(2) 
2471(2) 
2782(2) 
2522(1) 
1586(14) 
1619(10) 
2779(8) 
2703(12) 
1958(13) 
1649(8) 
2742(11) 
3107(15) 
3108(2) 
1383(2) 
2265(1) 
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5428(2) 
6476(2) 
6884(2) 
7576(2) 
6559(3) 
6502(1) 
10577(15) 
10669(10) 
9264(11) 
9083(11) 
10262(12) 
10957(11) 
9635(14) 
8987(9) 
10403(2) 
9490(2) 
9931(1) 
164(3) 
93(1) 
74(1) 
48(1) 
88(1) 
40(1) 
96(6) 
78(3) 
75(4) 
84(4) 
71(4) 
80(5) 
78(4) 
122(6) 
72(1) 
71(1) 
36(1) 
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Table 3. Bond lengths [A] and angles [°] for [8][PF6-]2. 
C(1)-N(1) 1.335(4) C(17)-N(4) 1.480(4) 
C(1)-C(2) 1.403(4) C(18)-C(19) 1.376(4) 
C(1)-H(1) 0.9500 C(18)-H(18) 0.9500 
C(2)-C(3) 1.371(4) C(19)-H(19) 0.9500 
C(2)-H(2) 0.9500 C(20)-O(2) 1.442(4) 
C(3)-C(4) 1.412(4) C(20)-H(20A) 0.9800 
C(3)-H(3) 0.9500 C(20)-H(20B) 0.9800 
C(4)-C(5) 1.400(4) C(20)-H(20C) 0.9800 
C(4)-C(12) 1.427(4) C(21)-N(5) 1.346(4) 
C(5)-N(1) 1.376(4) C(21)-C(22) 1.395(5) 
C(5)-C(6) 1.422(4) C(21)-H(21) 0.9500 
C(6)-N(2) 1.372(4) C(22)-C(23) 1.371(7) 
C(6)-C(10) 1.407(4) C(22)-H(22) 0.9500 
C(7)-N(2) 1.332(4) C(23)-C(24) 1.377(6) 
C(7)-C(8) 1.397(4) C(23)-H(23) 0.9500 
C(7)-H(7) 0.9500 C(24)-C(25) 1.392(4) 
C(8)-C(9) 1.369(4) C(24)-H(24) 0.9500 
C(8)-H(8) 0.9500 C(25)-N(5) 1.360(4) 
C(9)-C(10) 1.413(4) C(25)-C(26) 1.467(4) 
C(9)-H(9) 0.9500 C(26)-N(6) 1.358(4) 
C(10)-C(11) 1.454(4) C(26)-C(27) 1.389(5) 
C(11)-C(12) 1.364(4) C(27)-C(28) 1.382(5) 
C(l1)-N(3) 1.402(4) C(27)-H(27) 0.9500 
C(12)-H(12) 0.9500 C(28)-C(29) 1.388(5) 
C(13)-O(1) 1.219(4) C(28)-H(28) 0.9500 
C(13)-N(3) 1.363(4) C(29)-C(30) 1.376(4) 
C(13)-C(14) 1.509(4) C(29)-H(29) 0.9500 
C(14)-C(19) 1.398(4) C(30)-N(6) 1.351(4) 
C(14)-C(15) 1.410(5) C(30)-H(30) 0.9500 
C(15)-O(2) 1.355(4) C(31)-N(7) 1.342(4) 
C(15)-C(16) 1.395(4) C(31)-C(32) 1.383(5) 
C(16)-C(17) 1.390(5) C(31)-H(31) 0.9500 
C(16)-H(16) 0.9500 C(32)-C(33) 1.367(6) 
C(17)-C(18) 1.372(6) C(32)-H(32) 0.9500 
240 
Appendix 2 
C(33)-C(34) 
C(33)-H(33) 
C(34)-C(35) 
C(34)-H(34) 
C(35)-N(7) 
C(35)-C(36) 
C(36)-N(8) 
C(36)-C(37) 
C(37)-C(38) 
C(37)-H(37) 
C(38)-C(39) 
C(38)-H(38) 
C(39)-C(40) 
C(39)-H(39) 
C(40)-N(8) 
C(40)-H(40) 
N(1)-Ru(1) 
N(2)-Ru(1) 
N(3)-H(3A) 
N(4)-O(3) 
N(4)-O(4) 
N(5)-Ru(1) 
N(6)-Ru(1) 
N(7)-Ru(1) 
N(8)-Ru(1) 
C(41)-N(9) 
C(41)-C(42) 
C(42)-H(42A) 
C(42)-H(42B) 
C(42)-H(42C) 
C(43A)-N(1 OA) 
X-ray Crystallography Data for 8 
1.375(6) C(43A)-C(44A) 
0.9500 C(44A)-H(44A) 
1.384(4) C(44A)-H(44B) 
0.9500 C(44A)-H(44C) 
1.360(4) C(43B)-N(1 OB) 
1.473(4) C(43B)-C(44B) 
1.360(4) C(44B)-H(44D) 
1.389(5) C(44B)-H(44E) 
1.380(6) C(44B)-H(44F) 
0.9500 C(43C)-N(1 OC) 
1.377(6) C(43C)-C(44C) 
0.9500 C(44C)-H(44G) 
1.376(5) C(44C)-H(44H) 
0.9500 C(44C)-H(441) 
1.350(4) F(1)-P(1) 
0.9500 F(2)-P(1) 
2.066(2) F(3)-P(1) 
2.071(2) F(4)-P(1) 
0.80(4) F(5)-P(1) 
1.221(5) F(6)-P(1) 
1.225(5) F(7A)-P(2) 
2.062(3) F(8A)-P(2) 
2.059(2) F(9A)-P(2) 
2.066(3) F(1 OA)-P(2) 
2.061(3) F(7B)-P(2) 
1.180(9) F(8B)-P(2) 
1.416(8) F(9B)-P(2) 
0.9800 F(1 OB)-P(2) 
0.9800 F(11)-P(2) 
0.9800 F(12)-P(2) 
1.1399(19) 
1.4754(19) 
0.9800 
0.9800 
0.9800 
1.1374(19) 
1.4711(19) 
0.9800 
0.9800 
0.9800 
1.1362(17) 
1.4701(17) 
0.9800 
0.9800 
0.9800 
1.586(3) 
1.575(3) 
1.595(3) 
1.612(3) 
1.564(2) 
1.581(3) 
1.616(13) 
1.549(14) 
1.545(10) 
1.578(10) 
1.556(11) 
1.575(11) 
1.616(11) 
1.589(11) 
1.580(3) 
1.601(3) 
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C(25)-C(24)-H(24) 120.5 C(37)-C(36)-C(35) 123.8(3) 
N(5)-C(25)-C(24) 121.6(3) C(38)-C(37)-C(36) 119.5(3) 
N(5)-C(25)-C(26) 115.0(3) C(38)-C(37)-H(37) 120.3 
C(24)-C(25)-C(26) 123.4(3) C(36)-C(37)-H(37) 120.3 
N(6)-C(26)-C(27) 121.1(3) C(39)-C(38)-C(37) 119.2(3) 
N(6)-C(26)-C(25) 114.9(3) C(39)-C(38)-H(38) 120.4 
C(27)-C(26)-C(25) 124.0(3) C(37)-C(38)-H(38) 120.4 
C(28)-C(27)-C(26) 120.1(3) C(40)-C(39)-C(38) 119.2(3) 
C(28)-C(27)-H(27) 120.0 C(40)-C(39)-H(39) 120.4 
C(26)-C(27)-H(27) 120.0 C(38)-C(39)-H(39) 120.4 
C(27)-C(28)-C(29) 118.5(3) N(8)-C(40)-C(39) 122.4(3) 
C(27)-C(28)-H(28) 120.7 N(8)-C(40)-H(40) 118.8 
C(29)-C(28)-H(28) 120.7 C(39)-C(40)-H(40) 118.8 
C(30)-C(29)-C(28) 119.1(3) C(1)-N(1)-C(5) 117.7(2) 
C(30)-C(29)-H(29) 120.5 C(1)-N(1)-Ru(1) 128.9(2) 
C(28)-C(29)-H(29) 120.5 C(5)-N(1)-Ru(1) 113.06(19) 
N(6)-C(30)-C(29) 122.8(3) C(7)-N(2)-C(6) 117.9(3) 
N(6)-C(30)-H(30) 118.6 C(7)-N(2)-Ru(1) 128.4(2) 
C(29)-C(30)-H(30) 118.6 C(6)-N(2)-Ru(1) 113.66(19) 
N(7)-C(31)-C(32) 122.5(3) C(13)-N(3)-C(11) 126.6(3) 
N(7)-C(31)-H(31) 118.7 C(13)-N(3)-H(3A) 111(3) 
C(32)-C(31)-H(31) 118.7 C(11)-N(3)-H(3A) 122(3) 
C(33)-C(32)-C(3 1) 118.3(3) O(3)-N(4)-O(4) 124.1(3) 
C(33)-C(32)-H(32) 120.8 O(3)-N(4)-C(17) 117.8(4) 
C(31)-C(32)-H(32) 120.8 O(4)-N(4)-C(17) 118.1(4) 
C(32)-C(33)-C(34) 120.2(3) C(21)-N(5)-C(25) 118.6(3) 
C(32)-C(33)-H(33) 119.9 C(21)-N(5)-Ru(1) 126.0(2) 
C(34)-C(33)-H(33) 119.9 C(25)-N(5)-Ru(1) 115.3(2) 
C(33)-C(34)-C(35) 119.2(4) C(30)-N(6)-C(26) 118.4(3) 
C(33)-C(34)-H(34) 120.4 C(30)-N(6)-Ru(1) 126.1(2) 
C(35)-C(34)-H(34) 120.4 C(26)-N(6)-Ru(1) 115.3(2) 
N(7)-C(35)-C(34) 121.0(3) C(31)-N(7)-C(35) 118.7(3) 
N(7)-C(35)-C(36) 115.1(3) C(31)-N(7)-Ru(1) 126.1(2) 
4)-C(35)-C(36) 123.9(3) C(35)-N(7)-Ru(1) 115.2(2) 
N(8)-C(36)-C(37) 121.2(3) C(40)-N(8)-C(36) 118.5(3) 
N(8)-C(36)-C(35) 115.0(3) C(40)-N(8)-Ru(1) 126.0(2) 
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C(36)-N(8)-Ru(1) 115.2(2) F(5)-P(1)-F(1) 90.79(14) 
C(15)-O(2)-C(20) 118.3(3) F(2)-P(1)-F(1) 90.4(2) 
N(6)-Ru(1)-N(8) 93.59(10) F(6)-P(1)-F(1) 88.87(17) 
N(6)-Ru(1)-N(5) 78.80(10) F(5)-P(1)-F(3) 88.51(18) 
N(8)-Ru(1)-N(5) 95.92(10) F(2)-P(1)-F(3) 92.0(3) 
N(6)-Ru(1)-N(7) 95.84(10) F(6)-P(1)-F(3) 178.4(2) 
N(8)-Ru(1)-N(7) 79.04(10) F(1)-P(1)-F(3) 91.38(18) 
N(5)-Ru(1)-N(7) 172.48(10) F(5)-P(1)-F(4) 88.95(15) 
N(6)-Ru(1)-N(1) 93.75(9) F(2)-P(1)-F(4) 89.9(2) 
N(8)-Ru(1)-N(1) 169.81(10) F(6)-P(1)-F(4) 90.89(18) 
N(5)-Ru(1)-N(1) 92.43(10) F(1)-P(1)-F(4) 179.65(19) 
N(7)-Ru(1)-N(1) 93.19(10) F(3)-P(1)-F(4) 88.85(17) 
N(6)-Ru(1)-N(2) 171.42(10) F(9A)-P(2)-F(8A) 89.1(7) 
N(8)-Ru(1)-N(2) 93.56(10) F(9A)-P(2)-F(7B) 159.1(7) 
N(5)-Ru(1)-N(2) 95.75(10) F(8A)-P(2)-F(7B) 111.4(7) 
N(7)-Ru(1)-N(2) 90.17(10) F(9A)-P(2)-F(8B) 108.6(7) 
N(1)-Ru(1)-N(2) 79.77(10) F(8A)-P(2)-F(8B) 23.1(7) 
N(9)-C(41)-C(42) 176.2(7) F(7B)-P(2)-F(8B) 92.2(7) 
C(41)-C(42)-H(42A) 109.5 F(9A)-P(2)-F(1OA) 91.2(6) 
C(41)-C(42)-H(42B) 109.5 F(8A)-P(2)-F(1OA) 166.1(7) 
H(42A)-C(42)-H(42B) 109.5 F(7B)-P(2)-F(1OA) 67.9(7) 
C(41)-C(42)-H(42C) 109.5 F(8B)-P(2)-F(1OA) 160.1(7) 
H(42A)-C(42)-H(42C) 109.5 F(9A)-P(2)-F(11) 96.0(6) 
H(42B)-C(42)-H(42C) 109.5 F(8A)-P(2)-F(11) 97.8(5) 
N(l0A)-C(43A)-C(44A) 167.6(11) F(7B)-P(2)-F(11) 85.4(6) 
N(1OB)-C(43B)-C(44B) 174(2) F(8B)-P(2)-F(11) 83.6(6) 
C(43B)-C(44B)-H(44D) 109.5 F(l0A)-P(2)-F(11) 96.1(4) 
C(43B)-C(44B)-H(44E) 109.5 F(9A)-P(2)-F(1OB) 69.3(7) 
H(44D)-C(44B)-H(44E) 109.5 F(8A)-P(2)-F(1OB) 158.3(8) 
C(43B)-C(44B)-H(44F) 109.5 F(7B)-P(2)-F(1OB) 90.3(7) 
H(44D)-C(44B)-H(44F) 109.5 F(8B)-P(2)-F(1OB) 166.2(12) 
H(44E)-C(44B)-H(44F) 109.5 F(1 OA)-P(2)-F(1 OB) 26.9(6) 
N(1OC)-C(43C)-C(44C) 179(2) F(11)-P(2)-F(1OB) 83.1(8) 
F(5)-P(1)-F(2) 178.7(3) F(9A)-P(2)-F(12) 85.4(6) 
F(5)-P(1)-F(6) 89.92(18) F(8A)-P(2)-F(12) 80.9(5) 
F(2)-P(1)-F(6) 89.6(3) F(7B)-P(2)-F(12) 93.7(6) 
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F(8B)-P(2)-F(12) 94.7(6) F(12)-P(2)-F(7A) 86.1(5) 
F(1OA)-P(2)-F(12) 85.3(4) F(9A)-P(2)-F(9B) 22.0(7) 
F(11)-P(2)-F(12) 177.99(18) F(8A)-P(2)-F(9B) 71.5(8) 
F(1OB)-P(2)-F(12) 98.7(8) F(7B)-P(2)-F(9B) 170.8(7) 
F(9A)-P(2)-F(7A) 171.4(9) F(8B)-P(2)-F(9B) 88.4(7) 
F(8A)-P(2)-F(7A) 88.6(9) F(1OA)-P(2)-F(9B) 111.5(6) 
F(7B)-P(2)-F(7A) 23.1(8) F(11)-P(2)-F(9B) 85.5(4) 
F(8B)-P(2)-F(7A) 71.1(7) F(1OB)-P(2)-F(9B) 87.0(6) 
F(1OA)-P(2)-F(7A) 89.0(7) F(12)-P(2)-F(9B) 95.4(4) 
F(11)-P(2)-F(7A) 92.5(5) F(7A)-P(2)-F(9B) 159.5(7) 
F(1OB)-P(2)-F(7A) 113.0(7) 
Table 4. Anisotropic displacement parameters (A2x 103) for [8][PF672. The anisotropic 
displacement factor exponent takes the form: -202[ h2 a*2U11 +... +2hk a* b* U12 ] 
Ull U22 U33 U23 U13 U12 
C(1) 24(2) 28(2) 31(2) -16(1) -1(1) -6(1) 
C(2) 22(2) 31(2) 34(2) -16(1) -5(1) -3(1) 
C(3) 22(1) 27(2) 33(2) -14(1) -2(1) 0(1) 
C(4) 20(1) 21(1) 25(1) -10(1) 2(1) -4(1) 
C(5) 22(1) 19(1) 22(1) -9(1) 3(1) -5(1) 
C(6) 20(1) 16(1) 24(1) -8(1) 0(1) -2(1) 
C(7) 23(2) 25(2) 37(2) -16(1) -3(1) 1(1) 
C(8) 23(2) 29(2) 33(2) -15(1) -6(1) -1(1) 
C(9) 29(2) 22(1) 23(1) -11(1) -1(1) -4(1) 
C(10) 22(1) 19(1) 21(1) -9(1) 1(1) -3(1) 
C(11) 25(1) 18(1) 22(1) -10(1) 3(1) -3(1) 
C(12) 22(1) 21(1) 26(1) -13(1) 2(1) 2(1) 
C(13) 31(2) 15(1) 16(1) -4(1) -2(1) 2(1) 
C(14) 38(2) 15(1) 15(1) -4(1) -1(1) 0(1) 
C(15) 41(2) 16(1) 16(1) -3(1) -1(1) -2(1) 
C(16) 55(2) 22(2) 21(1) -5(1) -7(1) -9(1) 
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C(17) 69(3) 16(1) 18(1) -7(1) -1(2) -7(2) 
C(18) 59(2) 19(1) 18(1) -6(1) 2(1) 4(1) 
C(19) 44(2) 19(1) 18(1) -5(1) -1(1) 5(1) 
C(20) 39(2) 46(2) 37(2) -19(2) -7(2) -10(2) 
C(21) 27(2) 25(2) 52(2) -17(2) 11(2) -7(1) 
C(22) 38(2) 27(2) 71(3) -14(2) 18(2) -14(2) 
C(23) 36(2) 34(2) 54(2) 7(2) 12(2) -2(2) 
C(24) 29(2) 35(2) 36(2) 3(2) 2(1) 1(1) 
C(25) 20(1) 18(1) 32(2) -3(1) -1(1) 4(1) 
C(26) 21(1) 21(1) 24(1) -5(1) -2(1) 4(1) 
C(27) 38(2) 34(2) 25(2) -2(1) -13(1) 5(2) 
C(28) 45(2) 46(2) 34(2) -15(2) -18(2) -2(2) 
C(29) 33(2) 31(2) 41(2) -17(2) -10(1) -2(1) 
C(30) 25(2) 22(1) 28(2) -11(1) -1(1) -1(1) 
C(31) 33(2) 32(2) 28(2) -15(1) 6(1) -13(1) 
C(32) 47(2) 41(2) 32(2) -19(2) 16(2) -23(2) 
C(33) 66(3) 32(2) 28(2) -5(2) 4(2) -22(2) 
C(34) 57(2) 26(2) 27(2) -7(1) 1(2) -13(2) 
C(35) 37(2) 21(1) 22(1) -11(1) -1(1) -6(1) 
C(36) 34(2) 18(1) 29(2) -12(1) -2(1) -3(1) 
C(37) 46(2) 22(2) 45(2) -6(2) -9(2) 4(2) 
C(38) 39(2) 31(2) 66(3) -8(2) -9(2) 11(2) 
C(39) 27(2) 29(2) 64(3) -13(2) 3(2) 5(1) 
C(40) 28(2) 23(2) 39(2) -11(1) 3(1) -1(1) 
N(1) 21(1) 21(1) 26(1) -12(1) 2(1) -4(1) 
N(2) 21(1) 19(1) 29(1) -12(1) -1(1) -2(1) 
N(3) 24(1) 21(1) 24(1) -12(1) -2(1) -2(1) 
N(4) 88(3) 29(2) 33(2) -18(1) -3(2) -12(2) 
N(5) 20(1) 16(1) 37(2) -8(1) 4(1) 1(1) 
N(6) 21(1) 18(1) 25(1) -9(1) 1(1) 1(1) 
N(7) 30(1) 25(1) 22(1) -14(1) 3(1) -8(1) 
N(8) 26(1) 17(1) 29(1) -11(1) 0(1) -1(1) 
0(1) 29(1) 34(1) 26(1) -15(1) -4(1) 7(1) 
0(2) 30(1) 25(1) 27(1) -13(1) -5(1) -2(1) 
0(3) 95(3) 45(2) 50(2) -36(2) 9(2) -7(2) 
0(4) 100(3) 78(3) 84(3) -64(2) -24(2) 1(2) 
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Ru(1) 19(1) 16(1) 24(1) -10(1) 2(1) -3(1) 
C(41) 52(3) 65(3) 105(5) -31(3) 14(3) -17(3) 
C(42) 96(4) 45(3) 82(4) -27(3) -44(3) 10(3) 
N(9) 140(6) 142(6) 179(7) -99(6) 83(6) -83(5) 
C(43A) 33(7) 47(7) 77(10) -43(7) -11(7) -8(5) 
C(44A) 51(10) 101(13) 136(15) -74(12) 63(11) -19(9) 
N(1OA) 57(7) 39(6) 64(7) -27(5) -24(6) 2(5) 
C(43B) 36(8) 110(15) 57(9) -46(10) 8(7) -20(9) 
C(44B) 24(9) 330(50) 160(30) -170(30) -12(13) 29(16) 
N(1OB) 73(12) 230(30) 290(30) -220(30) -23(16) -10(14) 
C(43C) 120(20) 190(20) 580(60) -270(30) 240(30) -139(19) 
C(44C) 150(20) 270(30) 160(20) -20(20) 53(16) 31(19) 
N(1OC) 103(14) 450(40) 570(40) -490(40) 209(19) -175(19) 
F(1) 119(3) 33(1) 55(2) 10(1) -3g(2) -19(1) 
F(2) 364(7) 110(3) 41(2) -46(2) 66(3) -158(4) 
F(3) 122(3) 67(2) 97(2) 16(2) -78(2) -47(2) 
F(4) 72(2) 36(1) 107(2) -36(2) 38(2) -18(1) 
F(5) 82(2) 32(1) 26(1) -8(1) 0(1) -13(1) 
F(6) 57(2) 63(2) 143(3) -39(2) 18(2) -32(2) 
P(1) 65(1) 33(1) 26(1) -12(1) 3(1) -23(1) 
F(7A) 133(12) 85(9) 115(11) -70(8) -102(9) 52(7) 
F(8A) 134(8) 66(5) 38(5) -14(4) 6(5) -50(5) 
F(9A) 87(9) 43(4) 85(7) 14(4) -65(6) 6(4) 
F(1OA) 70(6) 99(8) 95(8) -51(7) 32(5) -51(5) 
F(7B) 32(4) 100(10) 103(9) -61(8) -32(4) 20(4) 
F(8B) 133(11) 37(4) 43(6) -5(4) 34(6) -16(5) 
F(9B) 47(5) 75(6) 146(11) -72(8) -46(6) 15(4) 
F(1OB) 129(12) 131(11) 57(5) 35(6) 4(7) -49(9) 
F(11) 79(2) 54(2) 101(2) -42(2) -37(2) 9(1) 
F(12) 60(2) 97(2) 84(2) -61(2) -28(2) 8(2) 
P(2) 32(1) 44(1) 32(1) -9(1) -10(1) -5(1) 
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Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2x 10 3) 
for [8][PF612. 
xyz U(eq) 
11(1) 5037 7891 4619 31 
H(2) 3309 8856 4886 33 
H(3) 3077 9699 5991 32 
H(7) 9078 7281 6847 33 
H(8) 9130 8148 7885 33 
H(9) 7587 9269 8184 29 
H(12) 3951 10164 7171 28 
H(16) 6642 11725 10284 38 
H(18) 3230 12627 10358 41 
H(19) 3139 11711 9374 35 
H(20A) 8070 11373 9119 57 
H(20B) 8489 10264 9096 57 
H(20C) 7897 10435 10093 57 
H(21) 8892 8907 4903 42 
H(22) 9800 9947 3441 58 
H(23) 9528 9831 1989 60 
H(24) 8408 8644 2012 47 
H(27) 7282 7535 2164 42 
H(28) 6276 6176 2435 48 
H(29) 5791 5113 4036 40 
H(30) 6261 5466 5297 30 
H(31) 4969 6546 6807 36 
H(32) 4298 5196 8106 47 
H(33) 5602 3857 8787 51 
H(34) 7547 3895 8179 45 
H(37) 9353 4075 7553 48 
H(38) 11214 4333 6732 59 
H(39) 11496 5718 5326 52 
H(40) 9940 6830 4794 37 
H(3A) 6120(30) 10320(30) 8230(20) 21(9) 
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H(42A) 783 4150 877 105 
H(42B) 1030 5253 744 105 
H(42C) 1950 4318 1132 105 
H(44A) 9397 1387 3228 145 
H(44B) 9788 2025 3773 145 
H(44C) 8471 2121 3660 145 
H(44D) 8229 2405 1996 228 
H(44E) 8513 1820 3068 228 
H(44F) 9249 2699 2351 228 
H(44G) 8003 3570 2273 341 
H(44H) 6981 2875 2729 341 
H(441) 7997 2629 1944 341 
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Table 6. Torsion angles["] for [8] [PF6-]2. 
N(1)-C(1)-C(2)-C(3) 0.7(5) 
C(1)-C(2)-C(3)-C(4) 0.7(5) 
C(2)-C(3)-C(4)-C(5) -1.1(4) 
C(2)-C(3)-C(4)-C(12) 177.8(3) 
C(3)-C(4)-C(5)-N(1) 0.0(4) 
C(12)-C(4)-C(5)-N(1) -178.9(3) 
C(3)-C(4)-C(5)-C(6) -178.8(3) 
C(12)-C(4)-C(5)-C(6) 2.3(4) 
N(1)-C(5)-C(6)-N(2) -4.0(4) 
C(4)-C(5)-C(6)-N(2) 174.9(3) 
N(1)-C(5)-C(6)-C(10) 176.9(3) 
C(4)-C(5)-C(6)-C(10) -4.2(4) 
N(2)-C(7)-C(8)-C(9) 0.5(5) 
C(7)-C(8)-C(9)-C(10) 0.1(5) 
N(2)-C(6)-C(10)-C(9) 1.2(4) 
C(5)-C(6)-C(10)-C(9) -179.8(3) 
N(2)-C(6)-C(10)-C(11) -176.3(3) 
C(5)-C(6)-C(10)-C(11) 2.7(4) 
C(8)-C(9)-C(10)-C(6) -0.9(4) 
C(8)-C(9)-C(10)-C(11) 176.5(3) 
C(6)-C(10)-C(11)-C(12) 0.7(4) 
C(9)-C(10)-C(11)-C(12) -176.6(3) 
C(6)-C(10)-C(11)-N(3) 179.3(3) 
C(9)-C(10)-C(11)-N(3) 2.0(4) 
N(3)-C(11)-C(12)-C(4) 178.9(3) 
C(10)-C(11)-C(12)-C(4) -2.6(4) 
C(5)-C(4)-C(12)-C(11) 1.1(4) 
C(3)-C(4)-C(12)-C(11) -177.7(3) 
0(1)-C(13)-C(14)-C(19) -7.7(4) 
N(3)-C(13)-C(14)-C(19) 172.4(3) 
0(1)-C(13)-C(14)-C(15) 171.8(3) 
N(3)-C(13)-C(14)-C(15) -8.2(4) 
C(19)-C(14)-C(15)-0(2) 176.7(3) 
C(13)-C(14)-C(15)-0(2) -2.7(4) 
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C(19)-C(14)-C(15)-C(16) -1.5(4) 
C(13)-C(14)-C(15)-C(16) 179.0(3) 
O(2)-C(15)-C(16)-C(17) -177.2(3) 
C(14)-C(15)-C(16)-C(17) 1.0(4) 
C(15)-C(16)-C(17)-C(18) -0.4(5) 
C(15)-C(16)-C(17)-N(4) 178.5(3) 
C(16)-C(17)-C(18)-C(19) 0.5(5) 
N(4)-C(17)-C(18)-C(19) -178.4(3) 
C(17)-C(18)-C(19)-C(14) -1.1(5) 
C(15)-C(14)-C(19)-C(18) 1.6(4) 
C(13)-C(14)-C(19)-C(18) -178.9(3) 
N(5)-C(21)-C(22)-C(23) 0.6(6) 
C(21)-C(22)-C(23)-C(24) -1.2(6) 
C(22)-C(23)-C(24)-C(25) 0.5(6) 
C(23)-C(24)-C(25)-N(5) 0.8(5) 
C(23)-C(24)-C(25)-C(26) -176.5(3) 
N(5)-C(25)-C(26)-N(6) -4.6(4) 
C(24)-C(25)-C(26)-N(6) 172.8(3) 
N(5)-C(25)-C(26)-C(27) 177.3(3) 
C(24)-C(25)-C(26)-C(27) -5.2(5) 
N(6)-C(26)-C(27)-C(28) -1.2(5) 
C(25)-C(26)-C(27)-C(28) 176.8(3) 
C(26)-C(27)-C(28)-C(29) -1.0(5) 
C(27)-C(28)-C(29)-C(30) 1.4(5) 
C(28)-C(29)-C(30)-N(6) 0.4(5) 
N(7)-C(31)-C(32)-C(33) -0.1(5) 
C(31)-C(32)-C(33)-C(34) 0.5(5) 
C(32)-C(33)-C(34)-C(35) -0.6(5) 
C(33)-C(34)-C(35)-N(7) 0.3(5) 
C(33)-C(34)-C(35)-C(36) -177.3(3) 
N(7)-C(35)-C(36)-N(8) -3.3(4) 
C(34)-C(35)-C(36)-N(8) 174.4(3) 
N(7)-C(35)-C(36)-C(37) 176.2(3) 
C(34)-C(35)-C(36)-C(37) -6.1(5) 
N(8)-C(36)-C(37)-C(38) 0.0(5) 
C(35)-C(36)-C(37)-C(38) -179.5(3) 
250 
Appendix 2 X-ray Crystallography Data for 8 
C(36)-C(37)-C(38)-C(39) -1.4(6) 
C(37)-C(38)-C(39)-C(40) 1.0(7) 
C(38)-C(39)-C(40)-N(8) 0.8(6) 
C(2)-C(1)-N(1)-C(5) -1.7(4) 
C(2)-C(1)-N(1)-Ru(1) 171.0(2) 
C(4)-C(5)-N(1)-C(1) 1.3(4) 
C(6)-C(5)-N(1)-C(1) -179.8(3) 
C(4)-C(5)-N(1)-Ru(1) -172.5(2) 
C(6)-C(5)-N(1)-Ru(1) 6.3(3) 
C(8)-C(7)-N(2)-C(6) -0.2(5) 
C(8)-C(7)-N(2)-Ru(1) -179.5(2) 
C(10)-C(6)-N(2)-C(7) -0.7(4) 
C(5)-C(6)-N(2)-C(7) -179.8(3) 
C(10)-C(6)-N(2)-Ru(1) 178.7(2) 
C(5)-C(6)-N(2)-Ru(1) -0.3(3) 
O(1)-C(13)-N(3)-C(11) 1.0(5) 
C(14)-C(13)-N(3)-C(11) -179.0(3) 
C(12)-C(11)-N(3)-C(13) 15.7(5) 
C(10)-C(11)-N(3)-C(13) -162.9(3) 
C(18)-C(17)-N(4)-O(3) -0.2(5) 
C(16)-C(17)-N(4)-O(3) -179.2(3) 
C(18)-C(17)-N(4)-O(4) 177.3(4) 
C(16)-C(17)-N(4)-O(4) -1.7(5) 
C(22)-C(21)-N(5)-C(25) 0.7(5) 
C(22)-C(21)-N(5)-Ru(1) 178.1(3) 
C(24)-C(25)-N(5)-C(21) -1.4(4) 
C(26)-C(25)-N(5)-C(21) 176.1(3) 
C(24)-C(25)-N(5)-Ru(1) -179.0(2) 
C(26)-C(25)-N(5)-Ru(1) -1.5(3) 
C(29)-C(30)-N(6)-C(26) -2.5(4) 
C(29)-C(30)-N(6)-Ru(1) 173.3(2) 
C(27)-C(26)-N(6)-C(30) 2.9(4) 
C(25)-C(26)-N(6)-C(30) -175.3(2) 
C(27)-C(26)-N(6)-Ru(1) -173.4(2) 
C(25)-C(26)-N(6)-Ru(1) 8.5(3) 
C(32)-C(31)-N(7)-C(35) -0.2(4) 
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C(32)-C(31)-N(7)-Ru(1) 179.4(2) 
C(34)-C(35)-N(7)-C(31) 0.1(4) 
C(36)-C(35)-N(7)-C(3 1) 177.8(3) 
C(34)-C(35)-N(7)-Ru(1) -179.6(2) 
C(36)-C(35)-N(7)-Ru(1) -1.8(3) 
C(39)-C(40)-N(8)-C(36) -2.2(5) 
C(39)-C(40)-N(8)-Ru(1) 171.6(3) 
C(37)-C(36)-N(8)-C(40) 1.7(5) 
C(35)-C(36)-N(8)-C(40) -178.7(3) 
C(37)-C(36)-N(8)-Ru(1) -172.7(3) 
C(35)-C(36)-N(8)-Ru(1) 6.9(3) 
C(16)-C(15)-O(2)-C(20) -8.5(4) 
C(14)-C(15)-O(2)-C(20) 173.3(3) 
C(30)-N(6)-Ru(1)-N(8) 81.6(2) 
C(26)-N(6)-Ru(1)-N(8) -102.5(2) 
C(30)-N(6)-Ru(1)-N(5) 176.9(3) 
C(26)-N(6)-Ru(1)-N(5) -7.2(2) 
C(30)-N(6)-Ru(1)-N(7) 2.3(2) 
C(26)-N(6)-Ru(1)-N(7) 178.2(2) 
C(30)-N(6)-Ru(1)-N(1) -91.3(2) 
C(26)-N(6)-Ru(1)-N(1) 84.6(2) 
C(40)-N(8)-Ru(1)-N(6) 84.8(3) 
C(36)-N(8)-Ru(1)-N(6) -101.3(2) 
C(40)-N(8)-Ru(1)-N(5) 5.7(3) 
C(36)-N(8)-Ru(1)-N(5) 179.6(2) 
C(40)-N(8)-Ru(1)-N(7) -180.0(3) 
C(36)-N(8)-Ru(1)-N(7) -6.0(2) 
C(40)-N(8)-Ru(1)-N(1) -139.2(5) 
C(36)-N(8)-Ru(1)-N(1) 34.7(7) 
C(40)-N(8)-Ru(1)-N(2) -90.5(3) 
C(36)-N(8)-Ru(1)-N(2) 83.5(2) 
C(21)-N(5)-Ru(1)-N(6) -172.9(3) 
C(25)-N(5)-Ru(1)-N(6) 4.6(2) 
C(21)-N(5)-Ru(1)-N(8) -80.4(3) 
C(25)-N(5)-Ru(1)-N(8) 97.1(2) 
C(21)-N(5)-Ru(1)-N(1) 93.8(3) 
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C(25)-N(5)-Ru(1)-N(1) -88.8(2) 
C(21)-N(5)-Ru(1)-N(2) 13.8(3) 
C(25)-N(5)-Ru(1)-N(2) -168.7(2) 
C(31)-N(7)-Ru(1)-N(6) -82.9(2) 
C(35)-N(7)-Ru(1)-N(6) 96.7(2) 
C(31)-N(7)-Ru(1)-N(8) -175.5(3) 
C(35)-N(7)-Ru(1)-N(8) 4.1(2) 
C(31)-N(7)-Ru(1)-N(1) 11.2(3) 
C(35)-N(7)-Ru(1)-N(1) -169.2(2) 
C(31)-N(7)-Ru(1)-N(2) 91.0(2) 
C(35)-N(7)-Ru(1)-N(2) -89.5(2) 
C(1)-N(1)-Ru(1)-N(6) 7.8(3) 
C(5)-N(1)-Ru(1)-N(6) -179.2(2) 
C(1)-N(1)-Ru(1)-N(8) -128.2(5) 
C(5)-N(1)-Ru(1)-N(8) 44.8(6) 
C(1)-N(1)-Ru(1)-N(5) 86.7(3) 
C(5)-N(1)-Ru(1)-N(5) -100.3(2) 
C(1)-N(1)-Ru(1)-N(7) -88.3(3) 
C(5)-N(1)-Ru(1)-N(7) 84.7(2) 
C(1)-N(1)-Ru(1)-N(2) -177.9(3) 
C(5)-N(1)-Ru(1)-N(2) -4.88(19) 
C(7)-N(2)-Ru(1)-N(8) 9.9(3) 
C(6)-N(2)-Ru(1)-N(8) -169.4(2) 
C(7)-N(2)-Ru(1)-N(5) -86.4(3) 
C(6)-N(2)-Ru(1)-N(5) 94.3(2) 
C(7)-N(2)-Ru(1)-N(7) 89.0(3) 
C(6)-N(2)-Ru(1)-N(7) -90.4(2) 
C(7)-N(2)-Ru(1)-N(1) -177.8(3) 
C(6)-N(2)-Ru(1)-N(1) 2.8(2) 
Symmetry transformations used to generate equivalent atoms: 
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Table 7. Hydrogen bonds for [8] [PF6-]2 [A and'] 
X-ray Crystallography Data for 8 
D-H... A d(D-H) d(H... A) d(D... A) <(DHA) 
N(3)-H(3A)... O(2) 
N(3)-H(3A)... F(4)#1 
0.80(4) 
0.80(4) 
1.97(4) 
2.60(4) 
2.662(3) 
3.097(4) 
144(3) 
121(3) 
Symmetry transformations used to generate equivalent atoms: 
#1 x, y+1, z 
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